<SEC-DOCUMENT>0001093557-25-000129.txt : 20250509
<SEC-HEADER>0001093557-25-000129.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250509161004
ACCESSION NUMBER:		0001093557-25-000129
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250508
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		25930497

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dxcm-20250508.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:1e684ce9-be39-49f9-b3e2-659eabc59be1,g:2d5e0c7d-e698-4991-ba3f-2e2e0964c401,d:9645be55f0b241c88a2cd63aa28bccb4-->
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dxcm-20250508</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001093557</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dxcm-20250508.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-08</xbrli:startDate><xbrli:endDate>2025-05-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9645be55f0b241c88a2cd63aa28bccb4_1"></div><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 8, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><img src="dxcm-20250508_g1.jpg" alt="dexcom-logo-green-rgb.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:250px" id="i-1"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">DEXCOM, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact Name of the Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.989%"><tr><td style="width:1.0%"/><td style="width:31.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.872%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-51222</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">33-0857544</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.402%"><tr><td style="width:1.0%"/><td style="width:42.399%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.901%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6340 Sequence Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zip Code)</span></div></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">200-0200</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:499.50pt"><tr><td style="width:1.0pt"/><td style="width:10.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:485.50pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:499.50pt"><tr><td style="width:1.0pt"/><td style="width:10.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:485.50pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:499.50pt"><tr><td style="width:1.0pt"/><td style="width:10.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:485.50pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:499.50pt"><tr><td style="width:1.0pt"/><td style="width:10.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:485.50pt"/><td style="width:1.0pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.711%"><tr><td style="width:1.0%"/><td style="width:32.984%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.903%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.875%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.903%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.835%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">DXCM</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.711%"><tr><td style="width:1.0%"/><td style="width:51.002%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.815%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.355%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric> </span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#9744;</span></div></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:0.5pt solid #000;border-top:0.5pt solid #000;padding:0 1pt"/></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i9645be55f0b241c88a2cd63aa28bccb4_154"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.02.&#160;&#160;&#160;&#160;DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As indicated below, on May 8, 2025, the stockholders of DexCom, Inc. (the &#8220;Company&#8221; or &#8220;Dexcom&#8221;) approved: (i) the Company&#8217;s Amended and Restated 2015 Equity Incentive Plan (the &#8220;A&amp;R 2015 EIP&#8221;) (as amended and restated) to, among other things, increase the number of shares reserved for issuance thereunder by 3,400,000 shares; and (ii) the Company&#8217;s Amended and Restated 2015 Employee Stock Purchase Plan (the &#8220;A&amp;R 2015 ESPP&#8221;) to, among other things, increase the number of shares reserved for issuance thereunder by 8,000,000 shares.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s board of directors (the &#8220;Board&#8221;) previously approved the A&amp;R 2015 EIP and the A&amp;R 2015 ESPP subject to stockholder approval. A detailed summary of the A&amp;R 2015 EIP and the A&amp;R 2015 ESPP is set forth in the Company&#8217;s proxy statement for its 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) filed with the Securities and Exchange Commission on March 27, 2025. A copy of the A&amp;R 2015 EIP and the A&amp;R 2015 ESPP are filed herewith as Exhibits 10.1 and 10.2, respectively.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board also approved a decrease in the size of the Company&#8217;s board of directors to nine directors effective May 8, 2025.</span></div><div id="i9645be55f0b241c88a2cd63aa28bccb4_94"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.07.&#160;&#160;&#160;&#160;SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 8, 2025, the Company held its Annual Meeting. At the close of business on March 13, 2025, the record date for the Annual Meeting, there were 392,107,501 shares of Dexcom&#8217;s common stock, $0.001 par value per share, outstanding and entitled to vote. 346,192,494 shares were present in person or represented by proxy at the Annual Meeting, which constituted a quorum for the transaction of business.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The matters described below were voted on at the Annual Meeting and the final number of votes cast for or against, as well as the number of abstentions and broker non-votes, with respect to each matter are as indicated.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposal 1: Election of Directors</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom stockholders elected the following nine nominees to the Company&#8217;s board of directors, each to serve until Dexcom&#8217;s 2026 annual meeting of stockholders or until their earlier death, resignation or removal, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.588%"><tr><td style="width:1.0%"/><td style="width:23.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.637%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.828%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker<br/>Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,069,685</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,459,529</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629,587</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Altman</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314,718,819</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,811,910</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628,072</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicholas Augustinos</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,210,018</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,107,058</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835,392</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,040,026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Richard A. Collins</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,988,336</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,533,918</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">636,547</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rimma Driscoll</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,658,290</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824,001</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676,510</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark G. Foletta</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317,368,791</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154,320</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635,690</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ren&#233;e Gal&#225;</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,771,931</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710,392</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676,478</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridgette P. Heller</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,743,961</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,765,849</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648,991</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kyle Malady</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319,054,161</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,468,879</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635,761</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposal 2: Ratification of Independent Registered Public Accounting Firm</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom stockholders ratified the selection by the audit committee of the board of directors of Deloitte &amp; Touche LLP as Dexcom&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2025, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.441%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker<br/>Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,809,914</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,752,038</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">630,542</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div><span><br/></span></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposal 3: Advisory Vote to Approve Named Executive Officer Compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Dexcom stockholders approved, on a non-binding advisory basis, the compensation of Dexcom&#8217;s named executive officers, as disclosed pursuant to Item 402 of Regulation S-K in the proxy statement for the Annual Meeting (which disclosure includes the Compensation Discussion and Analysis, the compensation tables and the narrative disclosures that accompany the compensation tables in such proxy statement), as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.441%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker<br/>Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,471,904</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,807,214</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879,683</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposal 4: Approval of Amended and Restated 2015 Equity Incentive Plan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dexcom stockholders approved the A&amp;R 2015 EIP, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.441%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker<br/>Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,650,593</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,687,212</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820,996</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposal 5: Approval of Amended and Restated 2015 Employee Stock Purchase Plan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Dexcom stockholders approved the A&amp;R 2015 ESPP, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.441%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker<br/>Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323,534,061</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983,333</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,407</span></td><td colspan="3" style="background-color:#bcedaf;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,033,693</span></td></tr></table></div><div id="i9645be55f0b241c88a2cd63aa28bccb4_185"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.588%"><tr><td style="width:1.0%"/><td style="width:7.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.972%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.851%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit101-ar2015eip.htm">Amended and Restated 2015 Equity Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit102-ar2015espp.htm">Amended and Restated 2015 Employee Stock Purchase Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL)</span></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i9645be55f0b241c88a2cd63aa28bccb4_202"></div><hr style="page-break-after:always"/><div style="min-height:28.8pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:40.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:13.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:453.25pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEXCOM, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr style="height:38pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ JEREME M. SYLVAIN</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jereme M. Sylvain</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief Financial Officer</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2025</span></div></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-ar2015eip.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i2b38d6feb56b44fd975da9d49239a942_460"></div><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Adopted by the Board on March 7, 2025)</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">PURPOSE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to the success of the Company, and any Parents and Subsidiaries that exist now or in the future, by offering them an opportunity to participate in the Company&#8217;s future performance through the grant of Awards. Capitalized terms not defined elsewhere in the text are defined in Section 28.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">SHARES SUBJECT TO THE PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Number of Shares Available</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Sections 2.2, 2.5, and 21 and any other applicable provisions hereof, the total number of Shares reserved and available for grant and issuance pursuant to this Plan as of the Amendment and Restatement Effective Date is </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3,400,000 additional Shares </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">plus (ii) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such Shares that remain available for grant and issuance immediately prior to the Amendment and Restatement Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Lapsed, Returned Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Shares subject to Awards, and Shares issued under this Plan under any Award, will again be available for grant and issuance in connection with subsequent Awards under this Plan to the extent such Shares&#58; (a) are subject to issuance upon exercise of an Option or SAR granted under this Plan but which cease to be subject to the Option or SAR for any reason other than exercise of the Option or SAR&#59; (b) are subject to Awards granted under this Plan that are forfeited or are repurchased by the Company at the original issue price&#59; (c) are subject to Awards granted under this Plan that otherwise terminate without such Shares being issued&#59; or (d) are surrendered pursuant to an Exchange Program. To the extent an Award under this Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under this Plan. Shares used to pay the exercise price of an Award, Shares withheld to satisfy the tax withholding obligations related to an Award or Shares repurchased by the Company for any reason other than Shares repurchased at their original issue price including for the payment of an Option Exercise Price, in each case, will not become available for future grant or sale under this Plan. Except as set forth above, any Awards granted, including but not limited to Awards granted as SARs, shall reduce the number of Shares granted on a one-for-one Share for Share basis and any Shares withheld shall not again be made available for Awards under the Plan. To the extent that any Award is forfeited, repurchased or terminates without Shares being issued, Shares may again be available for issuance under this Plan. For the avoidance of doubt, Shares that otherwise become available for grant and issuance because of the provisions of this Section 2.2 shall not include Shares subject to Awards that initially became available because of the substitution clause in Section 21.2 hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Minimum Share Reserve</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At all times the Company shall reserve and keep available a sufficient number of Shares as shall be required to satisfy the requirements of all outstanding Awards granted under this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Limitations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No more than 14,000,000 Shares shall be issued pursuant to the exercise of ISOs.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Adjustment of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the number of outstanding Shares is changed by an extraordinary cash dividend, a stock dividend, recapitalization, spin-off, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then (a) the number of Shares reserved for issuance and future grant under this Plan set forth in Sections 2.1 and 2.2, (b) the Exercise Prices of and number of Shares subject to outstanding Options and SARs, (c) the number of Shares subject to other outstanding Awards, (d) the maximum number of Shares that may be issued as ISOs set forth in Section 2.4, and (e) the maximum number of Shares that may be issued to an individual or to a new Employee in any one calendar year set forth in Section 3 or to a Non-Employee Director in Section 12 shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with applicable securities laws&#59; provided that fractions of a Share will not be issued but will either be replaced by a cash payment equal to the Fair Market Value of such fraction of a Share or will be rounded up (down in the case of ISOs) to the nearest whole Share, as determined by the Committee&#59; and provided further that the Exercise Price of any Option may not be decreased to below the par value of the Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards shall not provide for any vesting prior to at least twelve (12) months from grant. Notwithstanding the foregoing, the Committee may permit (i) acceleration of vesting of Awards in the event of the Participant&#8217;s death or Disability, a Corporate Transaction, or any other circumstance, and (ii) the vesting of Awards on any basis prior to twelve (12) months from grant representing up to an aggregate of five percent (5%) of the Shares reserved and available for grant under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">ELIGIBILITY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ISOs may be granted only to an eligible Employee. All other Awards may be granted to an eligible Employee, Consultant, Director or Non-Employee Director&#59; provided such Consultant, Director or Non-Employee Director renders bona fide services not in connection with the offer and sale of securities in a capital-raising transaction. No Participant will be eligible to be granted more than 4,000,000 Shares in any calendar year under this Plan pursuant to the grant of Awards except that a new Employee (including a new Employee who is also an officer or director of the Company or any Parent, Subsidiary or Affiliate) is eligible to be granted up to a maximum of 8,000,000 Shares in the calendar year in which such Employee commences employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">ADMINISTRATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Committee Composition&#59; Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Plan will be administered by the Committee or by the Board acting as the Committee. Subject to the general purposes, terms and conditions of this Plan, and to the direction of the Board, the Committee will have full power to implement and carry out this Plan&#59; provided that, the Board shall establish the terms for the grant of an Award to Non-Employee Directors. The Committee will have the authority to&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">construe and interpret this Plan, any Award Agreement and any other agreement or document executed pursuant to this Plan&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">prescribe, amend and rescind rules and regulations relating to this Plan or any Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">select persons to receive Awards&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">determine the form and terms and conditions, not inconsistent with the terms of this Plan, of any Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise price, subject to Section 5.4, the time or times when Awards may vest and be exercised (which may be based on performance criteria) or settled, any vesting acceleration or waiver of forfeiture restrictions, the method to satisfy tax withholding obligations or any other tax liability legally due, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case, on such factors as the Committee will determine&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">determine the number of Shares or other consideration subject to Awards&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">determine the Fair Market Value and interpret the applicable provisions of this Plan and the definition of Fair Market Value in connection with circumstances that impact the Fair Market Value, if necessary&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">determine whether Awards will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other Awards under this Plan or any other incentive or compensation plan of the Company or any Parent or Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">grant waivers of Plan or Award conditions&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">determine the vesting, exercisability and payment of Awards&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">correct any defect, supply any omission or reconcile any inconsistency in this Plan, any Award or any Award Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">determine whether an Award has been earned&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">determine the terms and conditions of any, and to institute any Exchange Program approved by stockholders&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.45pt">reduce or waive any criteria with respect to Performance Factors&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">adjust Performance Factors to take into account changes in law and accounting or tax rules as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships, including without limitation (i) restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring charges, (ii) an event either not directly related to the operations of the Company or not within the reasonable control of the Company&#8217;s management, or (iii) a change in accounting standards required by generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">adopt terms and conditions, rules and&#47;or procedures (including the adoption of any subplan under this Plan and any country addenda to the Award Agreements) relating to the operation and administration of this Plan to accommodate grants to Participants residing outside of the United States and comply with the requirements of local law and procedures&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">impose such terms, limitations, restrictions and conditions upon any such Award as the Committee shall deem appropriate, including a prohibition on the ability to exercise any Option, SAR or other exercisable Award during a period of up to 30 days prior to the consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the Shares of Common Stock or the share price of the Common Stock including any Corporate Transaction, for reasons of administrative convenience&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">make all other determinations necessary or advisable for the administration of this Plan&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">delegate any of the foregoing to a subcommittee consisting of one or more executive officers pursuant to a specific delegation as permitted by applicable law, including Section 157(c) of the Delaware General Corporation Law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Committee Interpretation and Discretion</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any determination made by the Committee with respect to any Award shall be made in its sole discretion at the time of grant of the Award or, unless in contravention of any express term of this Plan or Award, at any later time, and such determination shall be final and binding on the Company and all persons having an interest in any Award under this Plan. Any dispute regarding the interpretation of this Plan or any Award Agreement shall be submitted by the Participant or Company to the Committee for review. The resolution of such a dispute by the Committee shall be final and binding on the Company and the Participant. The Committee may delegate to one or more executive officers the authority to review and resolve disputes with respect to Awards held by Participants who are not Insiders, and such resolution shall be final and binding on the Company and the Participant.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Section 16 of the Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards granted to Participants who are subject to Section 16 of the Exchange Act must be approved by two or more &#8220;non-employee directors&#8221; (as defined in the regulations promulgated under Section 16 of the Exchange Act).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Documentation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Award Agreement for a given Award, this Plan and any other documents may be delivered to, and accepted by, a Participant or any other person in any manner (including electronic distribution or posting) that meets applicable legal requirements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Foreign Award Recipients</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws and practices in countries other than the United States in which the Company and its Subsidiaries and Affiliates operate or have employees or other individuals eligible for Awards, the Committee, in its sole discretion, shall have the power and authority to&#58; (i) determine which Subsidiaries and Affiliates shall be covered by this Plan&#59; (ii) determine which individuals outside the United States are eligible to participate in this Plan, which may include individuals who provide services to the Company, or its Subsidiaries or Affiliates under an agreement with a foreign nation or agency&#59; (iii) modify the terms and conditions of any Award granted to individuals who are located outside the United States or who are foreign nationals to comply with applicable foreign laws, policies, customs and practices&#59; (iv) establish subplans and modify exercise procedures and other terms and procedures, to the extent determined necessary or advisable by the Committee and provided that no such subplans and&#47;or modifications shall increase the Share limitations contained in Section 2.1 hereof&#59; and (v) take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no Award shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code or any other applicable United States governing statute or law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">OPTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Option is the right but not the obligation to purchase a Share, subject to certain conditions, if applicable, granted to an eligible Employee, Consultant or Director. All Options shall be granted pursuant to an Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Terms of Options</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Option granted under this Plan will be identified as an Incentive Stock Options within the meaning of the Code (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ISO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or a Nonqualified Stock Option (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NSO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Applicable conditions may be based on completion of a specified number of years of Service with the Company or upon satisfaction of performance goals based on Performance Factors during a Performance Period as set out in advance in the Award Agreement. Prior to the grant of an Option that is being earned upon satisfaction of performance goals based on Performance Factors, the Committee shall&#58; (a) determine the nature, length and starting date of any Performance Period for the Option&#59; (b) select from among the Performance Factors to be used to measure performance goals, if any&#59; and (c) determine the number of Shares that may be earned by the Participant. Performance Periods may overlap, and a Participant may participate simultaneously with respect to Options that are subject to different Performance Periods and having performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Option&#8217;s date of grant will be that date on which the Committee makes the determination to grant such Option, or any such future date specified by the Committee. The Award Agreement will be delivered to the Participant within a reasonable time after the date of grant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Exercise Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, Options will vest and be exercisable within the times or upon the conditions as set forth in the Award Agreement&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no Option will be exercisable after the expiration of ten (10) years from the date of grant&#59; and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no ISO granted to a person who, at the time the ISO is granted, directly or by attribution owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Parent or Subsidiary of the Company (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ten Percent Stockholder</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) will be exercisable after the expiration of five (5) years from the date the ISO is granted. The Committee also may provide for Options to vest and be exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage of Shares as the Committee determines.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Exercise Price of an Option will be determined by the Committee when the Option is granted&#59; provided that&#58; (i) the Exercise Price of an Option will be not less than one hundred percent (100%) of the Fair Market Value of the Shares on the date of grant and (ii) the Exercise Price of any ISO granted to a Ten Percent Stockholder will be not less than one hundred ten percent (110%) of the Fair Market Value of the Shares on the date of grant. Payment for the Shares purchased must be made in accordance with Section 11 of this Plan, the Award Agreement and any procedures established by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Option granted hereunder will vest and be exercisable at such times and under such conditions as determined by the Committee and set forth in the Award Agreement, subject to the terms and conditions of this Plan. An Option may not be exercised for a fraction of a Share. An Option will be deemed exercised when the Company receives&#58; (i) notice of exercise (in such form as the Committee may specify from time to time) from the person entitled to exercise the Option, and (ii) full payment for the Shares with respect to which the Option is exercised plus payment or provision for applicable withholding taxes. Shares issued upon exercise of an Option will be issued in the name of the Participant. Notwithstanding the exercise of the Option, until such time as the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section 2.5 of this Plan. Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of this Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement, if the Participant&#8217;s Service terminates for any reason except a termination by the Company for Cause or because of the Participant&#8217;s death or Disability, then the Participant may exercise such Participant&#8217;s Options only to the extent that such Options would have been exercisable by the Participant on the date Participant&#8217;s Service terminates, no later than three (3) months after the date Participant&#8217;s Service terminates (or such shorter or longer time period as may be determined by the Committee, with any exercise beyond three (3) months after the date Participant&#8217;s Service terminates deemed to be the exercise of an NSO), but in any event no later than the expiration date of the Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement, if the Participant&#8217;s Service terminates because of the Participant&#8217;s death (or the Participant dies within three (3) months after Participant&#8217;s Service terminates for any reason except a termination by the Company for Cause or because of the Participant&#8217;s Disability), then the Participant&#8217;s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant&#8217;s Service terminates and must be exercised by the Participant&#8217;s legal representative, or authorized assignee, no later than twelve (12) months after the date Participant&#8217;s Service terminates (or such shorter or longer time period as may be determined by the Committee), but in any event no later than the expiration date of the Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement, if the Participant&#8217;s Service terminates because of the Participant&#8217;s Disability, then the Participant&#8217;s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant&#8217;s Service terminates and must be exercised by the Participant (or the Participant&#8217;s legal representative or authorized assignee) no later than twelve (12) months after the date Participant&#8217;s Service terminates (with any exercise beyond (a) three (3) months after the date Participant&#8217;s employment terminates when the termination of Service is for a Disability that is not a &#8220;permanent and total disability&#8221; as defined in Section 22(e)(3) of the Code, or (b) twelve (12) months after the date Participant&#8217;s employment terminates when the termination of Service is for a Disability that is a &#8220;permanent and total disability&#8221; as defined in Section 22(e)(3) of the Code, deemed to be exercise of an NSO), but in any event no later than the expiration date of the Options.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Participant is terminated by the Company for Cause, then Participant&#8217;s Options shall expire on the date Service terminates, or at such later time and on such conditions as are determined by the Committee, but in any event no later than the expiration date of the Options. Unless otherwise provided in the Award Agreement, Cause shall have the meaning set forth in this Plan.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Limitations on Exercise</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may specify a minimum number of Shares that may be purchased on any exercise of an Option, provided that such minimum number will not prevent a Participant from exercising the Option for the full number of Shares for which it is then exercisable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Limitations on ISOs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Awards granted as ISOs, to the extent that the aggregate Fair Market Value of the Shares with respect to which such ISOs are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as NSOs. For purposes of this Section 5.7, ISOs will be so evaluated in the order in which they were granted, beginning with the grant first in time. The Fair Market Value of the Shares will be determined as of the Option&#8217;s date of grant. In the event that the Code or the regulations promulgated thereunder are amended after the Effective Date to provide for a different limit on the Fair Market Value of Shares permitted to be subject to ISOs, such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Modification, Extension or Renewal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the limitations on repricing contained in Section 18, the Committee may modify, extend or renew outstanding Options and authorize the grant of new Options in substitution therefor, provided that any such action may not, without the written consent of a Participant, materially impair any of such Participant&#8217;s rights under any Option previously granted. Any outstanding ISO that is modified, extended, renewed or otherwise altered will be treated in accordance with Section 424(h) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Notice of Disqualifying Dispositions of Shares Acquired on Exercise of an ISO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant sells or otherwise disposes of any Shares acquired pursuant to the exercise of an ISO on or before the later of (a) the date two years after the Date of Grant, and (b) the date one year after the exercise of the ISO (in either case, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disqualifying Disposition</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Company may require the Participant to immediately notify the Company in writing of such Disqualifying Disposition.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">No Disqualification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision in this Plan, no term of this Plan relating to ISOs will be interpreted, amended or altered, nor will any discretion or authority granted under this Plan be exercised, so as to disqualify this Plan under Section 422 of the Code or, without the consent of the Participant affected, to disqualify any ISO under Section 422 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">RESTRICTED STOCK AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Restricted Stock Award is an offer by the Company to sell Shares subject to restrictions (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to an eligible Employee, Consultant, or Director. The Committee will determine to whom an offer will be made, the number of Shares the Participant may purchase, the Purchase Price, the restrictions applicable to the Shares and all other terms and conditions of the Restricted Stock Award, subject to this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Restricted Stock Purchase Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All purchases under a Restricted Stock Award will be evidenced by an Award Agreement. Except as may otherwise be provided in an Award Agreement, a Participant accepts a Restricted Stock Award by signing and delivering to the Company an Award Agreement with full payment of the Purchase Price plus payment or provision for applicable withholding taxes, within thirty (30) days from the date the Award Agreement was delivered to the Participant. If the Participant does not accept such Award within thirty (30) days, then such Restricted Stock Award will terminate, unless the Committee determines otherwise.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Purchase Price for a Restricted Stock Award will be determined by the Committee and may be less than Fair Market Value but not less than the par value of the Shares on the date the Restricted Stock Award is granted. Payment of the Purchase Price must be made in accordance with Section 11 of this Plan, and the Award Agreement and in accordance with any procedures established by the Company.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Terms of Restricted Stock Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, Restricted Stock Awards will be subject to such restrictions as the Committee may impose or are required by law. Applicable restrictions may be based on completion of a specified number of years of Service with the Company or upon satisfaction of performance goals based on Performance Factors during a Performance Period as set out in advance in the Award Agreement. Prior to the grant of a Restricted Stock Award that is being earned upon satisfaction of performance goals based on Performance Factors, the Committee shall&#58; (a) determine the nature, length and starting date of any Performance Period for the Restricted Stock Award&#59; (b) select from among the Performance Factors to be used to measure performance goals, if any&#59; and (c) determine the number of Shares that may be earned by the Participant. Performance Periods may overlap and a Participant may participate simultaneously with respect to Restricted Stock Awards that are subject to different Performance Periods and having performance goals based on different Performance Factors and other criteria. For avoidance of doubt, a Performance Period should be at least one year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">STOCK BONUS AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Stock Bonus Award is an award of Shares made to an eligible Employee, Consultant, or Director in consideration for Services to be rendered or for past Services already rendered to the Company or any Parent or Subsidiary, as permitted by law. All Stock Bonus Awards shall be made pursuant to an Award Agreement. No payment from the Participant will be required for Shares awarded pursuant to a Stock Bonus Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Terms of Stock Bonus Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, the Committee will determine to whom a Stock Bonus Award will be made, the number of Shares under the Stock Bonus Award, the restrictions, if any, applicable to such Shares and all other terms and conditions of the Stock Bonus Award, subject to this Plan. Applicable restrictions may be based upon completion of a specified number of years of Service with the Company or upon satisfaction of performance goals based on Performance Factors during a Performance Period as set out in advance in the Award Agreement. Prior to the grant of any Stock Bonus Award that is being earned upon satisfaction of performance goals, the Committee shall&#58; (a) determine the nature, length and starting date of any Performance Period for the Stock Bonus Award&#59; (b) select from among the Performance Factors to be used to measure performance goals&#59; and (c) determine the number of Shares that may be awarded to the Participant. Performance Periods may overlap, and a Participant may participate simultaneously with respect to Stock Bonus Awards that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Form of Payment to Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As determined in the sole discretion of the Committee, a Stock Bonus Award may be paid in the form of cash, whole Shares, or a combination thereof, based on the Fair Market Value (as of the date of payment) of the Shares earned under such Stock Bonus Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">STOCK APPRECIATION RIGHTS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Stock Appreciation Right (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an award to an eligible Employee, Consultant, or Director that may be settled in cash, or Shares (which may consist of Restricted Stock), having a value equal to (a) the difference between the Fair Market Value on the date of exercise over the Exercise Price multiplied by (b) the number of Shares with respect to which the SAR is being settled (subject to any maximum number of Shares that may be issuable as specified in an Award Agreement). All SARs shall be made pursuant to an Award Agreement.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Terms of SARs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee will determine the terms of each SAR including, without limitation&#58; (a) the number of Shares subject to the SAR&#59; (b) the Exercise Price and the time or times during which the SAR may be settled&#59; (c) the consideration to be distributed on settlement of the SAR&#59; and (d) the effect of the Participant&#8217;s termination of Service on each SAR. The Exercise Price of the SAR will be determined by the Committee when the SAR is granted, and may be not less than Fair Market Value or the par value of the Shares. A SAR may be awarded upon satisfaction of Performance Factors, if any, during any Performance Period as are set out in advance in the Award Agreement. Prior to the grant of any SAR that is being earned upon satisfaction of performance goals, then the Committee will&#58; (x) determine the nature, length and starting date of any Performance Period for each SAR&#59; and (y) select from among the Performance Factors to be used to measure the performance, if any. Performance Periods may overlap and Participants may participate simultaneously with respect to SARs that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Exercise Period and Expiration Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, a SAR will be exercisable within the times or upon the occurrence of events determined by the Committee and set forth in the Award Agreement. The SAR Agreement shall set forth the expiration date&#59; provided that no SAR will be exercisable after the expiration of ten (10) years from the date the SAR is granted. The Committee may also provide for SARs to become exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage of the Shares subject to the SAR as the Committee determines. Notwithstanding the foregoing, the rules of Section 5.6 also will apply to SARs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Form of Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon exercise of a SAR, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying (i) the difference between the Fair Market Value of a Share on the date of exercise over the Exercise Price&#59; times (ii) the number of Shares with respect to which the SAR is exercised (subject to any maximum number of Shares that may be issuable as specified in an Award Agreement). At the discretion of the Committee, the payment from the Company for the SAR exercise may be in cash, in Shares of equivalent value, or in some combination thereof. The portion of a SAR being settled may be paid currently or on a deferred basis with such interest, if any, as the Committee determines, provided that the terms of the SAR and any deferral satisfy the requirements of Section 409A of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">RESTRICTED STOCK UNITS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Restricted Stock Unit (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an award to an eligible Employee, Consultant, or Director covering a number of Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock). All RSUs shall be made pursuant to an Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Terms of RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, the Committee will determine the terms of an RSU including, without limitation&#58; (a) the number of Shares subject to the RSU&#59; (b) the time or times during which the RSU may be settled&#59; (c) the consideration to be distributed on settlement&#59; and (d) the effect of the Participant&#8217;s termination of Service on each RSU. An RSU may be awarded upon satisfaction of such performance goals based on Performance Factors during any Performance Period as are set out in advance in the Award Agreement. Prior to the grant of any RSU that is being earned upon satisfaction of performance goals, the Committee will&#58; (x) determine the nature, length and starting date of any Performance Period for the RSU&#59; (y) select from among the Performance Factors to be used to measure the performance, if any&#59; and (z) determine the number of Shares deemed subject to the RSU. Performance Periods may overlap and Participants may participate simultaneously with respect to RSUs that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Form and Timing of Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Payment of earned RSUs shall be made as soon as practicable after the date(s) determined by the Committee and set forth in the Award Agreement. The Committee, in its sole discretion, may settle earned RSUs in cash, Shares, or a combination of both. The Committee may also permit a Participant to defer payment under a RSU to a date or dates after the RSU is earned provided that the terms of the RSU and any deferral satisfy the requirements of Section 409A of the Code.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.34pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">PERFORMANCE AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Performance Award is an award to an eligible Employee or Consultant, of Performance Shares or a cash bonus denominated in Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock). Grants of Performance Awards shall be made pursuant to an Award Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Terms of Performance Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, the Committee will determine the terms of a Performance Award including, without limitation&#58; (a) the number of Shares or amount of cash subject to the Performance Award&#59; (b) the time or times during which the Performance Award may be settled&#59; and (c) the consideration to be distributed on settlement, and the effect of the Participant&#8217;s termination of Service on each Performance Award. A Performance Award may be awarded upon satisfaction of performance goals based on Performance Factors during any Performance Period as set out in advance in the Award Agreement. Prior to the grant of any Performance Award that is being earned upon satisfaction of performance goals, the Committee will&#58; (x) determine the nature, length and starting date of any Performance Period for the Performance Award&#59; (y) select from among the Performance Factors to be used to measure such performance goals, if any&#59; and (z) determine the number of Shares deemed subject to the Performance Award. Performance Periods may overlap and Participants may participate simultaneously with respect to Performance Awards that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria. For avoidance of doubt, a Performance Period shall be at least 12 months.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">PAYMENT FOR SHARE PURCHASES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Payment from a Participant for Shares purchased pursuant to this Plan may be made in cash or by check or, where approved for the Participant by the Committee and where permitted by law (and to the extent not otherwise set forth or prohibited in the applicable Award Agreement)&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">by surrender of Shares held by the Participant that have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Shares as to which said Award will be exercised or settled&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">by consideration received by the Company pursuant to a broker-assisted or other form of cashless or net exercise program implemented by the Company in connection with this Plan or an individual Award&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">by any combination of the foregoing&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">by any other method of payment as is permitted by applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless determined otherwise by the Committee, all payments under any of the methods indicated above shall be made in United States dollars.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">GRANTS TO NON-EMPLOYEE DIRECTORS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Non-Employee Directors are eligible to receive any type of Award offered under this Plan except ISOs or Performance Awards. Awards pursuant to this Section 12 may be automatically made pursuant to policy adopted by the Board, or made from time to time as determined in the discretion of the Board. The maximum number of Shares of Common Stock subject to Awards granted during any one calendar year to any Non-Employee Director, taken together with any cash fees paid by the Company to such Non-Employee Director during such calendar year, will not exceed one million five-hundred thousand dollars ($1,500,000) in total value, (calculating the value of any such Awards based on the grant date fair value of such Awards for financial reporting purposes).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards pursuant to this Section 12 shall be granted only to Non-Employee Directors. A Non-Employee Director who is elected or re-elected as a member of the Board will be eligible to receive an Award under this Section 12.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Vesting, Exercisability and Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as set forth in Section 2.6 and 21, Awards shall vest, be exercisable and be settled as determined by the Board. With respect to Options and SARs, the Exercise Price granted to Non-Employee Directors shall be not less than the Fair Market Value of the Shares at the time that such Option or SAR is granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Election to receive Awards in Lieu of Cash</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent approved by the Board, a Non-Employee Director may elect to receive his or her annual retainer payments and&#47;or meeting fees from the Company in the form of cash or Awards or in a combination thereof, as determined by the Board. Such Awards shall be issued under this Plan. An election under this Section 12.3 shall be filed with the Company on the form prescribed by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">WITHHOLDING TAXES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Withholding Generally</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to any relevant taxable or tax withholding event, as applicable, in connection with Awards granted under this Plan, the Company may require the Participant to make adequate arrangements satisfactory to the Company or, if different, the Participant&#8217;s employer or the Parent, Subsidiary or Affiliate to which the Participant provides Service, to satisfy all Tax-Related Items prior to the delivery of Shares pursuant to exercise or settlement of any Award. Whenever payments in satisfaction of Awards granted under this Plan are to be made in cash, such payment will be net of an amount sufficient to satisfy all applicable Tax-Related Items or any other tax liability legally applicable to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Withholding Methods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement, the Committee, or its delegate(s), as permitted by applicable law, in its sole discretion and pursuant to such procedures as it may specify from time to time and to limitations of local law, may require or permit a Participant to satisfy such tax withholding obligation or any other tax liability legally due from the Participant, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or a number Shares, (iii) delivering to the Company a number of Shares or (iv) withholding from the proceeds of the sale of otherwise deliverable Shares acquired pursuant to an Award either through a voluntary sale or through a mandatory sale arranged by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">TRANSFERABILITY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Transfer Generally</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless determined otherwise by the Committee or pursuant to Section 14.2 and otherwise consistent with the requirements to permit resales under the Form S-8, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent and distribution. If the Committee makes an Award transferable, including, without limitation, by instrument to an inter vivos or testamentary trust in which the Awards are to be passed to beneficiaries upon the death of the trustor (settlor) or by gift or by domestic relations order to a Permitted Transferee, such Award will contain such additional terms and conditions as the Committee deems appropriate. All Awards shall be exercisable&#58; (i) during the Participant&#8217;s lifetime only by (A) the Participant, or (B) the Participant&#8217;s guardian or legal representative&#59; (ii) after the Participant&#8217;s death, by the legal representative of the Participant&#8217;s heirs or legatees&#59; and (iii) in the case of all Awards except ISOs, by a Permitted Transferee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Beneficiaries</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise determined by the Committee, each Participant under this Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Plan is to be paid in case of such Participant&#8217;s death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by the Committee, and will be effective only when filed by such Participant in writing with the Company during such Participant&#8217;s lifetime. In the absence of any such beneficiary designation, benefits remaining unpaid or rights remaining unexercised at such Participant&#8217;s death shall be paid to or exercised by such Participant&#8217;s executor, administrator, or legal representative.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">PRIVILEGES OF STOCK OWNERSHIP&#59; RESTRICTIONS ON SHARES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Voting and Dividends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Participant will have any of the rights of a stockholder with respect to any Shares until the Shares are issued to the Participant. After Shares are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such Shares, including the right to vote and receive all dividends or other distributions made or paid with respect to such Shares&#59; provided, that if such Shares are Restricted Stock, then any new, additional or different securities the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split or any other change in the corporate or capital structure of the Company will be subject to the same restrictions as the Restricted Stock&#59; provided, further, that the Participant will have no right to such stock dividends or stock distributions with respect to Unvested Shares, and any such dividends or stock distributions shall be accrued and paid only at such time if any, as such Unvested Shares become vested Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">CERTIFICATES&#47;ELECTRONIC DELIVERY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All Shares or other securities delivered under this Plan, whether or not certificated and including Shares or other securities delivered electronically, will be subject to such stock transfer orders, legends and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable U.S. federal, state or foreign securities law, or any rules, regulations and other requirements of the SEC or any stock exchange or automated quotation system upon which the Shares may be listed or quoted and any non-U.S. exchange controls or securities law restrictions to which the Shares are subject.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">ESCROW&#59; PLEDGE OF SHARES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To enforce any restrictions on a Participant&#8217;s Shares, the Committee may require the Participant to deposit all certificates representing Shares, together with stock powers or other instruments of transfer approved by the Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions have lapsed or terminated, and the Committee may cause a legend or legends referencing such restrictions to be placed on the certificates. Any Participant who is permitted to execute a promissory note as partial or full consideration for the purchase of Shares under this Plan will be required to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of the Participant&#8217;s obligation to the Company under the promissory note&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Committee may require or accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full recourse against the Participant under the promissory note notwithstanding any pledge of the Participant&#8217;s Shares or other collateral. In connection with any pledge of the Shares, the Participant will be required to execute and deliver a written pledge agreement in such form as the Committee will from time to time approve. The Shares purchased with the promissory note may be released from the pledge on a pro rata basis as the promissory note is paid.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">EXCHANGE AND BUYOUT OF AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Exchange Program, including but not limited to any repricing of Options or SARs and cancellation of regrant of Awards, is not permitted without prior stockholder approval.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">SECURITIES LAW AND OTHER REGULATORY COMPLIANCE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Award will not be effective unless such Award is in compliance with all applicable U.S. and foreign federal and state securities and exchange control laws, rules and regulations of any governmental body, and the requirements of any stock exchange or automated quotation system upon which the Shares may then be listed or quoted, as they are in effect on the date of grant of the Award and also on the date of exercise or other issuance. Notwithstanding any other provision in this Plan, the Company will have no obligation to issue or deliver certificates for Shares under this Plan prior to&#58; (a) obtaining any approvals from governmental agencies that the Company determines are necessary or advisable&#59; and&#47;or (b) completion of any registration or other qualification of such Shares under any state or federal or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable. The Company will be under no obligation to register the Shares with the SEC or to effect compliance with the registration, qualification or listing requirements of any foreign or state securities laws, exchange control laws, stock exchange or automated quotation system, and the Company will have no liability for any inability or failure to do so.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">NO OBLIGATION TO EMPLOY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing in this Plan or any Award granted under this Plan will (a) form or amend a Service agreement, (b) confer or be deemed to confer on any Participant any right to continue in the employ of, or to continue any other relationship with, the Company or any Parent, Subsidiary or Affiliate or (c) limit in any way the right of the Company or any Parent, Subsidiary or Affiliate to terminate Participant&#8217;s employment or other relationship at any time (subject to compliance with applicable law).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">CORPORATE TRANSACTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Assumption or Replacement of Awards by Successor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that the Company is subject to a Corporate Transaction, outstanding Awards acquired under this Plan shall be subject to the documentation evidencing the Corporate Transaction, which need not treat all outstanding Awards in an identical manner. Such agreement, without the Participant&#8217;s consent, shall provide for one or more of the following with respect to all outstanding Awards as of the effective date of such Corporate Transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The continuation of an outstanding Award by the Company (if the Company is the successor entity).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">The assumption of an outstanding Award by the successor or acquiring entity (if any) of such Corporate Transaction (or by its parents, if any), which assumption, will be binding on all selected Participants&#59; provided that the Exercise Price and the number and nature of Shares issuable upon exercise of any such Option or SAR, or any Award that is subject to Section 409A of the Code, will be adjusted appropriately pursuant to Section 424(a) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The substitution by the successor or acquiring entity in such Corporate Transaction (or by its parents, if any) of an equivalent award with substantially the same terms for such outstanding Award (except that the Exercise Price and the number and nature of Shares issuable upon exercise of any such Option or SAR, or any Award that is subject to Section 409A of the Code, will be adjusted appropriately pursuant to Section 424(a) of the Code).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">A payment to the Participant equal to the excess of (i) the Fair Market Value of the Shares subject to the Award as of the effective date of such Corporate Transaction over (ii) the Exercise Price or Purchase Price of Shares, as the case may be, subject to the Award in connection with the cancellation of the Award. Such payment will be made in the form of cash, cash equivalents, or securities of the surviving corporation or its Parent with a Fair Market Value equal to the required amount. The successor corporation may provide substantially similar consideration to Participants as was provided to stockholders (after taking into account the existing provisions of the Awards). Subject to Section 409A of the Code, such payment may be made in installments, may be deferred until the date or dates when the Award would have become exercisable or such Shares would have vested, and such payment may be subject to vesting based on the Participant&#8217;s continuing employment or Service, provided that such payment initially will be calculated without regard to whether or not the Award is then exercisable or such Shares are then vested. In addition, any escrow, holdback, earnout or similar provisions in the agreement for such Corporate Transaction may apply to such payment to the same extent and in the same manner as such provisions apply to the holders of Shares. If the Exercise Price of the Shares subject to an Option exceeds the Fair Market Value of such Shares, then the Option may be cancelled without making a payment to the Participant. For purposes of this subsection, the Fair Market Value of any security will be determined without regard to any vesting conditions that may apply to such security.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall have full power and authority to assign the Company&#8217;s right to repurchase or re-acquire or forfeiture rights to such successor or acquiring corporation. Notwithstanding the foregoing, solely upon a Corporate Transaction in which the successor or acquiring corporation refuses to assume, convert, replace or substitute Awards, as provided above, pursuant to a Corporate Transaction notwithstanding any other provision in this Plan to the contrary, and unless otherwise determined by the Committee, all Awards granted under this Plan shall accelerate in full as of the time of consummation of the Corporate Transaction. In such event, the Committee will notify the Participant in writing or electronically that such Award will be exercisable for a period of time determined by the Committee in its sole discretion, and such Award will terminate upon the expiration of such period. Awards need not be treated similarly in a Corporate Transaction.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Assumption of Awards by the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company, from time to time, also may substitute or assume outstanding awards granted by another company, whether in connection with an acquisition of such other company or otherwise, by either&#59; (a) granting an Award under this Plan in substitution of such other company&#8217;s award&#59; or (b) assuming such award as if it had been granted under this Plan if the terms of such assumed award could be applied to an Award granted under this Plan. Such substitution or assumption will be permissible if the holder of the substituted or assumed award would have been eligible to be granted an Award under this Plan if the other company had applied the rules of this Plan to such grant. In the event the Company assumes an award granted by another company, the terms and conditions of such award will remain unchanged (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">except</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that the Purchase Price or the Exercise Price, as the case may be, and the number and nature of Shares issuable upon exercise or settlement of any such Award will be adjusted appropriately pursuant to Section 424(a) of the Code). In the event the Company elects to grant a new Option in substitution rather than assuming an existing option, such new Option may be granted with a similarly adjusted Exercise Price. Substitute Awards shall not reduce the number of Shares authorized for grant under this Plan or authorized for grant to a Participant in a calendar year.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Non-Employee Directors&#8217; Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary herein, in the event of a Corporate Transaction, the vesting of all Awards granted to Non-Employee Directors and outstanding at such time shall accelerate and such Awards shall become exercisable (as applicable) in full prior to the consummation of such event at such times and on such conditions as the Committee determines.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt;text-decoration:underline">Release of Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with a Corporate Transaction, the Committee may require that the Award holder provide a release of claims as a condition of receipt of any cash-out payment or other transaction consideration, or any continued, assumed or substituted Award.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">ADOPTION AND STOCKHOLDER APPROVAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Plan shall be submitted for the approval of the Company&#8217;s stockholders, consistent with applicable laws, within twelve (12) months before or after the date this Plan, as amended and restated, is adopted by the Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">TERM OF PLAN&#47;GOVERNING LAW</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless earlier terminated as provided herein, this Plan will become effective on the Amendment and Restatement Effective Date and will terminate ten (10) years from the date this Plan is adopted by the Board. After this Plan is terminated or expires, no Awards may be granted but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and this Plan&#8217;s terms and conditions. This Plan and all Awards granted hereunder shall be governed by and construed in accordance with the laws of the State of Delaware (excluding its conflict of laws rules).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">AMENDMENT OR TERMINATION OF PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board may at any time terminate or amend this Plan in any respect, including, without limitation, amendment of any form of Award Agreement or instrument to be executed pursuant to this Plan&#59; provided, however, that the Board will not, without the approval of the stockholders of the Company, amend this Plan in any manner that requires such stockholder approval&#59; provided further, that a Participant&#8217;s Award shall be governed by the version of this Plan then in effect at the time such Award was granted.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">NONEXCLUSIVITY OF THE PLAN&#59; UNFUNDED PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither the adoption of this Plan by the Board, the submission of this Plan to the stockholders of the Company for approval, nor any provision of this Plan will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of stock awards and bonuses otherwise than under this Plan, and such arrangements may be either generally applicable or applicable only in specific cases.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">INSIDER TRADING POLICY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Participant who receives an Award shall comply with any policy adopted by the Company from time to time covering transactions in the Company&#8217;s securities by Employees, officers and&#47;or Directors of the Company.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">ALL AWARDS SUBJECT TO COMPANY CLAWBACK OR RECOUPMENT POLICY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All Awards held by an executive officer shall be subject to clawback, recoupment or forfeiture (i) to the extent that such executive officer is determined to have engaged in fraud or intentional illegal conduct materially contributing to a financial restatement, as determined by the Board in its sole discretion, (ii) as provided under any clawback, recoupment or forfeiture policy adopted by the Board or (iii) required by law. Such clawback, recoupment or forfeiture policy, in addition to any other remedies available under applicable law, may require the cancellation of outstanding Awards and the recoupment of any gains realized with respect to Awards.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">DEFINITIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As used in this Plan, and except as elsewhere defined herein, the following terms will have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) any entity that, directly or indirectly, is controlled by, controls or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case as determined by the Committee, whether now or hereafter existing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amendment and Restatement Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Plan, as amended and restated, is approved by the stockholders of the Company at the Company&#8217;s 2025 annual stockholders meeting.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any award under this Plan, including any Option, Restricted Stock, Stock Bonus, Stock Appreciation Right, Restricted Stock Unit or award of Performance Shares.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to each Award, the written or electronic agreement between the Company and the Participant setting forth the terms and conditions of the Award and country-specific appendix thereto for grants to non-U.S. Participants, which shall be in substantially a form (which need not be the same for each Participant) that the Committee (or in the case of Award agreements that are not used for Insiders, the Committee&#8217;s delegate(s)) has from time to time approved, and will comply with and be subject to the terms and conditions of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (except as otherwise set forth in an Award Agreement) termination of the Participant&#8217;s Service on the basis of the Participant&#8217;s conviction (or a plea of nolo contendere) of fraud, misappropriation, embezzlement or any other act or acts of dishonesty constituting a felony and resulting or intended to result directly or indirectly in a substantial gain or personal enrichment to the Participant at the expense of the Company or any Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee of the Board or those person(s) to whom administration of this Plan, or part of this Plan, has been delegated as permitted by law (which may include a committee of one member of the Board).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the common stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Dexcom, Inc., or any successor corporation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including an advisor or independent contractor, engaged by the Company or a Parent, Subsidiary or Affiliate to render services to such entity.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then-outstanding voting securities&#59; provided, however, that for purposes of this subclause (i) the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction&#59; (ii) the consummation of the sale, transfer or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation&#59; (iv) any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding Shares of the Company) or (v) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purpose of this subclause (v), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction. For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a Corporate Transaction shall not be deemed to result from any transaction precipitated by the Company&#8217;s insolvency, appointment of a conservator, or determination by a regulatory agency that the Company is insolvent, nor from any transaction the sole purpose of which is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means in the case of ISOs, total and permanent disability as defined in Section 22(e)(3) of the Code and in the case of other Awards, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Plan was originally approved by the stockholders of the Company, which is the date of the annual meeting of stockholders of the Company held in 2015.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including officers and Directors, providing services as an employee to the Company or any Parent, Subsidiary or Affiliate. Neither service as a Director nor payment of a Director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Program</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a program pursuant to which (i) outstanding Awards are surrendered, cancelled or exchanged for cash, the same type of Award or a different Award (or combination thereof) or (ii) the Exercise Price of an outstanding Award is increased or reduced.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exercise Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to an Option, the price at which a holder may purchase the Shares issuable upon exercise of an Option and with respect to a SAR, the price at which the SAR is granted to the holder thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of a Share determined as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Journal or such other source as the Committee deems reliable&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Committee deems reliable&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">if none of the foregoing is applicable, by the Board or the Committee in good faith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insider</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an officer or director of the Company or any other person whose transactions in the Company&#8217;s Common Stock are subject to Section 16 of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IRS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Internal Revenue Service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Director who is not an Employee of the Company or any Parent or Subsidiary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award of an option to purchase Shares pursuant to Section 5.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who holds an Award under this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.27.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means cash or stock granted pursuant to Section 10 or Section 12 of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.28.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Factors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the metrics or factors selected by the Committee and specified in an Award Agreement, from among the following objective measures, either individually, alternatively or in any combination, applied to the Company as a whole or any business unit or Subsidiary, either individually, alternatively, or in any combination, on a GAAP or non-GAAP basis, and measured, to the extent applicable on an absolute basis or relative to a pre-established target, to determine whether the performance goals established by the Committee with respect to applicable Awards have been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Profit Before Tax&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Billings&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Revenue&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Net revenue&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Earnings (which may include earnings before interest and taxes, earnings before taxes, and net earnings, or as otherwise adjusted)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Operating income&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Operating margin&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Operating profit&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Controllable operating profit, or net operating profit&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Net Profit&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Gross margin&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Operating expenses or operating expenses as a percentage of revenue&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.45pt">Net income&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Earnings per share&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Total stockholder return&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Market share&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Return on assets or net assets&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.45pt">The Company&#8217;s stock price&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Growth in stockholder value relative to a pre-determined index&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">Return on equity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">Return on invested capital&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Cash Flow (including free cash flow or operating cash flows)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.57pt">Cash conversion cycle&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(x)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Economic value added&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(y)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Individual confidential business objectives&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(z)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Contract awards or backlog&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">Overhead or other expense reduction&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(bb)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.14pt">Credit rating&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(cc)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">Strategic plan development and implementation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dd)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.14pt">Succession plan development and implementation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ee)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">Improvement in workforce diversity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ff)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Customer indicators&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(gg)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.14pt">New product invention or innovation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(hh)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.14pt">Attainment of research and development milestones&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Improvements in productivity&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(jj)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Bookings&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(kk)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">Attainment of objective operating goals and employee metrics&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ll)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.8pt">Any other metric that is capable of measurement as determined by the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.29.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period of Service determined by the Committee during which years of Service or performance is to be measured for the Award.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.30.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section 10 or Section 12 of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.31.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Permitted Transferee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (including adoptive relationships) of the Employee, any person sharing the Employee&#8217;s household (other than a tenant or employee), a trust in which these persons (or the Employee) have more than 50% of the beneficial interest, a foundation in which these persons (or the Employee) control the management of assets, and any other entity in which these persons (or the Employee) own more than 50% of the voting interests.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.32.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning as such term is used in Sections 13(d) and 14(d) of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.33.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this DexCom, Inc. 2015 Equity Incentive Plan, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.34.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the price to be paid for Shares acquired under this Plan, other than Shares acquired upon exercise of an Option or SAR.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.35.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award of Shares pursuant to Section 6 or Section 12 of this Plan, or issued pursuant to the early exercise of an Option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.36.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Unit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section 9 or Section 12 of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.37.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.38.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities Act of 1933, as amended.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.39.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean service as an Employee, Consultant, Director or Non-Employee Director, to the Company or a Parent, Subsidiary or Affiliate of the Company, subject to such further limitations as may be set forth in this Plan or the applicable Award Agreement. An Employee will not be deemed to have ceased to provide Service in the case of (i) medical leave, (ii) military leave, or (iii) any other leave of absence approved by the Company. In the case of any Employee on an approved leave of absence, Awards shall not vest during such leave of absence, except as (A) may be required by applicable law, or (B) as otherwise provided by the Committee or the Company in writing. No fractional shares may be issued. In the event of military leave, if required by applicable laws, vesting shall continue for not less than the longest period that vesting continues under any other statutory or Company approved leave of absence and, upon a Participant&#8217;s returning from military leave (under conditions that would entitle him or her to protection upon such return under the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to Awards to the same extent as would have applied had the Participant continued to provide services to the Company throughout the leave on the same terms as he or she was providing services immediately prior to such leave. Except as set forth in this Section 28.39, a Participant shall be considered to have terminated Service as of the date he or she ceases to provide active Service (regardless of the reason for the termination and whether the termination is later found to be invalid or in breach of local employment laws in the jurisdiction where the Participant is providing Service or the terms of the Participant&#8217;s Service agreement, if any) and Service shall not be extended by any notice period, period of garden leave, or similar period mandated by local law or the Participant&#8217;s Service agreement (if any), provided however, that a change in a Participant&#8217;s status from an Employee to a Consultant or advisor shall not be treated as a termination of the Participant&#8217;s active Service, unless determined by the Committee, in its discretion. The Committee will have sole discretion to determine whether a Participant has ceased to provide Services (including whether the Participant may still be considered to be providing Service while on a leave of absence) and the effective date on which the Participant ceased to provide Services.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.40.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means shares of the Company&#8217;s Common Stock and the common stock of any successor security.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.41.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section 8 or Section 12 of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.42.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Bonus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section 7 or Section 12 of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.43.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.44.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean any or all income tax, social insurance contributions, payroll tax, payment on account or other tax-related items arising in connection with a Participant&#8217;s participation in the Plan and legally applicable to the Participant.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.45.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means regulations promulgated by the United States Treasury Department.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.46.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.22pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unvested Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Shares that have not yet vested or are subject to a right of repurchase in favor of the Company (or any successor thereto).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-ar2015espp.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ia25b324b994f459786b2917a7980b12f_4"></div><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2015 EMPLOYEE STOCK PURCHASE PLAN</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Adopted by the Board on March 7, 2025)</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">PURPOSE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of this Plan is to provide eligible employees of the Company and the Participating Corporations with a means of acquiring an equity interest in the Company through payroll deductions, to enhance such employees&#8217; sense of participation in the affairs of the Company. Capitalized terms not defined elsewhere in the text are defined in Section 28.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">ESTABLISHMENT OF PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company proposes to grant rights to purchase shares of Common Stock to eligible employees of the Company and its Participating Corporations pursuant to this Plan. The Company intends this Plan to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Code (including any amendments to or replacements of such Section), and this Plan shall be so construed. Any term not expressly defined in this Plan but defined for purposes of Section 423 of the Code shall have the same definition herein. In addition, with regard to offers of options to purchase shares of Common Stock under the Plan to employees working for a Subsidiary or an Affiliate outside the United States, the Board or Committee (as defined herein) may grant options to purchase shares Common Stock under the Non-423 Component that are not intended to meet the Code Section 423 requirements, provided, if necessary under Code Section 423, that the other terms and conditions of the Plan are met.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to Section 14, a total of (i) 6,000,000 Shares plus (ii) an additional 8,000,000 Shares as of the Effective Date are reserved for issuance under this Plan. The number of shares initially reserved for issuance under this Plan and the maximum number of shares that may be issued under this Plan shall be subject to adjustments effected in accordance with Section 14.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">ADMINISTRATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan will be administered by the Committee. Subject to the provisions of this Plan and the limitations of Section 423 of the Code or any successor provision in the Code, all questions of interpretation or application of this Plan shall be determined by the Committee and its decisions shall be final and binding upon all Participants. The Committee will have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility, to designate the Participating Corporations, to determine when to grant options under the Non-423 Component and to decide upon any and all claims filed under the Plan. Every finding, decision and determination made by the Committee will, to the full extent permitted by law, be final and binding upon all parties. Notwithstanding any provision to the contrary in this Plan, the Committee may adopt rules, sub-plans, and&#47;or procedures relating to the operation and administration of the Plan designed to comply with local laws, regulations or customs or to achieve tax, securities law or other objectives for eligible employees outside of the United States. The Committee will have the authority to determine the Fair Market Value of the Common Stock (which determination shall be final, binding and conclusive for all purposes) in accordance with Section 8 below and to interpret Section 8 of the Plan in connection with circumstances that impact the Fair Market Value. Members of the Committee shall receive no compensation for their services in connection with the administration of this Plan, other than standard fees as established from time to time by the Board for services rendered by Board members serving on Board committees. All expenses incurred in connection with the administration of this Plan shall be paid by the Company. For purposes of this Plan, the Committee may designate separate offerings under the Plan (the terms of which need not be identical) in which eligible employees of one or more Participating Corporations will participate, even if the dates of the applicable Offering Periods of each such offering are identical.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">ELIGIBILITY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any employee of the Company or the Participating Corporations is eligible to participate in an Offering Period under this Plan, except that one or more of the following categories of employees may be excluded from coverage under the Plan by the Committee (other than where prohibited by applicable law)&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">Employees who are not employed by the Company or a Participating Corporation prior to the beginning of such Offering Period or prior to such other time period as specified by the Committee&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">employees who are customarily employed for twenty (20) hours or less per week&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">employees who are customarily employed for five (5) months or less in a calendar year&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">employees who have been an employee of the Company for less than thirty (30) days prior to the first day of an Offering Period (or such longer period of time, not to exceed two (2) years, as determined by the Committee)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">employees who do not meet any other eligibility requirements that the Committee may choose to impose (within the limits permitted by the Code).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing notwithstanding, an individual shall not be eligible if his or her participation in the Plan is prohibited by the law of any country that has jurisdiction over him or her, if complying with the laws of the applicable country would cause the Plan to violate Section 423 of the Code. In the case of the&#160;Non-423&#160;Component, eligible employees may be excluded from participation in the Plan or an Offering Period if the Committee determines that participation of such eligible employees is not advisable or practicable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">No employee who, together with any other person whose stock would be attributed to such employee pursuant to Section 424(d) of the Code, owns stock or holds options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or its Parent or Subsidiary or who, as a result of being granted an option under this Plan with respect to such Offering Period, would own stock or hold options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of the Company or its Parent or Subsidiary shall be granted an option to purchase Common Stock under the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">OFFERING</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The offering periods of this Plan (each, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) are described below. Each Offering Period shall consist of one or more purchase periods (individually, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) during which payroll deductions of the Participants are accumulated under this Plan. The first business day of each Offering Period is referred to as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Date.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; The last business day of each Purchase Period is referred to as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; The Committee shall have the power to change the Offering Dates, the Purchase Dates, the duration of Offering Periods (provided that an Offering Period will in no event be longer than twenty-seven (27) months), and the Purchase Periods, in each case, without stockholder approval if such change is announced prior to the relevant Offering Period or prior to such other time period as specified by the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All Offering Periods shall be of six (6) months duration commencing on March 1 and September 1 of each year and respectively ending on August 31st and February 28th (or the 29th if February has 29 days) of each year. Each such Offering Period shall consist of one six (6)-month Purchase Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">PARTICIPATION IN THIS PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any employee who is an eligible employee determined in accordance with Section&#160;4 immediately prior to an Offering Period will be eligible to participate in this Plan, subject to the requirement of Section 6(b) hereof and the other terms and provisions of this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">With respect to each Offering Period, a Participant may elect to participate in this Plan by submitting an enrollment agreement (or any electronic or online enrollment form provided by the Company) prior to the commencement of the Offering Period (or such earlier date as the Committee may determine) to which such agreement (or any electronic or online enrollment form provided by the Company) relates.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Once an employee becomes a Participant in an Offering Period, then such Participant will automatically participate in each subsequent Offering Period commencing immediately following the last day of the prior Offering Period unless the Participant withdraws or is deemed to withdraw from this Plan or terminates further participation in an Offering Period as set forth in Section 11 below. A Participant who is continuing participation pursuant to the preceding sentence is not required to file any additional enrollment agreement in order to continue participation in this Plan&#59; provided that, a Participant who is not continuing participation pursuant to the preceding sentence is required to file an enrollment agreement (or any electronic or online enrollment form provided by the Company) prior to the commencement of the Offering Period (or such earlier date as the Committee may determine) to which such agreement (or any electronic or online enrollment form provided by the Company) relates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">GRANT OF OPTION ON ENROLLMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Becoming a Participant with respect to an Offering Period will constitute the grant (as of the Offering Date) by the Company to such Participant of an option to purchase on the Purchase Date up to that number of shares of Common Stock of the Company determined by a fraction, the numerator of which is the amount accumulated in such Participant&#8217;s payroll deduction account during such Purchase Period and the denominator of which is the lower of (i) eighty-five percent (85%) of the Fair Market Value of a share of Common Stock on the Offering Date (but in no event less than the par value of a share of the Common Stock), or (ii) eighty-five percent (85%) of the Fair Market Value of a share of the Common Stock on the Purchase Date, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the number of shares of Common Stock subject to any option granted pursuant to this Plan shall not exceed the lesser of (x) the maximum number of shares set by the Committee pursuant to Section 10(b) below with respect to the applicable Purchase Date, or (y) the maximum number of shares which may be purchased pursuant to Section 10(a) below with respect to the applicable Purchase Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">PURCHASE PRICE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Purchase Price at which each share of Common Stock may be acquired in an Offering Period shall be established by the Committee&#59; provided, however, that the Purchase Price on each Purchase Date shall not be less than eighty-five percent (85%) of the lesser of (a)&#160;the Fair Market Value of a share of Common Stock on the Offering Date of the Offering Period or (b)&#160;the Fair Market Value of a share of Common Stock on the Purchase Date. Subject to adjustment as provided by the Plan and unless otherwise provided by the Committee, the Purchase Price for each Offering Period shall be eighty-five percent (85%) of the lesser of (a)&#160;the Fair Market Value of a share of Common Stock on the Offering Date of the Offering Period or (b)&#160;the Fair Market Value of a share of Common Stock on the Purchase Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">PAYMENT OF PURCHASE PRICE&#59; PAYROLL DEDUCTION CHANGES&#59; SHARE ISSUANCES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Price shall be accumulated by regular payroll deductions made during each Offering Period, unless the Committee determines with respect to categories of Participants outside the United States that contributions may be made in another form due to local legal requirements or if the Participants are participating in the Non-423 Component. The deductions are made as a percentage of the Participant&#8217;s compensation in one percent (1%) increments not less than one percent (1%), nor greater than fifteen percent (15%) after taking into account any such lower limit set by the Committee. Compensation shall mean regular base wages or salary, overtime payments, shift premiums and payments for paid time off, calculated before deduction of (i) any income or employment tax withholdings or (ii) any amounts deferred pursuant to Section 401(k) or Section 125 of the Code. Compensation shall be limited to such amounts actually payable in cash or deferred during the Offering Period. Compensation shall not include (A) sign-on bonuses, annual or other incentive bonuses, commissions, profit-sharing distributions or other incentive-type payments, (B) any contributions made by a Participating Company on the Participant&#8217;s behalf to any employee benefit or welfare plan now or hereafter established (other than amounts deferred pursuant to Section 401(k) or Section 125 of the Code), (C) payments in lieu of notice, payments pursuant to a severance agreement, termination pay, moving allowances, relocation payments, or (D) any amounts directly or indirectly paid pursuant to the Plan or any other stock purchase, stock option or other stock-based compensation plan, or any other compensation not expressly included by this Section. For purposes of determining a Participant&#8217;s Compensation, any election by such Participant to reduce his or her regular cash remuneration under Sections 125 (i.e. pre-tax cafeteria plan contributions) or 401(k) (i.e. pre-tax retirement contributions) of the Code (or in foreign jurisdictions, equivalent salary deductions) shall be treated as if the Participant did not make such election and as if such reductions were not </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made. Payroll deductions shall commence on the first payday following the last Purchase Date and shall continue to the end of the Offering Period unless sooner altered or terminated as provided in this Plan. Notwithstanding the foregoing, the terms of any sub-plan may permit matching shares without the payment of any purchase price.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Committee may (i) reduce the maximum percentage of compensation a Participant may elect to set aside as payroll deductions if the Committee determines, in its discretion, that it is necessary or advisable for legal or administrative reasons and (ii) require that a lesser percentage of a Participant&#8217;s compensation than indicated by the Participant may be contributed if necessary to comply with applicable laws (in particular, applicable laws related to minimum salary requirements). The Committee may require a Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">A Participant may decrease (but not increase) the rate of payroll deductions during an Offering Period by filing with the Company a new authorization (or any electronic or online authorization form provided by the Company) for payroll deductions, with the new rate to become effective no later than the second payroll period commencing after the Company&#8217;s receipt of the authorization or once any trading restrictions are lifted and continuing for the remainder of the Offering Period unless changed as described below. A decrease in the rate of payroll deductions may be made once during a Purchase Period or more frequently under rules determined by the Committee. A Participant may increase or decrease the rate of payroll deductions for any subsequent Purchase Period by filing with the Company a new authorization for payroll deductions prior to the beginning of the Offering Period for such applicable Purchase Period, or such other time period as specified by the Committee.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">A Participant may reduce his or her payroll deduction percentage to zero during an Offering Period by filing with the Company a request (or any electronic or online request form provided by the Company) for cessation of payroll deductions. Such reduction shall be effective beginning no later than the second payroll period after the Company&#8217;s receipt of the request or once any trading restrictions are lifted and no further payroll deductions will be made for the duration of the Offering Period. Payroll deductions credited to the Participant&#8217;s account prior to the effective date of the request shall be used to purchase shares of Common Stock in accordance with Subsection (e) below. A reduction of the payroll deduction percentage to zero shall be treated as such Participant&#8217;s withdrawal from such Offering Period and the Plan, effective as of the day after the next Purchase Date following the filing date of such request with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">All payroll deductions made for a Participant are credited to his or her account under this Plan and are deposited with the general funds of the Company, except to the extent local legal restrictions outside the United States require segregation of such payroll deductions. No interest accrues on the payroll deductions, except to the extent required due to local legal requirements. All payroll deductions received or held by the Company may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions, except to the extent necessary to comply with local legal requirements outside the United States.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">On each Purchase Date, so long as this Plan remains in effect and provided that the Participant has not submitted a signed and completed withdrawal form before that date which notifies the Company that the Participant wishes to withdraw from that Offering Period under this Plan and have all payroll deductions accumulated in the account maintained on behalf of the Participant as of that date returned to the Participant, the Company shall apply the funds then in the Participant&#8217;s account to the purchase of whole shares of Common Stock reserved under the option granted to such Participant with respect to the Offering Period to the extent that such option is exercisable on the Purchase Date. The Purchase Price per share shall be as specified in Section&#160;8 of this Plan. Any fractional share, as calculated under this Subsection (e), shall be rounded down to the next lower whole share, unless the Committee determines with respect to all Participants that any fractional share shall be credited as a fractional share. Any amount remaining in a Participant&#8217;s account on a Purchase Date which is less than the amount necessary to purchase a full share of Common Stock shall be returned to the Participant, without interest (except to the extent necessary to comply with local legal requirements outside of the United States), unless the Committee determines that such amount shall be applied to the Participant&#8217;s account, without interest (except to the extent necessary to comply with local legal requirements outside the United States). In the event that this Plan has been oversubscribed, all funds not used to purchase shares on the Purchase Date shall be returned to the Participant, without interest (except to the extent required due to local legal requirements outside the United States). No Common Stock shall be purchased on a Purchase Date on behalf of any employee whose participation in this Plan has terminated prior to such Purchase Date, except to the extent required due to local legal requirements outside the United States.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">As promptly as practicable after the Purchase Date, the Company shall issue shares for the Participant&#8217;s benefit representing the shares purchased upon exercise of his or her option.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Unless determined otherwise by the Committee, the shares issued pursuant to Section 9(f) above shall be deposited into an account established in the Participant&#8217;s name at the ESPP Broker. Subject to any applicable insider trading policy, a Participant shall be free to undertake a disposition (as that term is defined in Section 424(c) of the Code) of the shares in his or her ESPP Broker account at any time but in the absence of such a disposition of the shares, the shares must remain in the Participant&#8217;s ESPP Broker account until the holding period set forth in Section&#160;423(a) of the Code has been satisfied. With respect to shares for which the Section&#160;423(a) holding period has been satisfied, the Participant may move those shares to another brokerage account of Participant&#8217;s choosing. Notwithstanding the above, a Participant who is participating in the Non-423 Component may move his or her shares to another brokerage account of his or her choosing at any time, without regard to the satisfaction of the Section&#160;423(a) holding period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">During a Participant&#8217;s lifetime, his or her option to purchase shares hereunder is exercisable only by him or her. The Participant will have no interest or voting right in shares covered by his or her option until such option has been exercised.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">A Participant shall make arrangements satisfactory to the Company for the satisfaction of all Tax-Related Items in connection with the Plan. The Company or any Subsidiary or Affiliate, as applicable, may satisfy all applicable withholding obligations with regard to Tax-Related Items by any method permissible under applicable law, including any withholding required to make available to the Company or Subsidiary or Affiliate, as applicable, any tax deductions or benefits attributable to the sale or (if applicable) early disposition of shares of Common Stock by a Participant. The Company shall not be required to issue any shares of Common Stock under the Plan until such obligations are satisfied.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">LIMITATIONS ON SHARES TO BE PURCHASED</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Notwithstanding any provision of the Plan to the contrary, no Participant shall be given a right to purchase shares which permits his or her right to purchase shares of Common Stock under the Plan to accrue at a rate which, when aggregated with such Participant&#8217;s rights to purchase shares under all other employee stock purchase plans of the Company, its parent or its Subsidiary intended to meet the requirements of Section 423 of the Code, to exceed Twenty-Five Thousand Dollars ($25,000) in Fair Market Value (or such other limit, if any, as may be imposed by the Code) for each calendar year in which such right is outstanding at any time. For purposes of the preceding sentence, the Fair Market Value of shares purchased during a given Offering Period shall be determined as of the Offering Date for such Offering Period. The limitation described in this Section shall be applied in conformance with Section 423(b)(8) of the Code and the regulations thereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Initially, a Participant shall not be permitted to purchase more than 20,000 shares on any one Purchase Date. The Committee may, in its sole discretion, set a new maximum number of shares which may be purchased by any employee at any single Purchase Date, which shall then be the Maximum Share Amount for subsequent Offering Periods. If a lower limit is set under this Subsection (b), then all Participants will be notified of such limit prior to the commencement of the next Offering Period for which it is to be effective. If a new Maximum Share Amount is set, then all Participants must be notified of such Maximum Share Amount prior to the commencement of the next Offering Period for which it is to be effective. The Maximum Share Amount shall continue to apply with respect to all succeeding Purchase Dates and Offering Periods unless revised by the Committee as set forth above.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">If the number of shares to be purchased on a Purchase Date by all Participants exceeds the number of shares then available for issuance under this Plan, then the Company will make a pro rata allocation of the remaining shares in as uniform a manner as shall be reasonably practicable and as the Committee shall determine to be equitable. In such event, the Company shall give written notice of such reduction of the number of shares to be purchased under a Participant&#8217;s option to each Participant affected.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Any payroll deductions accumulated in a Participant&#8217;s account which are not used to purchase stock due to the limitations in this Section 10 shall be returned to the Participant as soon as practicable after the end of the applicable Purchase Period, without interest.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant is precluded by Subsection (a) from purchasing additional Common Stock under the Plan, then his or her employee contributions may be automatically discontinued by the Company and shall automatically resume at the beginning of the earliest Purchase Period that will end in the next calendar year (if he or she then is an eligible employee), provided that when the Company automatically resumes such payroll deductions, the Company must apply the rate in effect immediately prior to such suspension.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Any payroll deductions accumulated in a Participant&#8217;s account which are not used to purchase stock due to the limitations in this Section 10, and not covered by Section 9(e), shall be returned to the Participant as soon as practicable after the end of the applicable Purchase Period, without interest (except to the extent required due to local legal requirements outside the United States).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">WITHDRAWAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Each Participant may withdraw from an Offering Period under this Plan pursuant to a method specified for such purpose by the Company. Such withdrawal may be elected at any time prior to the end of an Offering Period, or such other time period as specified by the Committee.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Upon withdrawal from this Plan, the accumulated payroll deductions shall be returned to the withdrawn Participant, without interest (except to the extent required due to local legal requirements outside the United States), and his or her interest in this Plan shall terminate. In the event a Participant voluntarily elects to withdraw from this Plan, he or she may not resume his or her participation in this Plan during the same Offering Period, but he or she may participate in any Offering Period under this Plan which commences on a date subsequent to such withdrawal by filing a new authorization for payroll deductions in the same manner as set forth in Section 6 above for initial participation in this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">TERMINATION OF EMPLOYMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Termination of a Participant&#8217;s employment for any reason, including retirement, death, disability, or the failure of a Participant to remain an eligible employee of the Company or of a Participating Corporation, immediately terminates his or her participation in this Plan. In such event, accumulated payroll deductions credited to the Participant&#8217;s account will be returned to him or her or, in the case of his or her death, to his or her legal representative, without interest (except to the extent required due to local legal requirements outside the United States). For purposes of this Section 12, an employee will not be deemed to have terminated employment or failed to remain in the continuous employ of the Company or of a Participating Corporation in the case of sick leave, military leave, or any other leave of absence approved by the Company&#59; provided that such leave is for a period of not more than ninety (90) days or reemployment upon the expiration of such leave is guaranteed by contract or statute (except as otherwise required under applicable law). The Company will have sole discretion to determine whether a Participant has terminated employment and the effective date on which the Participant terminated employment, regardless of any notice period or garden leave required under local law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">RETURN OF PAYROLL DEDUCTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event a Participant&#8217;s interest in this Plan is terminated by withdrawal, termination of employment or otherwise, or in the event this Plan is terminated by the Board, the Company shall deliver to the Participant all accumulated payroll deductions credited to such Participant&#8217;s account. No interest shall accrue on the payroll deductions of a Participant in this Plan (except to the extent required due to local legal requirements outside the United States).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">CAPITAL CHANGES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the number of outstanding shares is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then the Committee shall adjust the number and class of Common Stock that may be delivered under the Plan, the Purchase Price per share and the number of shares of Common Stock covered by each option under the Plan which has not yet been exercised, and the numerical limits of Sections 2 and 10 shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with the applicable securities laws&#59; provided that fractions of a share will not be issued.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">NONASSIGNABILITY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither payroll deductions credited to a Participant&#8217;s account nor any rights with regard to the exercise of an option or to receive shares under this Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 22 below) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition shall be void and without effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">USE OF PARTICIPANT FUNDS AND REPORTS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may use all payroll deductions received or held by it under the Plan for any corporate purpose and the Company will not be required to segregate Participant payroll deductions (except to the extent required due to local legal requirements outside the United States). Until shares are issued, a Participant will only have the rights of an unsecured creditor unless otherwise required under local law. Each Participant shall receive promptly after the end of each Purchase Period a report of his or her account setting forth the total payroll deductions accumulated, the number of shares purchased, the per share price thereof and the remaining cash balance, if any, carried forward to the next Purchase Period or Offering Period, as the case may be.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">NOTICE OF DISPOSITION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each U.S. taxpayer Participant shall notify the Company in writing if the Participant disposes of any of the shares purchased in any Offering Period pursuant to this Plan if such disposition occurs within the Notice Period. The Company may, at any time during the Notice Period, place a legend or legends on any certificate representing shares acquired pursuant to this Plan requesting the Company&#8217;s transfer agent to notify the Company of any transfer of the shares. The obligation of the Participant to provide such notice shall continue notwithstanding the placement of any such legend on the certificates.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">NO RIGHTS TO CONTINUED EMPLOYMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither this Plan nor the grant of any option hereunder shall (a) form or amend an employment or service agreement, (b) confer any right on any employee to remain in the employ of the Company or any Participating Corporation, or (c) restrict the right of the Company or any Participating Corporation to terminate such employee&#8217;s employment at any time, subject to compliance with applicable law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">EQUAL RIGHTS AND PRIVILEGES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All eligible employees granted an option under this Plan that is intended to meet the Code Section 423 requirements shall have equal rights and privileges with respect to this Plan or within any separate offering under the Plan so that this Plan qualifies as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 or any successor provision of the Code and the related regulations. Any provision of this Plan which is inconsistent with Section 423 or any successor provision of the Code, without further act or amendment by the Company, the Committee or the Board, shall be reformed to comply with the requirements of Section 423. This Section 19 shall take precedence over all other provisions in this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">NOTICES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All notices or other communications by a Participant to the Company under or in connection with this Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">TERM&#59; STOCKHOLDER APPROVAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Plan (as amended and restated) will become effective on the Effective Date. This Plan shall be approved by the stockholders of the Company, in any manner permitted by applicable corporate law, within twelve (12) months before or after the date this Plan is adopted by the Board. No purchase of shares that are subject to such stockholder approval before becoming available under this Plan shall occur prior to stockholder approval of such shares and the Board or Committee may delay any Purchase Date and postpone the commencement of any Offering Period subsequent to such Purchase Date as deemed necessary or desirable to obtain such approval (provided that if a Purchase Date would occur more than twelve (12) months after commencement of the Offering Period to which it relates, then such Purchase Date shall not occur and instead such Offering Period shall terminate without the purchase of such shares and Participants in such Offering Period shall be refunded their contributions without interest, unless otherwise required under applicable law). This Plan shall continue until the earlier to occur of (a) termination of this Plan by the Board (which termination may be effected by the Board at any time pursuant to Section 25 below), or (b) issuance of all of the shares of Common Stock reserved for issuance under this Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">DESIGNATION OF BENEFICIARY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Unless otherwise determined by the Committee, a Participant may file a written designation of a beneficiary who is to receive any cash from the Participant&#8217;s account under this Plan in the event of such Participant&#8217;s death prior to a Purchase Date. Such form shall be valid only if it was filed with the Company at the prescribed location before the Participant&#8217;s death.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Such designation of beneficiary may be changed by the Participant at any time by written notice filed with the Company at the prescribed location before the Participant&#8217;s death. In the event of the death of a Participant and in the absence of a beneficiary validly designated under this Plan who is living at the time of such Participant&#8217;s death, the Company shall deliver such cash to the executor or administrator of the estate of the Participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such cash to the spouse or, if no spouse is known to the Company, then to any one or more dependents or relatives of the Participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate (except to the extent required due to local legal requirements outside the United States).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">CONDITIONS UPON ISSUANCE OF SHARES&#59; LIMITATION ON SALE OF SHARES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Shares shall not be issued with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange or automated quotation system upon which the shares may then be listed, exchange control restrictions and&#47;or securities law restrictions outside the United States, and shall be further subject to the approval of counsel for the Company with respect to such compliance. Shares may be held in trust or subject to further restrictions as permitted by any subplan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">APPLICABLE LAW</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Plan shall be governed by the substantive laws (excluding the conflict of laws rules) of the State of Delaware.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">AMENDMENT OR TERMINATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee, in its sole discretion, may amend, suspend, or terminate the Plan, or any part thereof, at any time and for any reason. If the Plan is terminated, the Committee, in its discretion, may elect to terminate all outstanding Offering Periods either immediately or upon completion of the purchase of shares of Common Stock on the next Purchase Date (which may be sooner than originally scheduled, if determined by the Committee in its discretion), or may elect to permit Offering Periods to expire in accordance with their terms (and subject to any adjustment pursuant to Section 14). If an Offering Period is terminated prior to its previously-scheduled expiration, all amounts then credited to Participants&#8217; accounts for such Offering Period, which have not been used to purchase shares of Common Stock, shall be returned to those Participants (without interest thereon, except as otherwise required under local laws) as soon as administratively practicable. Further, the Committee will be entitled to change the Purchase Periods and Offering Periods, limit the frequency and&#47;or number of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld or contributed in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the administration of the Plan, establish reasonable waiting and adjustment periods and&#47;or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant properly correspond with amounts withheld from the Participant&#8217;s base salary and other eligible compensation, and establish such other limitations or procedures as the Committee determines in its sole discretion advisable which are consistent with the Plan. Such actions will not require stockholder approval or the consent of any Participants. However, no amendment shall be made without approval of the stockholders of the Company (obtained in accordance with Section 21 above) within twelve (12) months of the adoption of such amendment (or earlier if required by Section 21) if such amendment would&#58; (a) increase the number of shares that may be issued under this Plan&#59; or (b) change the designation of the employees (or class of employees) eligible for participation in this Plan. In addition, in the event the Board or Committee determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Board or Committee may, in its discretion and, to the extent necessary or desirable, modify, amend or terminate the Plan to reduce or eliminate such accounting consequences including, but not limited to&#58; (i) amending the definition of compensation, including with respect to an Offering Period underway at the time&#59; (ii) altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase Price&#59; (iii) shortening any Offering Period by setting a Purchase Date, including an Offering Period underway at the time of the Committee&#8217;s action&#59; (iv) reducing the maximum percentage of compensation a Participant may elect to set aside as payroll deductions&#59; and (v) reducing the maximum number of shares a Participant may purchase during any Offering Period. Such modifications or amendments will not require approval of the stockholders of the Company or the consent of any Participants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">CORPORATE TRANSACTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of a Corporate Transaction, the Offering Period for each outstanding right to purchase Common Stock will be shortened by setting a new Purchase Date and will end on the new Purchase Date (unless otherwise specified in the agreement effecting the applicable Corporate Transaction). The new Purchase Date shall occur on or prior to the consummation of the Corporate Transaction, as determined by the Board or Committee, and the Plan shall terminate on the consummation of the Corporate Transaction (unless otherwise specified in the agreement effecting the applicable Corporate Transaction).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">CODE SECTION 409A&#59; TAX QUALIFICATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted under the Plan are intended to be exempt from the application of Section 409A. Neither the&#160;Non-Section 423&#160;Component nor any Option granted pursuant to an Offering thereunder is intended to constitute or provide for &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A. Notwithstanding any provision of the Plan to the contrary, if the Company determines that any Option granted under the Plan may be or become subject to Section&#160;409A or that any provision of the Plan may cause an Option granted under the Plan to be or become subject to Section&#160;409A, the Company may adopt such amendments to the Plan and&#47;or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions as the Company determines are necessary or appropriate to avoid the imposition of taxes under Section&#160;409A, either through compliance with the requirements of Section&#160;409A or with an available exemption therefrom.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">DEFINITIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) any entity that, directly or indirectly, is controlled by, controls or is under common control with, the Company and (ii) any entity in which the Company has a significant equity interest, in either case as determined by the Committee, whether now or hereafter existing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the Compensation Committee of the Board that consists exclusively of one or more members of the Board appointed by the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the common stock of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean Dexcom, Inc.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i)&#160;any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean May 8, 2025, the date on which the Company obtained the stockholder approval pursuant to Section 21.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP Broker</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean a stock brokerage or other entity designated by the Company to establish account for stock purchased under the Plan by Participants.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean, as of any date, the value of a share of Common Stock determined as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">if such Common Stock is then quoted on the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nasdaq Market</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), its closing price on the Nasdaq Market on the date of determination, or if there are no sales for such date, then the last preceding business day on which there were sales, as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Board or the Committee deems reliable&#59; or</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Board or the Committee deems reliable&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">if such Common Stock is publicly traded but is neither quoted on the Nasdaq Market nor listed or admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Board or the Committee deems reliable&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">if none of the foregoing is applicable, by the Board or the Committee in good faith.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-423 Component</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means that component of the Plan pursuant to which a right to purchase Common Stock may be granted that is not intended to satisfy the requirements of Section 423 of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean within two (2) years from the Offering Date or within one (1) year from the Purchase Date on which such shares were purchased.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:21.01pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the first business day of each Offering Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Offering Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean a period with respect to which the right to purchase Common Stock may be granted under the Plan, as determined by the Committee pursuant to Section 5(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the same meaning as &#8220;parent corporation&#8221; in Sections 424(e) and 424(f) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean an eligible employee who meets the eligibility requirements set forth in Section 4 and who is either automatically enrolled in the initial Offer Period or who elects to participate in this Plan pursuant to Section 6(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participating Corporation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean any Parent, Subsidiary or Affiliate that the Committee designates from time to time as eligible to participate in this Plan, provided, however, that employees of Affiliates that are designated for participation may be granted only options under the Non-423 Component.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.01pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean this Amended and Restated Dexcom, Inc. 2015 Employee Stock Purchase Plan, as amended from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the last business day of each Purchase Period.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean a period during which contributions may be made toward the purchase of Common Stock under the Plan, as determined by the Committee pursuant to Section 5(b).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean the price at which Participants may purchase shares of Common Stock under the Plan, as determined pursuant to Section 8.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the same meaning as &#8220;subsidiary corporation&#8221; in Sections&#160;424(e) and 424(f) of the Code.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean any or all income tax, social insurance contributions, payroll tax, payment on account or other tax-related items arising in connection with a Participant&#8217;s participation in the Plan and legally applicable to the Participant.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dxcm-20250508.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:1e684ce9-be39-49f9-b3e2-659eabc59be1,g:2d5e0c7d-e698-4991-ba3f-2e2e0964c401-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dxcm="http://www.dexcom.com/20250508" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dexcom.com/20250508">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20250508_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20250508_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.dexcom.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>dxcm-20250508_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:1e684ce9-be39-49f9-b3e2-659eabc59be1,g:2d5e0c7d-e698-4991-ba3f-2e2e0964c401-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_a9161767-fb18-42cc-a073-1831d0a7334c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_074bea01-c016-4dda-a1da-19e49f6bfe54_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d2de8569-73f6-4b36-9063-4847d64fbd38_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d2ad8adc-d230-46f9-95e6-cc7e5126f3b5_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_415558d8-dcd4-4e90-bbdd-005ca5ed0af8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_e6db4f0a-2076-4c96-b113-f6c4c7d005a5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ea5570b0-61a8-4869-97a4-a72dc212e971_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_270211f9-1e24-422b-9914-37fa36f86427_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_dad2a659-ce79-432b-a046-f1039750e67a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_53fb9d14-110d-4c5c-9de6-c1a49d408318_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_08f447aa-064e-462e-b6ba-0d555b24cfbf_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_38550b1d-22df-43ba-be68-22714a67d57b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bcff5f43-4073-4ebd-baf8-8b6a97aa8252_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3f20446b-af1d-4311-a26a-c090ad912821_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_63375adb-2fc4-4534-800f-272c72b26f85_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d9e9c5f8-18ac-49cb-8def-5dc6bb81ddf3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cdede7f8-199a-4739-9505-cf58d9d432ce_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8c7772cc-80f2-48f7-b8ca-ff686ef3170a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_aeda49bd-55aa-4f65-9a1e-16a050c9f790_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_db046c42-b13c-4a5b-88da-234cff3cabd9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b304cdb5-d2b4-46f9-bf6b-571624a90b24_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_eed81c8d-01d6-444b-8df7-e75de3229c7c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_914811d7-7e8d-448b-a30e-6571bec4af43_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>dxcm-20250508_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:1e684ce9-be39-49f9-b3e2-659eabc59be1,g:2d5e0c7d-e698-4991-ba3f-2e2e0964c401-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:type="simple" xlink:href="dxcm-20250508.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c2623a20-e678-4cf1-b593-8a95ee77f6f5" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_DocumentType_c2623a20-e678-4cf1-b593-8a95ee77f6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_59fbff25-3f46-4685-9d70-2e38fe800a22" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_DocumentPeriodEndDate_59fbff25-3f46-4685-9d70-2e38fe800a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f9ed49f8-91f6-4c6e-9104-66602c921078" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_AmendmentFlag_f9ed49f8-91f6-4c6e-9104-66602c921078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c6514594-f500-4837-9230-39a2eea688b4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityCentralIndexKey_c6514594-f500-4837-9230-39a2eea688b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8986aea6-a07f-4cfe-8193-9c7418f59796" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2870238b-9578-4c06-8246-60fc3a040ab4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityRegistrantName_2870238b-9578-4c06-8246-60fc3a040ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8b80b66f-bdfe-436c-b683-813132748452" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8b80b66f-bdfe-436c-b683-813132748452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1c417cbb-3f40-47b1-ab08-62697ab83723" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityFileNumber_1c417cbb-3f40-47b1-ab08-62697ab83723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_4f7b7508-ffd6-4f80-a9dc-3cdb57af597f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityTaxIdentificationNumber_4f7b7508-ffd6-4f80-a9dc-3cdb57af597f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ee5086aa-ee7e-4351-8ec6-72f4aec48b26" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityAddressAddressLine1_ee5086aa-ee7e-4351-8ec6-72f4aec48b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8ac6c4f4-4060-4072-9993-f2aecb98f9aa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityAddressCityOrTown_8ac6c4f4-4060-4072-9993-f2aecb98f9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1b6a49bb-4162-4e0d-8a33-e70f289664a1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityAddressStateOrProvince_1b6a49bb-4162-4e0d-8a33-e70f289664a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c71f718c-bdc8-43ff-bd22-ef1405f03438" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityAddressPostalZipCode_c71f718c-bdc8-43ff-bd22-ef1405f03438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fa46c4a5-635e-4c42-a5a9-7e144cc23331" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_CityAreaCode_fa46c4a5-635e-4c42-a5a9-7e144cc23331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8e3329de-53b3-4987-bea1-01cd7f7fb9ed" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_LocalPhoneNumber_8e3329de-53b3-4987-bea1-01cd7f7fb9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5a4fe034-1078-4ffb-bf41-a27287ccb4a4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_WrittenCommunications_5a4fe034-1078-4ffb-bf41-a27287ccb4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_d1ce9e1c-d035-41fe-95b6-c5ee45f8b54e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_SolicitingMaterial_d1ce9e1c-d035-41fe-95b6-c5ee45f8b54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_00600fb9-ac67-45b5-a75b-cb6a13210d18" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_PreCommencementTenderOffer_00600fb9-ac67-45b5-a75b-cb6a13210d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_0cb07985-1833-469b-8f40-05d6c617a379" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_0cb07985-1833-469b-8f40-05d6c617a379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d81144be-cc39-4315-aabf-63cbef1a8cac" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_Security12bTitle_d81144be-cc39-4315-aabf-63cbef1a8cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d2dbd2b9-1688-4287-8068-89fca53482aa" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_TradingSymbol_d2dbd2b9-1688-4287-8068-89fca53482aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ea99b94b-eeb3-453e-a427-4fcc20796644" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_SecurityExchangeName_ea99b94b-eeb3-453e-a427-4fcc20796644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1e4e6011-804b-4709-8070-d79c84316d50" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_fa014ae2-1b3c-4d68-8e26-b275721eecd8" xlink:to="loc_dei_EntityEmergingGrowthCompany_1e4e6011-804b-4709-8070-d79c84316d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>dxcm-20250508_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20250508_g1.jpg
M_]C_X  02D9)1@ ! @$$L 2P  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M_?R@",T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M[R<E]TKK\#KO^&GO%W_00_\ )>V_^-5O_:57^;\(_P"1V_ZP8G^?_P DA_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?YOPC_D'^L&)_G_ /)(?_(A_P -/>+O^@A_Y+VW_P :H_M*K_-^$?\ (/\
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M()[Z>+IU-I+7I>S^YZGMT<SHUK<LXZNR3:3O>VSL_334]&KK/3"@ H * "@
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M ,DA_P#(A_PT]XN_Z"'_ )+VW_QJC^TJO\WX1_R#_6#$_P __DD/_D30TO\
M:K\5:?,LDEU'<(N<Q201!&R".3$L;\9R-K#D#.1D&HYI53O>_DTOT29I3XCQ
M,'=R4O)QC;_R51?XG7?\-G^(/^?:P_[]S?\ Q^NC^V*G:/W/_P"2.S_6JO\
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ME0RDCC<.HX7G7:/_ )-_P$>-+BUVTIZVTO.ZOZ<JO]Z]3B?^&S_$'_/M8?\
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M_P#DD/\ Y$X'_A:WB#_H*W__ (%S?_%US?6JG\TO_ G_ )GG?VC7_P"?D_\
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M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * /,O''QBT/X>K)]NNX_.CX-O&0\Y8H75?+4Y7<,89]B?,N7 8&N.
MMBX4?B>O9:O:^W^>AY6+S2CA+\\E=?96LMKK1;7[NRVU/C[QW^V;=7;-%HEL
ML,95AYUP-\N64898U;8A4[L;C,K?*2HY4^%7SAO2"MYO?[MOS/B\9Q5*6E&-
ME9ZRU>V]D[*VN_-?3T/F3Q=\7-=\=*4U"^FEC*JK1 B.)@K;ANBC"HQ!YW%2
MW"\_*,>/5Q<ZOQ-ORV7W*R/E<3F=;$Z3FVK;;+1WVC9/UL><UR'F!0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 >NZ'\>O$_A[?Y.I7#;\9\XBXQMSC;YXDV]>
M=N-W&<X&.Z&.J0VD_GK^=SV:.<XBE>TY:_S>_P#^E7M\CZ;\%_MI_>76[/U*
MR6G_  '"F.5_]XEQ)_=7R^K5[%'./YU\X_Y-_K\CZK"<5_\ /V/HX?+2TGZZ
MW^74^R?!_CW3/'T)GTRYCN$7[P4D.F2P&^-@'3.UMNY1N R,CFO?I5XUE>+O
M_7;<^VPN,IXI7IR4OS6^Z=FMM+K4ZZMSM"@ H * "@ H * "@ H * "@ H *
M "@"AJFJV^B0M<74L<$*8W22.J(N2 ,LQ &20!D\D@=34RDH*[=EW>AG4J1I
MKFDTDNK:2[;L\JUK]H/PMH,@BFU*%F*A@80\ZX)(Y>%74'C[I.X#!Q@@GBGC
MZ4-')?*[_*YY%7.\/2=G-;?9O)??%-?(Q_\ AI[PC_T$/_)>Y_\ C59_VE2_
MF_"7^1C_ *P8;^?_ ,DG_P#(A_PT]X1_Z"'_ )+W/_QJC^TJ7\WX2_R#_6##
M?S_^23_^1#_AI[PC_P!!#_R7N?\ XU1_:5+^;\)?Y!_K!AOY_P#R2?\ \B'_
M  T]X1_Z"'_DO<__ !JC^TJ7\WX2_P @_P!8,-_/_P"23_\ D0_X:>\(_P#0
M0_\ )>Y_^-4?VE2_F_"7^0?ZP8;^?_R2?_R(?\-/>$?^@A_Y+W/_ ,:H_M*E
M_-^$O\@_U@PW\_\ Y)/_ .1#_AI[PC_T$/\ R7N?_C5']I4OYOPE_D'^L&&_
MG_\ ))__ "(?\-/>$?\ H(?^2]S_ /&J/[2I?S?A+_(/]8,-_/\ ^23_ /D0
M_P"&GO"/_00_\E[G_P"-4?VE2_F_"7^0?ZP8;^?_ ,DG_P#(FAI?[1GA75YE
M@CU&-7;.#(DL2< GF25$1>G&YADX R2 :CF%*3MS?>FOQ:2-*>>8:H[*:U[J
M45]\DE^)[):7<=_&DT+K)'(H9'4AE96&0RD<$$<@C@CFO03OJCVXR4E=:IJZ
M:U5BQ3*"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#R+7/CUX8
M\/;/.U*W;?G'DDW&-N,[O($FWKQNQNYQG!QPSQU.&\E\M?RN>-6SG#TK7G'7
M^7W_ /TF]OF8'_#3WA'_ *"'_DO<_P#QJLO[2I?S?A+_ ".?_6##?S_^23_^
M1#_AI[PC_P!!#_R7N?\ XU1_:5+^;\)?Y!_K!AOY_P#R2?\ \B'_  T]X1_Z
M"'_DO<__ !JC^TJ7\WX2_P @_P!8,-_/_P"23_\ D0_X:>\(_P#00_\ )>Y_
M^-4?VE2_F_"7^0?ZP8;^?_R2?_R(?\-/>$?^@A_Y+W/_ ,:H_M*E_-^$O\@_
MU@PW\_\ Y)/_ .1#_AI[PC_T$/\ R7N?_C5']I4OYOPE_D'^L&&_G_\ ))__
M "(?\-/>$?\ H(?^2]S_ /&J/[2I?S?A+_(/]8,-_/\ ^23_ /D0_P"&GO"/
M_00_\E[G_P"-4?VE2_F_"7^0?ZP8;^?_ ,DG_P#(A_PT]X1_Z"'_ )+W/_QJ
MC^TJ7\WX2_R#_6##?S_^23_^1#_AI[PC_P!!#_R7N?\ XU1_:5+^;\)?Y!_K
M!AOY_P#R2?\ \B>NZ'XKT_Q/O^P75O<^7C?Y,J2;=V=N[83C.#C/7!]*[H58
MU/A:=NS3_(]FCB85K\DHRMORR3W]&^QOUJ= 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0!0U35;?1(6N+J6."%,;I)'5$7) &68@#)( R>20.IJ924%=NR[
MO0SJ5(TUS2:275M)=MV?)OB[]LG1](8IIMO-?,&7YR?(B*E<DJ65I,@X7:T:
M@_,0V -WAU<WA'X4Y?@O\_P/C\3Q32IZ4TYZ[_"K6\TWY:I>O?Y=\2_M4>)_
M$.Y4GCM(VC*,EO&%SG.6#R>9(KX. 4==N 1ALD^-4S.I/K;3HO\ .[_$^3K\
M18BKLU%-6M%6^=W=I^C7EJ>!ZIJMQK<S7%U+)/,^-TDCL[M@ #+,23@  9/
M '05YLI.;NW=]WJ?.U*DJCYI-MOJVV^V[,^H,PH * "@ H * "@ H * "@ H
M * "@#?T/Q7J'AC?]@NKBV\S&_R97CW;<[=VPC.,G&>F3ZUK"K*G\+:OV;7Y
M'31Q,Z-^24HWWY9-;>C7<]M\-?M4>)_#VU7GCNXUC"*EQ&&QC&&+Q^7(SX&"
M7=MV23EL$>A3S.I#K?3JO\K/\3W:'$6(I;M225K25_G=6;?JWYZGUSX'_:XT
M/Q,T<-\LFGS/P3(0\ 8N%5?-7!&00Q9TC1<-E\ %O=HYK"II+W7YZK?O_FDC
M[+"<2T:UE.\&^^L=[+5??=I):ZGTWI>JV^MPK<6LL<\+YVR1NKHV"0<,I(."
M"#@\$$=17L1DIJZ=UW6I]53J1J+FBTT^J::[;HOU1H% !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 5[N[CL(WFF=8XXU+.[$*JJHR68G@
M#DD\ <TF[:LF4E%7>B2NV]%8^9?'?[66A>%U9+$MJ%P&9=L>4B!5@#F9EP01
MN*-$LJMMZJ&#5X]?-(4_A]Y^6B^__*Y\KC.)*-#2'ON[VT6C[M?<TG?\3Y-\
M8_M8>(?$VZ.V>.QA;S%Q"N9"C\ -*^XAU'1XA$<DM@';M\2MFE2>WNK7;?[W
M^:L?'XKB2O6TC:"U^%:V?F[ZKNK=^UOG35-5N-;F:XNI9)YGQNDD=G=L  99
MB2<  #)X  Z"O*E)S=V[ON]3YFI4E4?-)MM]6VWVW9GU!F% !0 4 % !0 4
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MLX)4-M8=4<!@2C ,N>0#7MTZL:BO%W1]A0Q$,1'F@U)=T_*]GV>NSU1OUJ=
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M3"C\3M^+^Y7?0\[%YA2PG\225^FK?76R3=M-[6/D;QI^VG]U=$L_0M)=_P#
MLJ(XG_W2',G]Y?+Z-7AULX_D7SE_DG^OR/C<7Q7_ ,^H^KG\]+1?IK?Y=3Y<
M\3_&_P 1^,(_)O-0F,>UU9(]L*NK@!E<0J@<$#&'W  D#&XY\:IC:E31R?RT
MW]+7/D\1F]?$*TINUFK*T4T][\J5_F>55Q'D!0 4 % !0 4 % !0 4 % !0
M4 % 'HWA'XN:[X%4)I]]-%&%95B)$D2AFW';%(&123SN"AN6Y^8YZZ6+G2^%
MM>6Z^YW1Z>&S.MAM(3:5MMUJ[[2NEZV/I/P=^V??66V/5[2.X0>6IEA/E28'
M$CLAW([GA@J^2N01P"-OK4<XDOC5]M5H_/R?X'U&%XJG'2K%2VUC[K\W;5-^
M2Y5^GV#X$^->A?$5EBL;I?M!53]GD!CER5+%0K8$A4*V_P HNJXSNP03[U#&
M0K:1>O9Z/_@_*Y]I@\VHXO2$M;+W7H]KVUWM;6U['JM=IZX4 % !0 4 % 'A
M?C[]HOP_\/9/(FF:YN VUX;8+(R8+ [V+*BE2NUD+>8"0=F#FO-KYA3HZ-W?
M9:_\#Y;G@8W/*.$=F^9WU4;-K??5);:J]_(^-O%W[8.NZTQ73TAL(]RE2%$T
MN N"K/(-A!/S<1JPPHW'!+>!5S:<OAM'\7^.GX'Q&)XGK5/@2@K]N9[;7EI_
MY*O\_F76O$%YXDD$U]<37,@4*'FD:1@H)(4%R3C))QTR2>]>1.HYZR;?J[_F
M?*U:\JSO-N3M:\FV[?,QZS,0H * "@ H * "@ H * "@ H * -C1?$%YX;D,
MUC<36TA4J7AD:-BI()4E"#C(!QTR >U:0J.&L6UZ.WY&U*O*B[P;B[6O%M.W
MR/>_#'[5WB7PY'Y4DD-XH5%0W,9+*%!'WXVC9RW&YI"[$@'.2Q/IT\TJ0TT?
MJO\ *WXGT6'XCQ%%6;4M%;F6NGG%Q;\V[GTWX1_;)T?5V":E;S6+%F^<'SX@
MH7(+%563).5VK&P'RDM@G;Z]+-X2^)./XK_/\#ZK#<4TJFE1.&N_Q*UO))^6
MB?KV^LM+U6WUN%;BUECGA?.V2-U=&P2#AE)!P00<'@@CJ*]R,E-73NNZU/L*
M=2-1<T6FGU337;=%^J- H * "@!RT .H * //OBM_P B_JO_ %X7?_HEZY<5
M_#E_AE^3/.S'^!4_Z]S_ /26?B;7YZ?A04 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % '3Z+XVU3PW&8;&]NK:,L6*0SR1J6( +$(P
M&< #/7  [5M"M*&D6UZ-K\CKI8NI15H2E%7O:,FE?Y,]LT7]K'Q3I<A>:>&Z
M4J0(YH$"@Y!W PB)LC&.6*X)^7."/1AFE6.[3]4OTL>[2XDQ$'=M2TVE%6]?
M=Y7^)Z[H'[;4B+$FH:<K-N_>RP3%1M+=4B=6Y"_PF7#,/O*#QW4\Y_FCZM/]
M'_F>S1XL>BG#KJXRMI?HFGT_O:]T>^>$?VGO#7BQA&;AK.0LP"72B,$!=VXR
M M$H/(&YU8L,;>5W>G2S*G4ZV_Q:?CJOQ/H<-Q!AZ^G-RN^TU;I>]TW%?-_H
M>]VEW'?QI-"ZR1R*&1U(965AD,I'!!'((X(YKTT[ZH^BC)25UJFKIK56+%,H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H \3^*GQYTGX5J8Y6^T7AR%M8F4NIV;E,IS^Z0Y7D@L0VY4<!L>=BL=##[Z
MOLO3KV_K0\+,<YIX'1^]+^5-7VOKV6WGK=)GP!X^_:7\0>-I/W,[6%N&RD5L
MS(W!;&^4$.QPV& *QL5#>6I%?,5\QJ5=GRKLM/QW_3R/SK&Y_6Q+T?(KZ*+:
M?7=[O?79=;'SW7EGS84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 :&EZK<:),MQ:RR03)G;)&[(ZY!!PRD$9!(.#R"1T-7&3@[IV?=:&E.I*F^
M:+::ZIM/MNC[1^&/[8-U;21VWB!%EB9@#=QKMD0$L2SQH-K@94?NPC*BD[97
M.#]!ALV:TJ:KNM_N6_RM\S[G+^)Y1:C65U?XTK-;ZM+1]-K:=V?=_AKQ38^,
M+=;K3YX[B%L?,C9P2H;:PZHX# E& 9<\@&OI*=6-17B[H_0:&(AB(\T&I+NG
MY7L^SUV>J-^M3H"@ H * "@ H * "@ H * "@ H ^"/VX/\ F$_]OG_M"OF<
MZ^S_ -O?^VGYYQ;_ ,N_^XG_ +8? ]?,GYX% !0 4 % !0 4 % !0 4 % 'O
MGP&^-%Q\++Y8I'W:9<2*+F-MQ$><*9T"AB'4<L%!\Q1L(W!&3T\#C'AY6^RW
MK_G_ %O]Q]%DV:RP,[-^Y)KF6NG3F5KZKKW6G9K]<Z^Y/V0* "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H ^#_ -K+XS263'P]I\C(Q7_3V"D':ZJR
M0J^>C*=TN!@J43?@RI7S6:8RW[N/_;W^7^?_  Y^?<29JX_N(.VGOZ=&DTK^
M:>OR5]T? %?,'YT% !0 4 % !0 4 % !0 4 % &QH&OW7A>ZBO;*5H;B%MT<
MB]0>AX/!!&0RD%64E2""16E.HZ;NM&C:C6E0DIP=FGHU_7WKKLS]UZ_2#^@
MH * "@ H * "@ H * "@ H * "@ H X'X@_$S3/AC;BXU*79OW"*-06DE95R
M511^ +,512RAG7<,\M?$QH*\GZ+J_P"ON/.QN/IX*/-4=KWLMV[*^B_5V6JN
MU<^%_''[8^IZHTD>D0QVD)X260"6?AR=V#^Z7<N 4*R;<MB0G:5^<K9O*6D%
M9=WJ]_N_/U/@<7Q14G=4DHKHW[TM]^RNNEG;74^3M:\07GB2037UQ-<R!0H>
M:1I&"@DA07).,DG'3))[UXDZCGK)M^KO^9\=5KRK.\VY.UKR;;M\S'K,Q"@
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M^V?_ ,B_;?\ 7_'_ .B9Z\/./X:_Q+\I'QO%7\"/_7Q?^DS/S)KX\_*PH *
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M3K6C5]R7?>+V6^ZUOOHEO(^N:]P^R"@ H * "@ H * "@ H * "@ H * "@
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MYI-MOJVV^V[,^H,PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_3YVN[NW4\YKD/,"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MN]3\IJ5)5'S2;;?5MM]MV9]09A0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M+%8Y&0%B !G YP ,]A7YS6AR2<5T;7W.Q^"8NDJ-24%M&<DK[V3:.8K$Y H
M* "@ H * "@ H * +%I=R6$B30NT<D;!D=25964Y#*1R"#R".0>::=M45&3B
M[K1IW36CN%W=R7\CS3.TDDC%G=B69F8Y+,3R23R2>2>:&[ZL)2<G=ZMN[;U=
MRO2)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#8T#7[KPO
M=17ME*T-Q"VZ.1>H/0\'@@C(92"K*2I!!(K2G4=-W6C1M1K2H24X.S3T:_K[
MUUV9^R/PM^)5K\5=-74+96C.XQS1-R8Y5 ++NP PPP*L.JD9"MN1?O<-B%B(
M\R]&O,_;<NQ\<=3YXZ:V:?1Z:>>^C_)Z'HU=9Z8Y: '4 % 'GWQ6_P"1?U7_
M *\+O_T2]<N*_AR_PR_)GG9C_ J?]>Y_^DL_$VOST_"@H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^NOA
M)^U;?>$MMKK/F7MH-Y\W.^Z4GD#<[@2)G(PY# -P^U%C/NX3-)4])^\M==Y?
MB]?ZUZ'V66<1SH>[5O..NN\_O;U7KKKO9)'Z/:!K]KXHM8KVRE6:WF7='(O0
MCH>#R"#D,I 96!4@$$5]73J*HKK5,_3J-:->*G!W36C7]?>NFS->M#8* "@
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MK?@[;/M=(^BZ]4^F"@ H * "@ H * "@ H * /@C]L?X;?ZGQ!;)Z07>U?\
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M]Y^/XW'U,;+FJ.]KV6R5W?1?J[O17;L<#7*><% !0 4 % !0 4 % !0 4 %
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M_$#Q*=.EI&]G+K)>G1?BU:]M4?'M>"?%A0 4 % !0 4 % !0 4 % !0 4 %
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MJWX77FGSX4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5C.6,:*W;YGJUHKI+SN]=].7;8_/"OE3\V"@ H * "@ H * "@ H * "@ H
M^F_V5OAW_P )GK@O)1FVT[;,W/68D^0O#*PPRF3(#+^[V,,.*]C+,/[6=WM'
M7Y].OS^1]5P[@?K%;F?PT[2_[>^SU3W5^JTL]S]5*^T/UP* "@ H * "@ H
M* "@ H \Y^*7Q*M?A5IK:A<JTAW".&)>#)*P)5=V"%&%)9CT4' 9MJ-R8G$+
M#QYGZ)>9YF8X^.!I\\M=;)+J]=/+;5_F]#\A?''CB^^(E])?W\F^5^%4<)&@
MSMCC7)VH,G Y))+,6=F8_"UJTJTN:6_]:'XSB\7/%S<YN[?W)=EY?\.]3D*P
M.(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6
MK9M1HRKR4(*[;T2_K[WTW9^W'A30_P#A&-/M;#?YGV:WBAWXV[O+0)NVY.,X
MSC)QTR:_0Z4/9Q4>R2^Y6/WC#4?8PC"]^6,8WVV27GV-^M3H"@ H * "@ H
M* "@ H KW=W'81O-,ZQQQJ6=V(5551DLQ/  '))X YI-VU9,I**N]$E=MZ*Q
M^7?[07[04GQ)D;3]/9H]+C;D\JURRGAW'41@\QQGG.)'&_:L7QN/Q_M_=C\/
MY_\  [+YOR_)\ZSIXQ\D-*:?HY/N_+LOF];)?+E>,?)A0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'UU^S'\
M<?\ A"[@:3J<^W39<^2S\K!,S \MD;(GRV_@JKD/\@,KGW<MQOLGR2?NO;R?
MZ+]>VI]EP_F_U>7LZC]Q[7Z2OWZ)]>B>NFK/TUKZ\_5 H * "@ H * "@ H
M* "@ H * "@ H _.']M719(-4L;XE?+FM6A49.X-#(SL2,8P1,NW!)R&R!@9
M^3SF%I*7=6^YW_4_,N*Z352$^CA;SO%MO_TI?B?%U?/GPP4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M7W5.HJBNM4S]GHUHUXJ<'=-:-?U]ZZ;,UZT-@H * "@ H * "@ H * "@ H
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MA6,Q3Q5251_:>W9;);+9)*_4Y"L#B"@ H * "@ H * "@ H * "@ H _7O\
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MM_+_ )7WVTLD_O"OI3]!"@ H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 =O:?#37+^-)H=-OI(Y%#(ZVTK*RL,AE(7!!'((X(Y
MKH6&F]5&7_@+_P COC@*TE=0FTU=-0DU;[CT7_AF'Q=_T#__ "8MO_CM=?\
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MA18XXU"HB@*JJHP%4#@ #@ < <5](E;1'W\8J*LM$E9):*Q8IE!0 4 % !0
M4 % 'RK\>?V<K?Q["U]I4<<&IIN9E4*B7.268/T E))*RG[Q.V0[2KQ^+CLO
M59<T=)?=?_@^?W^7R.<Y%'%+GII*:N^B4NNOGV?79]U^85W:26$CPS(T<D;%
M71@5964X*L#R"#P0>0>*^.:MHS\IE%Q=GHT[-/1W*](D* "@ H * "@ H *
M"@ H _2[]D'XAMX@TV72KF9I+BS8&$.5S]F8 *J<[V$; @Y&$5XD#8VJOUV4
MXCGBXMZQV]/^!^&A^I<,8[VM-TY.[@]+V^#1675V?W72\C[!KWC[0* "@ H
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M[M:^2_X/Y>J9\3Q%FOL8^Q@US23YNMHM;=KM/U2Z:IGYLU\D?EX4 % !0 4
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M * "@ H * "@ H * /T7_9R_9R_L#R]:UJ/_ $KA[:V<?ZGN)) ?^6O=$/\
MJOO'][@1?5Y?E_)[\]^B[>;\_P O7;]+R+(O96JU5[V\8OIYOS[+IZ[?;%?0
MGW84 % !0 4 % !0 4 % !0!\C?M6_"3_A+;'^V;5<W=E&?-R^ UJF]VP#P7
M0DN,%25+CYV\M1X>:83VD>=;Q6NOV=7^'^?D?&\1Y9[>'M8_%!:Z_85V_FM^
MFE]W9'YDU\>?E84 % !0 4 % !0 4 % !0![+\ _';> /$%K.658)F%O<%F5
M%$4K %F=@=H1@LA(VY";2P4DUZ&!K^QJ)]'H_1_Y;GMY-C/JM:+Z2?+*[25F
MUK=[6=G\K7/V*K[P_:PH * "@ H * "@ H * "@#XN_:R^$"ZW:G7[)%%Q;+
M_I85&+S1?*%?Y<C,0R6) _=9)<")5/S^:83F7M%NM_-?\#\NNA\/Q)EGM(^V
M@M8KWK)W:T5].W7RW>B1^<-?)GYB% !0 4 % !0 4 % !0 4 % !0!]P_LD_
M%]=+D/A^^=5BE8O:2.[<2L5!@ .5 ?ET'R?O-P^=Y5 ^CRK%\O[N6SV]>W]=
M?4^]X:S/D?L)O1N\6V]W;W>VNZVUONVC]#J^I/TD* "@ H * "@ H * "@ H
M * .!^)GQ!M_ACIDNI7 W[,+'$&56ED8X5%)_%F(#%45V"MMP>7$UU0BY/Y+
MN_Z_ \['XV."INI+6VRNE=O9:_>]]$W9V/QFU_7[KQ1=2WM[*TUQ,VZ21NI/
M0<#@ # 50 JJ H   KX&I4=1W>K9^(5JTJ\G.;NV]6_Z^Y=-D8]9F(4 % !0
M 4 % !0 4 % !0 4 ;_A;PU<>,+Z#3[5=TUQ(J+PQ SU9MH8A%&6<@':H+=!
M6M*FZDE%;MG3AZ$L1-0CO)I=?OTOHMWV1^S7P\\"6OPXTV'3K55Q&H,D@7:9
M92 'E8$L<L1T).U=J [54#[_  ]!48J*^?F^Y^W8'!QPE-0CT6KM:[ZOKOZZ
M;;([:N@[PH * "@ H * "@ H * /(OC1\5(?A1ICW68WNY/EM87)_>/D9)"\
ME$!WO]T'A-ZLZFN'&8I8>-^KV7]=O^!U/&S7,5@:;EHY/2*?5_+HMWMVNFT?
MCK=W<E_(\TSM))(Q9W8EF9F.2S$\DD\DGDGFO@F[ZL_%)2<G=ZMN[;U=RO2)
M"@ H * "@ H * "@ H * "@ H ^F_@1^SO-\4LWM\9+?3%W*KI@23.,C$>X,
M BG[[D$$CRU!;>T?L8'+WB/>EI'\7Z?Y_+T^JR?(WC??G>,-=5NWY73T75_)
M=;?I[H&@6OA>UBLK*)8;>%=L<:] .IY/)).2S$EF8EB2237V%.FJ:LM$C]6H
MT8T(J$%9):)?U][Z[LUZT-@H * "@ H * "@ H * "@ H * /G3QQ^R]X>\7
MK(T$/V&Y;E9+?Y4!"%5!A_U>S.&8((V8C[X+,3Y5;+:=39<K[KT[;?=;U/F<
M7P]0Q%[+DD^L=%M;X=K=7:S?<^3?%W['VNZ*Q;3WAOX]RA0&$,N"N2S)(=@
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M=QW\:30NLD<BAD=2&5E89#*1P01R".".:_0$[ZH_<8R4E=:IJZ:U5BQ3*"@
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M5?\ KPN__1+URXK^'+_#+\F>=F/\"I_U[G_Z2S\3:_/3\*"@ H * "@ H *
M"@ H * "@ H * /KK]C#_D8+G_KPD_\ 1T%>[D_\1_X7^<3[+A7^/+_KV_\
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MT7AW*8N*KSU=WRKHK-J[\[K3MOO:WWA7TI^@A0 4 % !0 4 % !0 4 % !0
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M<&OL<JK^TARO[/Y/;\ONL?JW#.-=>DX/>FTK_P!UWMU>UFNB2L?65>V?8!0
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MR6_^7S/D^),9["CR+>H[:-K16;_1-=;^I^65?&'Y*% !0 4 % !0 4 % !0
M4 % !0 4 ?L'\!OA6OPKTE8I!F\N-LMTQ"95RHQ$&7.4CY ^9@6+N,!]H^[P
M.%^KPMU>KV^[Y?YG[3DV7?4:=G\4K.6V]MM.B]7K=K<]LKT3W0H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#PO]H+XI
M-\+M':6W91?7#>5; A6P>KR;"1D(O0X91(T892K$5YN/Q/L(76[T7^?]=;'@
M9UF/U*E>/Q2=H[/U=F^B]=6KJS/R$KX4_& H * "@ H * "@ H * "@ H *
M/KK]D?X;?\)+J;:M<)FVL,>7N7*O<,/EQE2I\M<N<%71S"PX->[E6'YY<[VC
MMZ_=TW\G8^RX:P'MJGM9+W8;><GMNK:+7>Z?*S]-:^O/U0* "@ H * "@ H
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M,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]5_Z\+O\ ]$O7+BOX<O\
M#+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_
M8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O_P!*@?IK7UY^J!0 4 %
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M5+?RI+[];_C^!^2\38AU*_+TA%+?2[7,W;INE\D?+E>,?)A0 4 % !0 4 %
M!0 4 % !0 4 ?3?[*WP[_P"$SUP7DHS;:=MF;GK,2?(7AE8893)D!E_=[&&'
M%>QEF']K.[VCK\^G7Y_(^JX=P/UBMS/X:=I?]O?9ZI[J_5:6>Y^JE?:'ZX%
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MHKYON_Z_ _<\!@HX*FJ<=;;NR5V]WI]RWT25W8[ZNH]$* "@ H * "@ H *
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
M4 % '[%_L^:+)H/A;3892I9H3,"I)&V=VF0<@<A7 ;L&R 2,$_>X"')2BGVO
M][O^I^UY)2=+#P3_ );Z=I-R7X/4]DKO/;"@ H * "@ H * "@ H * "@#\$
M*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\ R+^E?]>%I_Z)2OT+"_PX
M_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK?\B_JO\ UX7?_HEZY<5_
M#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'U
MU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\ 'E_U[?\ Z5 _36OKS]4"
M@ H * "@ H * "@ H * "@#\E/VD_AI'\.=:/V8,+2\4SQCRPJ1L7;?"A4!2
M$X(  *(Z*0>&;X?,<-[&>FTM5IIOM_72Q^.Y]@%A*ON_#-<RTLD[N\5;33\$
MTO-_/=>6?-A0 4 % !0 4 % !0 4 % !0 4 ?;/[&'C'[%?7>D2-A+B,31!I
M,#S(N'5(SP7=&W,5P=L/((&5^AR>M:3AW5UKU7EZ?D?=\*XKEG*D_M+F6O5;
MV7=IW?E'[OT6KZL_2PH * "@ H * "@ H * "@#\Z?VV-<^T:AI]ALQY-O)-
MOS][SWV;=N.-ODYSDYW8P-O/RF<SO*,>R;^]V_0_-.+*UYPA;:+E?_$[?^V?
MB?$U?/'P@4 % !0 4 % !0 4 % !0 4 % 'W1^Q/X:\RXU#4V60;(X[>-L?N
MV\QO,D&<<NOEQ< _*'Y!W*1])DU/64O)+RUU?Y(^_P"$Z%Y3J:Z)17;5W?S5
ME]_FC]!Z^H/T<* "@ H * "@ H * "@ H * "@ H * /S2_;-T!K'6K:]6)4
MCN;4*9!M!DEB=@^X#YB51HAN8<KM4$[2!\CG%.TT^Z_%/_)H_+>*J/+5C.UE
M*&^FKBW?\''7Y=#X]KP3XL* "@ H * "@ H * "@ H _>#2M4AUNWBNK=M\,
M\:21M@C<CJ&4X(!&00<$ CN :_2HR4TFMFKKYG]!4ZBJ14HZJ233\FKK<OU1
MH% !0 4 % !0 4 % !0 4 % &1K^@6OBBUELKV)9K>9=LD;=".HY'((."K A
ME8!@00#6=2FJBL]4S&M1C7BX35TUJG_7W/INC\F_C=\$;KX1W6Y=TVG3,1!.
M1R#U\J7' D S@\+(H+* 0Z)\3C<$\.^\7L_T?G^?Y?C^;93+ 2[P;]V7Z/S_
M #W75+PNO-/GPH * "@ H * "@ H * "@ H _3W]EWXS2>/+5]+U"1I-0M5W
M*[*<R6XVJ&9\G=(K-M8G:64HWSMYC#['+,9[9<LOB7XK_/\ K74_5N'LU>*C
M[.;O.*NG;>.BU?=-V>U]-W=GUE7MGV 4 % !0 4 4-5U2'1+>6ZN&V0P1O)(
MV"=J(I9C@ DX )P 2>P)J924$V]DKOY&=2HJ<7*6BBFV_)*[V/Q\^-'Q4F^*
M^IO=9D2TC^6UA<C]VF!DD+P'<C>_WB.$WLJ*:^#QF*>(E?HME_7?_@=#\6S7
M,7CJCEJHK2*?1?+J]WOVNTD>15PGC!0 4 % !0 4 % !0 4 % !0!Z=\*_A7
M??%B^%K:C9$F&N+AAE(D/<]-SG!"(""Q!Y5%=U[,+A98B5EMU?;^NB/5R[+I
MXZ?+'1+XI=$O\^RZ^EVOUS\#^!['X=V,=A81[(DY9CR\CG&Z21L#<YP,G@
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MW_EW_P!Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\
M7A:?^B4K]"PO\./^&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0
M4 % 'X(5^9G\\A0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E
M?H6%_AQ_PQ_)'[KEW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\
M1+URXK^'+_#+\F>=F/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@
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MQ^%/_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0
M4 % !0 4 % !0 4 % &1K^@6OBBUELKV)9K>9=LD;=".HY'((."K AE8!@00
M#6=2FJBL]4S&M1C7BX35TUJG_7W/INC\F_C=\$;KX1W6Y=TVG3,1!.1R#U\J
M7' D S@\+(H+* 0Z)\3C<$\.^\7L_P!'Y_G^7X_FV4RP$N\&_=E^C\_SW75+
MPNO-/GPH * "@ H * "@ H * "@#8T#7[KPO=17ME*T-Q"VZ.1>H/0\'@@C(
M92"K*2I!!(K2G4=-W6C1M1K2H24X.S3T:_K[UUV9^S/PS^(-O\3M,BU*W&S?
ME9(BRLT4BG#(Q'X,I(4LC(Q5=V!]]AJZKQ4E\UV?]?@?M^ QL<;352.E]U=.
MS6ZT^];:-.RN=]74>B% !0 4 ?GC^UM\7UU20>'[%U:*)@]W(CMS*I8" @84
MA.'<?/\ O-H^1XF!^6S7%\W[N.RW]>W]=?0_-N)<SYW["#T3O)IO=7]WMIN]
M];;-,^'J^</@@H * "@ H * "@ H * "@ H ].^%?PKOOBQ?"UM1LB3#7%PP
MRD2'N>FYS@A$!!8@\JBNZ]F%PLL1*RVZOM_71'JY=ET\=/ECHE\4NB7^?9=?
M2[7ZY^!_ ]C\.[&.PL(]D2<LQY>1SC=)(V!N<X&3P  %4*BJH^YHT8T8\L=O
MZU/V3"82&$@H05DOO;[OS_X9:'75N=H4 % !0 4 % !0 4 % !0 4 >!_M,>
M*/\ A&/#%WMD\N6YV6T?R[MWF']XG0@9B$OS'&.Q#[:\S,JOLZ;[O3[]_P +
MGSV?XCV.'EK9RM%:7WW6S^RG_P /8_(ROAC\:"@ H * "@ H * "@ H * "@
M H W_"FA_P#"3ZA:V&_R_M-Q%#OQNV^8X3=MR,XSG&1GID5K2A[22CW:7WNQ
MTX:C[:<87MS2C&^^[2\NY^Y%I:1V$:0PHL<<:A410%5548"J!P !P . .*_1
MDK:(_>XQ459:)*R2T5BQ3*"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /DW]L77VTSP_':I*JM=72*\?R[GBC5I#@'G
M"N(BS+C!*J3AL'Q,WJ<M.W=K3R6OYV/C^**W)144_BFKK2[23?X-+5>7<_,*
MOCC\I"@ H * "@ H * "@ H * "@ H ^V?V)]#^T:AJ%_OQY-O'#LQ][SWW[
MMV>-ODXQ@YW9R-O/T.30O*4NR2^]W_0^[X3HWG.=]HJ-O\3O_P"V?B?HM7U9
M^EA0 4 % !0 4 % !0 4 % !0 4 % !0!Y5\<=%CU[PUJ<,I8*MK),"I .Z
M><@Y!X+( W<KD @X(XL;#GIR3[-_=K^AY&;TE5P]1/\ D;T[Q]Y?BM3\9:^
M/Q * "@ H * "@ H * "@ H * "@"Q:7<EA(DT+M')&P9'4E65E.0RD<@@\@
MCD'FFG;5%1DXNZT:=TUH[G[D>%-<_P"$GT^UO]GE_:;>*;9G=M\Q ^W=@9QG
M&<#/7 K]&I3]I%2[I/[U<_?,-6]M",[6YHQE;?=)^7<WZU.@* "@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
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M%G=B69F8Y+,3R23R2>2>:_-F[ZL_G^4G)W>K;NV]7<KTB0H * "@ H * "@
MH * "@ H * /W!^'^ES:)H^GVMPNR:"SMXY%R#M=(E5AD$@X((R"0>Q(K]%H
M1<(13W44G\D?O."ING2A&6CC"*:\U%)['75N=H4 % !0 4 % !0 4 % !0 4
M % !0 4 ?!'[<'_,)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"
M@ H * "@ H * "@ H * /VQ^%/\ R+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_
M@4_^O</_ $E'?5U'HA0 4 % !0 4 % !0 4 % !0 4 % &1K^@6OBBUELKV)
M9K>9=LD;=".HY'((."K AE8!@00#6=2FJBL]4S&M1C7BX35TUJG_ %]SZ;H_
M)OXW?!&Z^$=UN7=-ITS$03D<@]?*EQP) ,X/"R*"R@$.B?$XW!/#OO%[/]'Y
M_G^7X_FV4RP$N\&_=E^C\_SW75+PNO-/GPH * "@ H * "@ H * "@#V7X(_
M%J3X1ZE]H*M+:3*([B)6()7.0ZC(4R)SMW<%6=,IOWKZ&"Q7U>5]T]&OU]3V
M\IS)X"IS;Q:M)7Z=UTNNE_-:7N?L%:7<=_&DT+K)'(H9'4AE96&0RD<$$<@C
M@CFONT[ZH_:8R4E=:IJZ:U5BQ3*"@#P/]H3XM_\ "J],_P!';&H76Y+7*;U7
M:5\R1LX7Y%8;0=V79,HR!\>9C\7]7CI\3VT^]_UUZ'SV=YG]1I^[\<KJ.E]K
M7?;1/3SMHU<_(ROAC\:"@ H * "@ H * "@ H * "@#V7X2_!'4OBY(QM]L-
MI$RK+<2 [021E4 ^_(%.[;E5 QN=-Z;O0PN"EB-M$MV_ZU9[>6Y34Q[]W2*:
MO)[>B[NVMOO:NC]7/ _@>Q^'=C'86$>R).68\O(YQNDD; W.<#)X  "J%154
M?:T:,:,>6.W]:GZ]A,)#"04(*R7WM]WY_P##+0ZZMSM"@ H * "@ H * "@
MH * "@ H _/C]MCQ+YEQI^F*T@V1R7$BY_=MYC>7&<9Y=?+EY(^4/P3N8#Y?
M.:FL8^3?EKHOR9^<<65[RA3UT3D^VKLOFK/[_-GPO7S9\ % !0 4 % !0 4
M% !0 4 % !0!])_LG:+)JGBF"9"H6UAGFD!)R5*&$!< Y.Z53S@;0QSG /KY
M7#FJI]DW^%OU/J.&Z3GB$U]F,F_2W+^<D?JY7VI^O!0 4 % !0 4 % !0 4
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M\,?R1^ZY=_ I_P#7N'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
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M9)?>[_H?=\)T;SG.^T5&W^)W_P#;/Q/T6KZL_2PH * "@ H * "@ H * "@
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MP:K_ -?]W_Z.>OSW%?Q)?XI?FS\*S'^/4_Z^3_\ 2F<#7*><% !0 4 % !0
M4 % !0 4 % !0!^@_P"Q'JDTMOJ=JS9ACDMY$7 X>59%<YQDY$2#!) V\ $G
M/U&32;4ET33^^_\ DC]'X2J-QJ1Z)Q:7FU)/_P!)1]T5](??A0 4 % !0 4
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MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X?^DH] 6NH]$=0 4
M>??%;_D7]5_Z\+O_ -$O7+BOX<O\,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H
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MT+"_PX_X8_DC]UR[^!3_ .O</_24=]74>B% !0 4 % !0 4 % !0 4 % !0
M4 % !0!D:_H%KXHM9;*]B6:WF7;)&W0CJ.1R"#@JP(96 8$$ UG4IJHK/5,Q
MK48UXN$U=-:I_P!?<^FZ/R;^-WP1NOA'=;EW3:=,Q$$Y'(/7RI<<"0#.#PLB
M@LH!#HGQ.-P3P[[Q>S_1^?Y_E^/YME,L!+O!OW9?H_/\]UU2\+KS3Y\* "@
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MH?"/_+S_ +A_^WGWO7TQ^AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!^%_BO7/^$GU"ZO\ 9Y?VFXEFV9W;?,<O
MMW8&<9QG SUP*_.*L_:2<N[;^]W/P+$UO;3E.UN:4I6WW;?EW,"LCF"@ H *
M "@ H * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^
M!3_Z]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 % !0 4 % 'XG?%;_D8-5_
MZ_[O_P!'/7Y[BOXDO\4OS9^%9C_'J?\ 7R?_ *4S@:Y3S@H * "@ H * "@
MH * "@ H * /JK]CS5(=/\2-'(VU[BSECB&"=SAHY2. 0/DC=LG XQG) /M9
M3)*IKUBTOO3_ "1]=PO44*]G]J$DO6\9?E%GZBU]D?K 4 % !0 4 % !0 4
M% 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9/SP*
M "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/
MW7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%
M?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M _;'X4_\B_I7_7A:?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4
M% !0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_
M )%_2O\ KPM/_1*5^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\
M5O\ D7]5_P"O"[_]$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H
M* "@ H * "@ H * "@ H ^NOV,/^1@N?^O"3_P!'05[N3_Q'_A?YQ/LN%?X\
MO^O;_P#2H'Z:U]>?J@4 % !0 4 % !0 4 % !0 4 % 'YL_MIZ7-%K%G=,N(
M9+/RT;(Y>*5V<8SD8$J') !W<$D''R6<1:FGT<;?<W_FC\PXKIM58RZ.%D_-
M2;?_ *4CXVKP#X@* "@ H * "@ H * "@ H * "@#U7X':U)H/B73)H@I9KJ
M.$A@2-LY\ESP1R%<E>P;!((R#VX*?)4BUW2^_3]3U\HJNEB*;7\Z6O:7NO\
M!Z'[-5]^?MX4 % !0 4 % !0 4 ?!'[<'_,)_P"WS_VA7S.=?9_[>_\ ;3\\
MXM_Y=_\ <3_VP^!Z^9/SP* "@ H * "@ H * "@ H * "@ H _>^OTP_H8*
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MQD\K&I#,"2B/Z6"P3Q#[16[_ $7G^7Y_093E,L?+M!/WI?HO/\MWT3_630-
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M/Q/.S&I[.C.5[6A*SO;6S2U[WM;S/Q.K\]/PH* "@ H * "@ H * "@ H *
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MN'_I*.^KJ/1"@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
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MGAWWB]G^C\_S_+\?S;*98"7>#?NR_1^?Y[KJEX77FGSX4 % !0 4 % !0 4
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M;_Q/\HGZIPK_  )?]?'_ .DP/KFO</L@H * "@ H * "@ H * "@ H * "@
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M 4 % !0!^]]?IA_0P4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
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MZ)-OOLC]#OV??V:6\*2+JNN1J;Q&S;V^5=82#Q*Y4E6D[Q@$K&,/DR8\KZG
M9=[/WI[]%O;S]>W;UV_2LER'V#]I67O)^['1I>;M=-]NV^^WVC7T!]P% !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 9&OZ!:^*+66RO8EFMYEVR1M
MT(ZCD<@@X*L"&5@&!! -9U*:J*SU3,:U&->+A-736J?]?<^FZ/Q\^+_PMNOA
M5J3VTJM]ED9VM)B=PDB!XRP"CS%! D7 PW(&QD9OA,7AGAY6>W1^7^?<_%LS
MRZ6!J.+^%M\KWNON6JZK]&CRJN(\@* "@ H * "@ H * "@ H * "@ H * "
M@ H ^H_V??V?9/B3(NH:@K1Z7&W Y5KEE."B'J(P>))!SG,:'?N:+V<!@/;^
M]+X?S_X'=_)>7UF2Y*\8^>>E-/T<GV7EW?R6MVOU$M+2.PC2&%%CCC4*B* J
MJJC 50.  . !P!Q7V25M$?K$8J*LM$E9):*Q8IE!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % !0!^FW[&'
M_(OW/_7_ "?^B8*^PR?^&_\ $_RB?JG"O\"7_7Q_^DP/KFO</L@H * "@ H
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M]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H * "@ H *
M/P0K\S/YY"@ H * "@ H * "@ H * "@ H _;'X4_P#(OZ5_UX6G_HE*_0L+
M_#C_ (8_DC]UR[^!3_Z]P_\ 24>@+74>B.H * //OBM_R+^J_P#7A=_^B7KE
MQ7\.7^&7Y,\[,?X%3_KW/_TEGXFU^>GX4% !0 4 % !0 4 % !0 4 % !0 4
M ?77[&'_ ",%S_UX2?\ HZ"O=R?^(_\ "_SB?9<*_P >7_7M_P#I4#]-:^O/
MU0* "@ H * "@ H * "@ H * "@#X(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?G
MG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0 4 % !0!^]]?IA_0P
M4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/
M@>OF3\\"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@"Q:6DE_(D,*-))(P5$4%F9F. J@<DD\ #D
MGBFE?1%1BY.RU;=DEJ[GUE\-OV1]3\2[+C5F^P6QVMY> UPZG:<;?NQ94L,N
M2Z.N&A(KW,/E4IZS]U=NO3[OGJNQ]A@.&JE:TJON1[;R>SVV6E]]4]XGZ#^#
M_ 6F> 83!IEM';HWWBH)=\%B-\C$N^-S;=S':#@8'%?44J$:*M%6_KON?H^%
MP=/"JU.*C^;WW;NWOI=Z'75N=H4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % '(^./ ]C\1+&2POX]\3\JPX>-QG;)&V#M<9.#R""58,C,IPK
M48UH\LMOZU.+%X2&+@X35T_O3[KS_P"&>A^1GQ4^%=]\)[XVMT-\3Y:WN%&$
ME0=QUVN,@.A)*DCED9';X;%866'E9[='W_KJC\;S'+IX&?++5/X9=&O\^ZZ>
MEF_,:XSR@H * "@ H * "@ H * "@ H * "@ H ^H_V??V?9/B3(NH:@K1Z7
M&W Y5KEE."B'J(P>))!SG,:'?N:+V<!@/;^]+X?S_P"!W?R7E]9DN2O&/GGI
M33]')]EY=W\EK=K]1+2TCL(TAA18XXU"HB@*JJHP%4#@ #@ < <5]DE;1'ZQ
M&*BK+1)626BL6*904 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'X(5^
M9G\\A0 4 % !0 4 % !0 4 % !0 4 % 'ZY_LP_\BCI__;Q_Z4RU]SEO\*/S
M_P#2F?LO#_\ NT/^W_\ TN1[Y7IGT(4 % !0 4 % !0 4 % !0 4 % !0 4
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M?_<3_P!L/@>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H *
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M_7_'_P"B9Z\/./X:_P 2_*1\;Q5_ C_U\7_I,S\R:^//RL* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?F5^V?_ ,C!;?\
M7A'_ .CIZ^0SC^(O\*_.1^5\5?QX_P#7M?\ I4SY%KPCXT* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0!\$?MP?\PG_M\_\ :%?,YU]G_M[_ -M/
MSSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/\ R+^E
M?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'?5U'HA0 4 % !0 4 % !
M0 4 % 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9
M/SP* "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_A
MC^2/W7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A
M0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN
M7?P*?_7N'_I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_ /1+URXK^'+_  R_)GG9
MC_ J?]>Y_P#I+/Q-K\]/PH* "@ H * "@ H * "@ H * "@ H ^NOV,/^1@N
M?^O"3_T=!7NY/_$?^%_G$^RX5_CR_P"O;_\ 2H'Z:U]>?J@4 % !0 4 % !0
M 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@
M>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H * "@ H * "@#
MX(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N'_I*.^KJ/1"@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
M'E_U[?\ Z5 _36OKS]4"@ H * "@ H * "@ H * "@ H ^"/VX/^83_V^?\
MM"OF<Z^S_P!O?^VGYYQ;_P N_P#N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4
M % !0 4 ?O?7Z8?T,% !0 4 % !0 4 % 'P1^W!_S"?^WS_VA7S.=?9_[>_]
MM/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H * "@ H * "@
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M 4 % !0 4 % !0 4 % !0!R/CCQQ8_#NQDO[^39$G"J.7D<YVQQKD;G.#@<
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M,OX4OE_Z4CY[B#_=I_\ ;G_I<3\C*^&/QH* "@ H * "@ H * "@ H * "@
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M -H5\SG7V?\ M[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H *
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M'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M[<;N,YP,>A# TX;17SU_.Y[=')L/2O:$=?YO?_\ 2KV^1Z[7<>R% !0 4 %
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
M"@ H * "@ H * "@ H * "@#X(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_
M "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1?TK_
M *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H *
M/@C]N#_F$_\ ;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0
M 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N
M'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_P#;Y_[0KYG.OL_]O?\
MMI^><6_\N_\ N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1
M?TK_ *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@
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MZT-@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC7(W.<' X
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M/#I+[,I)^M^;\I(^DZ]<^H"@ H * "@ H * "@ H * "@ H * "@ H * "@
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
M4 % '[8_"G_D7]*_Z\+3_P!$I7Z%A?X<?\,?R1^ZY=_ I_\ 7N'_ *2COJZC
MT0H * "@ H * "@ H * "@ H _!"OS,_GD* "@ H * "@ H * "@ H * "@#
M]L?A3_R+^E?]>%I_Z)2OT+"_PX_X8_DC]UR[^!3_ .O</_24>@+74>B.H *
M//OBM_R+^J_]>%W_ .B7KEQ7\.7^&7Y,\[,?X%3_ *]S_P#26?B;7YZ?A04
M% !0 4 % !0 4 % !0 4 % !0!]=?L8?\C!<_P#7A)_Z.@KW<G_B/_"_SB?9
M<*_QY?\ 7M_^E0/TUKZ\_5 H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 =O\-+2._P!<TV&9%DCDOK971@&5E:5058'@@C@@\$<5T897G%/^:/YH
M[\!%2K03U3J033U5N9'[<5^B'[N% !0 4 % !0 4 % 'P1^W!_S"?^WS_P!H
M5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H * "@ H * "@
M H * /VB^#GA:'PAH-C;QP?9Y&MXI)T*E7,[HIE,F[YM^[@AON@!  JA1^@8
M2DJ<$K6T3?JUJ?N.5X=8>C"*7*W&+DK6?,TKWOK>_P!VVR/3:[#U0H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC
M7(W.<' X  +,516885JT:,>:6W]:'%B\7#"0<YNR7WM]EY_\.]#\C/BI\5+[
MXL7QNKH[(DRMO;J<I$A[#IN<X!=R 6('"HJ(OPV*Q4L1*[VZ+M_75GXWF.8S
MQT^:6B7PQZ)?Y]WU]+)>8UQGE!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?HO^SE^T;_;_EZ+K4G^E<);7+G_ %W81R$_\M>R.?\ 6_=/[W!E^KR_
M,.?W)[]'W\GY_GZ[_I>19[[6U*J_>VC)]?)^?9]?7?[8KZ$^["@ H * "@ H
M * "@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H *
M "@#]%_V)]<^T:?J%ALQY-Q'-OS][STV;=N.-ODYSDYW8P-O/U>33O&4>S3^
M]6_0_2^$ZUX3A;:2E?\ Q*W_ +9^)]L5]"?=A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ' _%;_D7]5_Z\+O\ ]$O7
M+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$ZOST_"@H * "@ H * "@ H * "@ H
M* "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/W7+OX%/_ *]P_P#24=]7
M4>B% !0 4 % !0 4 % !0 4 % !0 4 % !0!^87[9-W'<>(H51U9H[&)9 ""
M48R2N%8#H=K*V#SM93T(KX[-W>HO**_-L_*>*9)UU;I3BGY/FD_R:9\FUXA\
M>% !0 4 % !0 4 % !0 4 % !0!ZK\#M%DU[Q+ID,14,MU',2Q(&V ^<XX!Y
M*H0O8M@$@9([<%#GJ12[I_=K^AZ^44G5Q%-+^=/7M'WG^"T/V:K[\_;PH *
M"@ H * "@ H * /@C]N#_F$_]OG_ +0KYG.OL_\ ;W_MI^><6_\ +O\ [B?^
MV'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%
M_AQ_PQ_)'[KEW\"G_P!>X?\ I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_
M )A/_;Y_[0KYG.OL_P#;W_MI^><6_P#+O_N)_P"V'P/7S)^>!0 4 % !0 4
M% !0 4 % !0 4 ?MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X
M?^DH[ZNH]$* "@ H * "@ H * "@ H * /P0K\S/YY"@ H * "@ H * "@ H
M * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1Z
MM=1Z(Z@ H \^^*W_ "+^J_\ 7A=_^B7KEQ7\.7^&7Y,\[,?X%3_KW/\ ])9^
M)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'UU^QA_R,%S_UX2?^CH*]W)_X
MC_PO\XGV7"O\>7_7M_\ I4#]-:^O/U0* "@ H * "@ H * "@ H * "@#X(_
M;@_YA/\ V^?^T*^9SK[/_;W_ +:?GG%O_+O_ +B?^V'P/7S)^>!0 4 % !0
M4 % !0 4 % !0 4 ?3?[)&A_VMXGCFW[?LEO--C&=^X"#;G(V_ZW=GG[N,<Y
M'L95#FJ7[)O]/U/JN&J/M,0G?X(REZ_9_P#;K_(_52OM#]<"@ H * "@ H *
M "@#XG_;8T/[1I^GW^_'DW$D.S'WO/3?NW9XV^3C&#G=G(V\_/9S"\8R[-K[
MU?\ 0^$XLHWA"=]I.-O\2O\ ^V?B?G17RA^:!0 4 % !0 4 % !0 4 % !0
M4 % '[WU^F']#!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M3_ _1ZOK#]-"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#-)3Q%W]F$FO72/Y29^IE?9GZT% !0 4 % !0 4 % !0!\$?MP?\PG_M\_\
M:%?,YU]G_M[_ -M/SSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@
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MR2268L[,Q^&K5I5I<TM_ZT/QO%XN>+FYS=V_N2[+R_X=ZG(5@<04 % !0 4
M% !0 4 % !0![I\-?V>=:^*%JU[:^3#;AMJ27#.@E(R&\L*CDA2,%B N[*@D
MJX7TL/@)UU=62\[Z_<F?08#)*N-CSQLE?1R;5^]K)[=_ET=N)^(/PSU/X8W
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M\K'[GEDE*A3MK^[@M.ZBD_N:LST:NL],* "@ H * "@ H * "@ H * "@ H
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MA'[J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % 'YI?MD^$5TC6+?4D"A;Z$A_F8L98-JEB#P!L:)5VGDJQ*@\M\CF
M]+EFI?S+\5_P+'Y;Q3AO9U547VXZ[WO&RO\ <TM.S^?Q[7@GQ84 % !0 4 %
M !0 4 % !0 4 % 'Z+_L3ZY]HT_4+#9CR;B.;?G[WGILV[<<;?)SG)SNQ@;>
M?J\FG>,H]FG]ZM^A^E\)UKPG"VTE*_\ B5O_ &S\3[8KZ$^["@ H * "@ H
M* "@ H * "@ H * "@ H _"CQ!K4GB2\N+Z8*)+F:29PH(4-(Q<A023C)XR2
M<=S7YO4GSMR?5M_?J?S_ %ZKK2<WO*3;MM=NYCUF8A0 4 % !0 4 % !0 4
M% !0 4 ?JY^R=HL>E^%H)D+%KJ:>:0$C 8.80%P!@;8E/.3N+'., ?:Y7#EI
M)]VW^-OT/U[ANDH8=-?:E)OUOR_E%'TG7KGU 4 % !0 4 % !0 4 % 'P1^W
M!_S"?^WS_P!H5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H
M * "@ H * "@ H _;'X4_P#(OZ5_UX6G_HE*_0L+_#C_ (8_DC]UR[^!3_Z]
MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * "@#ZZ_8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O
M_P!*@?IK7UY^J!0 4 % !0 4 % !0 4 % !0!@>*]<_X1C3[J_V>9]FMY9MF
M=N[RT+[=V#C.,9P<=<&LJL_9Q<NR;^Y7.?$UO8PE.U^6,I6VV3?GV/POK\X/
MP$* "@ H * "@ H * "@ H * "@ H _=#PIH?_",:?:V&_S/LUO%#OQMW>6@
M3=MR<9QG&3CIDU^CTH>SBH]DE]RL?OV&H^QA&%[\L8QOMLDO/L;]:G0% !0
M4 % !0 4 % !0!^*WQ=T!O#/B#4;4Q+"JW4K1QKM"K%(WF1;0O &QE(48VCY
M2 00/S[%T_9U)+;5Z>3U7X'X9F='V-:<;6]]V2M:S=UMY-:=#SFN0\P* "@
MH * "@ H * "@ H * "@#]5/V2-<_M;PQ'#LV_9+B:'.<[]Q$^[&!M_UNW'/
MW<YYP/M,JGS4[=FU^OZGZYPU6]IATK?!*4?7[7_MUOD?3=>P?5!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5Z1(4 % !0 4 % !0 4 % !0!]L_LY?M&_V!Y>BZU)_HO"6URY_U/81R$_\
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M%&$[W;BKNUO>6CZ+JGY=M#OJZCT0H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#PO]H_PBOB[PU>#"^9:K]JC+,P"F$$
MN?EZDQ>8JA@5W,,XP&7S<PI>TIORU7R_X%SP,]PWM\/+O%<RO?[.KV_NW2]?
MF?D)7PI^,!0 4 % !0 4 % !0 4 % !0 4 ?1G[*_B7_ (1[Q/ C-&L=W');
MNSG&-P\Q IR!O:2-$ .=V[:!N((]7+*G)47FFOU_-(^FX=K^RQ"6EIIQ=_O5
MO-M)?.VY^L=?;G[ % !0 4 % !0 4 % !0 4 % !0 4 % &1X@UJ/PW9W%],
M&,=M#),X4 L5C4N0H) S@<9(&>XK.I/D3D^B;^[4QKU51BYO:,6W;>R5S\)Z
M_-S^?PH * "@ H * "@ H * "@ H * "@#]P? 'AK_A#M)L]/*QJ]O;QI)Y8
MPAD"CS&'"D[GW,20"Q)8\DU^BT*?LX*/9+;OU_$_><%0^KTXPT]V*3MM>VKZ
M;N[\SKJW.T* "@ H * "@ H * "@#X(_;@_YA/\ V^?^T*^9SK[/_;W_ +:?
MGG%O_+O_ +B?^V'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 ?MC\*?\ D7]*
M_P"O"T_]$I7Z%A?X<?\ #'\D?NN7?P*?_7N'_I*.^KJ/1"@ H * "@ H * "
M@ H * /@C]N#_F$_]OG_ +0KYG.OL_\ ;W_MI^><6_\ +O\ [B?^V'P/7S)^
M>!0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%_AQ_PQ_)
M'[KEW\"G_P!>X?\ I*.^KJ/1"@ H * "@ H * "@ H * "@#\$*_,S^>0H *
M "@ H * "@ H * "@ H * /VQ^%/_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX
M%/\ Z]P_])1Z M=1Z(Z@ H \^^*W_(OZK_UX7?\ Z)>N7%?PY?X9?DSSLQ_@
M5/\ KW/_ -)9^)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'UU^QA_R,%S_
M ->$G_HZ"O=R?^(_\+_.)]EPK_'E_P!>W_Z5 _36OKS]4"@ H * "@ H * "
M@ H * "@#YL_:QUJ/2_"T\+ABUU-!#&0!@,'$Q+9(P-L3#C)W%1C&2/(S2?+
M2:[M+\;_ *'R_$E50P[3^U**7K?F_*+/RCKXH_(0H * "@ H * "@ H * "@
M H * /7?@+H?_"0^)]-AW[-MP)LXW9^S@S[<9'WO+VY_ASG!Q@]V!ASU(KSO
M]VOZ'LY-1]KB(*]K2YN_P^]^-K'[)5]\?MH4 % !0 4 % !0 4 % !0!^87[
M8/A%M%UU-04-Y=_"I+%E(\V$"-U4#Y@ GE'YLY9FPQP0OQV;4N6?-_,OQ6GY
M6/RGB?#>SK*?2<5VWC[K7W<OW_=\FUXA\>% !0 4 % !0 4 % !0 4 % !0!
M]A?L;>+ETC6+C37*A;Z$%/E8L98-S!01P!L:5FW#DJH# \-[V45>6;C_ #+\
M5_P+GVG"V)]G5=-_;CIO>\;NWW-O7LOG^EM?7'ZD% !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % 'B?QD^.%C\((4$B_:+R7!CME?:=F<&1VPVQ."%."78;0,!V3SL7C8X
M9=V]E^IX6:9O# )7]Z3VC>VG=NSLNVFKVZM?E7XX\<7WQ$OI+^_DWROPJCA(
MT&=L<:Y.U!DX')))9BSLS'XNM6E6ES2W_K0_(\7BYXN;G-W;^Y+LO+_AWJ<A
M6!Q!0 4 % !0 4 % !0 4 % 'HWPM^&MU\5=273[9EC&TR32MR(XE(#-MR"Q
MRP"J.K$9*KN=>O#8=XB7*O5OR/3R[ 2QU3DCII=M]%IKY[Z+\EJ?KWX'\#V/
MP[L8["PCV1)RS'EY'.-TDC8&YS@9/   50J*JC[JC1C1CRQV_K4_9L)A(82"
MA!62^]ON_/\ X9:'75N=H4 % !0!^>/[6WP@72Y!X@L458I6"7<:(W$K%B)R
M1E0'X1S\G[S:?G>5B/ELUPG+^\CL]_7O_77U/S;B7+.1^W@M&[223W=_>[:[
M/;6V[;/AZOG#X(* "@ H * "@ H * "@ H * /MG]G+]HW^P/+T76I/]%X2V
MN7/^I[".0G_EEV1S_JONG]U@Q?0Y?F')[D]NC[>3\OR]-ON\BSWV5J55^[M&
M3Z>3\NSZ>FWZ+5]6?I84 % !0 4 % !0 4 % !0 4 % !0!^,OQK\"+\.M=N
MK&)6%ON$EOE6 \J0;E"EBQ<(28M^3N9&)P<@? 8RA[&;BMMUZ/\ JWR/Q#-L
M']4K2@MKWCH]GKUO>VU^MCRJN(\@* "@ H * "@ H * "@ H * "@#]+OV-O
M%S:OH]QIKEBUC,"GRJ%$4^Y@H(Y)WK*S;AP&4!B.%^NRBKS0<?Y7^#_X-S]2
MX6Q/M*3IO[$M-K6E=V^]-Z]U\OL&O>/M H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H _$?XD>$6\":Q>::0P6"9A'
MN968Q'YHF8KQED*L< 8)P54Y _.\12]E-Q[/\.GX'X1C\-]5JRI_RR=KV;MN
MGIW33.(KG. * "@ H * "@ H * "@ H * -#2M4FT2XBNK=MDT$B21M@':Z,
M&4X((." <$$'N"*N,G!IK=.Z^1I3J.G)2CHXM-/S3NMS]T-*U2'6[>*ZMVWP
MSQI)&V"-R.H93@@$9!!P0".X!K]'C)32:V:NOF?OU.HJD5*.JDDT_)JZW+]4
M:!0 4 % !0 4 % !0 4 % !0 4 % '@?[3'BC_A&/#%WMD\N6YV6T?R[MWF'
M]XG0@9B$OS'&.Q#[:\S,JOLZ;[O3[]_PN?/9_B/8X>6MG*T5I??=;/[*?_#V
M/R,KX8_&@H * "@ H * "@ H * "@ H * /;?V>O Z^/?$-M!-'YEM#NN)U^
M3&R/[H97!#(TAC1U )*L>@RP]' 4?;5$GLM7MT]?.R/=R3"?6J\4U>*]Z6VR
M]=TW9-=F?L%7W9^TA0 4 % !0 4 % !0 4 % 'P1^W!_S"?^WS_VA7S.=?9_
M[>_]M/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/
M_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0 4 %
M!0 4 % !0!\$?MP?\PG_ +?/_:%?,YU]G_M[_P!M/SSBW_EW_P!Q/_;#X'KY
MD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\ 7A:?^B4K]"PO\./^
M&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A0
M4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%_AQ_PQ_)'[KE
MW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\ 1+URXK^'+_#+\F>=
MF/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_8P_P"1
M@N?^O"3_ -'05[N3_P 1_P"%_G$^RX5_CR_Z]O\ ]*@?IK7UY^J!0 4 % !0
M 4 % !0 4 % !0!^=/[9_C'[;?6FD1ME+>,S2A9,CS)>$5XQP'1%W*6R=LW
M .6^4SBM>2AV5WKU?EZ?F?FG%6*YIQI+[*YGKU>UUW25UY2^_P")J^>/A H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
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MP2-V<8&!7Y]B:WMIN7=_@M%WZ(_#,PQ?UNK*IMS/3T2275ZV2OYG URGG!0
M4 % !0 4 % !0 4 % !0!8M+22_D2&%&DDD8*B*"S,S' 50.22> !R3Q32OH
MBHQ<G9:MNR2U=S]H?A1X!C^&FCV^G+M,BKNG=<?/,_+MG:I8 _*A8;A&J*>E
M?H&%H>P@H_?Z]>WR\C]QRW!+!THPZI7D^\GOT5^ROK9(]&KK/3"@ H * "@
MH * "@ H * *]W:1W\;PS(LD<BE71@&5E88*L#P01P0>".*35]&3**DK/5-6
M:>JL?B?\2/"+>!-8O--(8+!,PCW,K,8C\T3,5XRR%6. ,$X*J<@?GF(I>RFX
M]G^'3\#\*Q^&^JU94_Y9.U[-VW3T[IIG$5SG % !0 4 % !0 4 % !0 4 %
M!0!^JG[)_C'_ (2;P\EM(VZ:QD:$[I-[F,_/$Q!Y1 &,2#D8B.#@;5^TRNMS
MT[=8NV]]-U_DO0_7.&\5[:ARO>#<=[NVZ]%K9>FG9?3=>P?5!0 4 % !0 4
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MKS3L]C/J#,* "@ H * "@ H * "@ H * /JK]G+X\S> KB/2KYM^F3R!59F
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MA7S.=?9_[>_]M/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H
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M!!%?=4ZBJ*ZU3/V>C6C7BIP=TUHU_7WKILS7K0V"@ H * "@ H * "@ H *
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MN9^B7D?B&8X^6.J<\M-+)+HM=//?5_DM#SFN0\P* "@ H * "@ H * "@ H
M* /5?@S\-6^*FL1V!9D@"M+<2+MW+$F =H8]68J@(#;2V\JRJ17;@\/]8GR]
M-WZ?UH>OE6 ^O55#96;DU:]EZ]VTNMKWL['[)6EI'81I#"BQQQJ%1% 5551@
M*H'  '  X XK[Y*VB/VV,5%66B2LDM%8L4R@H * "@ H * "@ H ^+OVLOA
MNMVIU^R11<6R_P"EA48O-%\H5_ER,Q#)8D#]UDEP(E4_/YIA.9>T6ZW\U_P/
MRZZ'P_$F6>TC[:"UBO>LG=K17T[=?+=Z)'YPU\F?F(4 % !0 4 % !0 4 %
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MW!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@
MH * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z
M]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 %
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MO)>?Y>NWPF>Y[[*]*D_>VE)=/)>?=]/7;\Z*^4/S0* "@ H * "@ H * "@
MH * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6K9M
M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [DMXPI;D;W)+2/@LQ&YRS;<D+
MG:. *_0:%)48J*Z+_A_Q/W/!X586G&FOLK?N]V]WNVW;H==6YVA0 4 % !0
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MGH^OW[=#]2P.;T<9I%VE_++277Y/17T;LM['KM=Q[(4 % !0 4 % !0 4 %
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
M"@ H ^NOV,/^1@N?^O"3_P!'05[N3_Q'_A?YQ/LN%?X\O^O;_P#2H'Z:U]>?
MJ@4 % !0 4 % %>[NX["-YIG6..-2SNQ"JJJ,EF)X  Y)/ '-)NVK)E)15WH
MDKMO16/&_$O[1/ACPQN5[^.:01EU2W!GW=<*'C!C#DC #NN,@G:I!KSZF84Z
M?VKZ=-?RT_$\2OGF'H[S3=KVC[WRNKJ^G5KST/B;XN_M27WC^&6PL(_L=C)E
M7;=F>5,MPS#"HCJ5WQKN/!4RLC,I^>Q>9RK)QCHG][_R]/QL?"9GQ#/%)P@N
M6+W_ )FM?DDU:Z7I=IGRK7BGR(4 % !0 4 % !0 4 % !0 4 % !0!^A_P"R
M3\(&TN,^(+Y&6652EI&Z+Q$P4F<$Y8%^40_)^[W'YTE4CZK*L)R_O);O;T[_
M -=/4_2>&LLY%[>:U:M%-+9V][OKLMM+[IH^X*^B/O0H * "@ H * "@ H *
M "@ H * "@ H ^'_ -K;X0-JD8\06*,TL2A+N-$7F)0Q$Y(PQ*<(Y^?]WM/R
M)$Q/SN:X3F_>1W6_IW_KIZ'P7$N6<Z]O!:I6DDELK^]WTV>^EMDF?GA7RI^;
M!0 4 % !0 4 % !0 4 % !0 4 % !0!]-_#O]JG7/!F(KP_VC;#/RS,1,/O'
MY9\,QRS GS!)\JA%V#FO8P^9SI:/WEY[]>O^=SZK \15L/I+WX_WG[W7[6KW
M?6^BLK'V3X'_ &H?#WB]8UGF^PW+<-'<?*@(0,Q$W^KV9RJES&S$?<!90??H
MYE3J;OE?9^G?;[[>A]MA.(:&(M=\DGTEHMK_ !;6Z*]F^Q]!VEW'?QI-"ZR1
MR*&1U(965AD,I'!!'((X(YKU$[ZH^DC)25UJFKIK56+%,H* "@ H * *]W=Q
MV$;S3.L<<:EG=B%5549+,3P !R2> .:3=M63*2BKO1)7;>BL>5:Y\>O#'A[9
MYVI6[;\X\DFXQMQG=Y DV]>-V-W.,X..*>.IPWDOEK^5SR*V<X>E:\XZ_P O
MO_\ I-[?,^;/%W[:L:J4T>Q8L57$MTP 5MWS Q1L=PV]&\U3N/*X7YO(JYS_
M "+YR_R7^9\OB>*UM2ATWGWOVBW?3^\O337YM\2_M$^)_$^Y7OY(8S(75+<"
M#;UPH>,"0H < .[9P"=S &O)J9A4J?:MKTT_+7\3Y>OGF(K;S:5[VC[ORNK.
MVO5OSU/$J\X\(* "@ H * .O\#^.+[X=WT=_82;)4X93RDB'&Z.1<C<AP,C@
M@@,I5U5AO1K2HRYH[_UH=N$Q<\)-3@[-?<UV?E_PZU/U,^"/QNM?BY:[6VPZ
MC"H,\ /!'3S8L\F,G&1RT;$*Q(*._P!G@L:L0NTENOU7E^7Y_K64YM''Q[32
M]Z/ZKR_+9]&_=*](]\* "@ H * "@ H * "@ H * "@#QOXY_$Z/X8:/+.LB
MK>S*T=HF1N,AP"X!5@1$#O;<-A(5"077/!C<3["#?5Z+U[]=M_PZGB9OF"P5
M)N_O-6BNM^^SVO?739=4?CY=W<E_(\TSM))(Q9W8EF9F.2S$\DD\DGDGFO@V
M[ZL_%I2<G=ZMN[;U=RO2)"@ H * "@ H * "@ H * "@#Z3_ &8?AC'\0M8,
M]W&LEE8J))48 J\C9$2,-P.,AG/#(1'L88>O7RW#>VG=[1U?KT7Z_*SW/J.'
M\O6+JWDKQ@KM/9M[+?U?5:6>Y^KE?:GZ\% !0 4 % !0 4 % !0 4 % '$_$
M/P):_$?39M.NE7$BDQR%=QBE (250"IRI/0$;EW(3M9@>?$4%6BXOY>3[G!C
ML''%TW"75:.U[/H^FWKKMLS\;?&7A&Z\"7\^FW@43P, VUMRD$!E93Z,I##(
M# '#*K9 ^!K4G2DXO='XGBL-+"S=.6\7TU6UT_FG?\SF*Q.0* "@ H * "@
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MU=RO2)"@ H * "@ H * "@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@
M#)9B0JJ"Q( )K2G3=1V6K9M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [D
MMXPI;D;W)+2/@LQ&YRS;<D+G:. *_0:%)48J*Z+_ (?\3]SP>%6%IQIK[*W[
MO=O=[MMVZ'75N=H4 % !0 4 % !0 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\S
MG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M_;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1WU=1Z(4 %
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MO_\ P+F_^+H^M5/YI?\ @3_S#^T:_P#S\G_X'+_,/^%K>(/^@K?_ /@7-_\
M%T?6JG\TO_ G_F']HU_^?D__  .7^8?\+6\0?]!6_P#_  +F_P#BZ/K53^:7
M_@3_ ,P_M&O_ ,_)_P#@<O\ ,X&N4\X* "@ H * "@ H * "@ H * "@ H *
M "@#ZC_9]_9]D^),BZAJ"M'I<;<#E6N64X*(>HC!XDD'.<QH=^YHO9P& ]O[
MTOA_/_@=W\EY?69+DKQCYYZ4T_1R?9>7=_):W:_4ROLS]:"@ H * "@ H *
M"@ H * "@ H * "@ H KW=I'?QO#,BR1R*5=& 965A@JP/!!'!!X(XI-7T9,
MHJ2L]4U9IZJQ^1GQ[^$4GPIU+Y-IL;II'M""<JH(W1,&);,>Y1N)(=2K9W;E
M7X;'83ZO+R=[?Y?*_P S\;SG+'@:FGPR;<?3MJV]+K7KOO=+PNO-/GPH * "
M@ H * "@ H * "@ H * "@ H * -#2]5N-$F6XM99()DSMDC=D=<@@X92",@
MD'!Y!(Z&KC)P=T[/NM#2G4E3?-%M-=4VGVW1Z+HOQQ\2Z#(98=3NF8J5(FD,
MZX)!X2;>H/'W@-P&1G!(/5#&U(:J3^;O^=STZ6;XBD[JI+;[3YE]TKKYG3_\
M-/>+O^@A_P"2]M_\:K;^TJO\WX1_R.O_ %@Q/\__ ))#_P"1#_AI[Q=_T$/_
M "7MO_C5']I5?YOPC_D'^L&)_G_\DA_\B'_#3WB[_H(?^2]M_P#&J/[2J_S?
MA'_(/]8,3_/_ .20_P#D3@?^%K>(/^@K?_\ @7-_\77-]:J?S2_\"?\ F>=_
M:-?_ )^3_P# Y?YG(ZIJMQK<S7%U+)/,^-TDCL[M@ #+,23@  9/  '05A*3
MF[MW?=ZG%4J2J/FDVV^K;;[;LSZ@S"@ H * "@ H * "@ H V- U^Z\+W45[
M92M#<0MNCD7J#T/!X((R&4@JRDJ002*TIU'3=UHT;4:TJ$E.#LT]&OZ^]==F
M?K'\$?C=:_%RUVMMAU&%09X >".GFQ9Y,9.,CEHV(5B04=_ML%C5B%VDMU^J
M\OR_/]ARG-HX^/::7O1_5>7Y;/HW[I7I'OA0 4 % !0 4 % !0 4 % %>[NX
M["-YIG6..-2SNQ"JJJ,EF)X  Y)/ '-)NVK)E)15WHDKMO16/QU^-'Q4F^*^
MIO=9D2TC^6UA<C]VF!DD+P'<C>_WB.$WLJ*:^"QF*>(E?HME_7?_ ('0_%,U
MS%XZHY:J*TBGT7RZO=[]KM)'D5<)XP4 % !0 4 % !0 4 % !0 4 6+2TDOY
M$AA1I))&"HB@LS,QP%4#DDG@ <D\4TKZ(J,7)V6K;LDM7<_:'X4> 8_AIH]O
MIR[3(J[IW7'SS/R[9VJ6 /RH6&X1JBGI7Z!A:'L(*/W^O7M\O(_<<MP2P=*,
M.J5Y/O)[]%?LKZV2/1JZSTPH * "@ H * "@ H * "@ H * /EW]I[X0-\0+
M 7]FC/J%FIVQHBEIHB060GAB4Y>, GDNBHS2 CQLRPGMH\R^*/XK^M5\]-3Y
M/B#+/K4.>"O."V25VKZKOINOFDKL_+*OC#\E"@ H * "@ H * "@ H * "@
MH _3W]E#XI-XPTUM+NF7[58*BQ\*I>V "IP#EC&1L=@H 4Q9+.S$_8Y7B?:1
MY7O&UO3_ ('^1^K<.9C]8I^SE\5-*VRO#9==;;-V[;MGUE7MGV 4 % !0 4
M% !0 4 % !0!0U72X=;MY;6X7?#/&\<BY(W(ZE6&001D$C((([$&IE%333V:
ML_F9U*:J1<9:J2::\FK/8_)/XW?!&Z^$=UN7=-ITS$03D<@]?*EQP) ,X/"R
M*"R@$.B?#XW!/#OO%[/]'Y_G^7X[FV4RP$N\&_=E^C\_SW75+PNO-/GPH *
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
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MHB@*JJHP%4#@ #@ < <5]<E;1'ZE&*BK+1)626BL6*904 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!R/CCP/8_$2QDL+^/?$_*L.'C<9VR1M@[7&3@\@@E6
M#(S*<*U&-:/++;^M3BQ>$ABX.$U=/[T^Z\_^&>A^-OCCP/??#N^DL+^/9*G*
ML.4D0YVR1M@;D.#@\$$%6"NK*/@:U&5&7++?^M3\3Q>$GA)N$U9K[FNZ\O\
MAGJ<A6!Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'Y#GF5?4IWBGR2V\GK[M_P 5?==[-GSG7E'S(4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^B_[.7[.7]@>7
MK6M1_P"E</;6SC_4]Q)(#_RU[HA_U7WC^]P(OJ\OR_D]^>_1=O-^?Y>NWZ7D
M61>RM5JKWMXQ?3S?GV73UV^V*^A/NPH * "@ H * "@ H * "@ H * "@ H
M^"/VX/\ F$_]OG_M"OF<Z^S_ -O?^VGYYQ;_ ,N_^XG_ +8? ]?,GYX% !0
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M ->%W_Z)>N7%?PY?X9?DSSLQ_@5/^O<__26?B;7YZ?A04 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 6+2T
MDOY$AA1I))&"HB@LS,QP%4#DDG@ <D\4TKZ(J,7)V6K;LDM7<^__ (#?LO0Q
M0KJ7B&'?*^UH;-\@1@$,&F7C<YQCRFRJJ2)%9V*Q_3X'+5;FJ+7I'_/_ "^_
MR_1<FX>27M*ZNW9J#Z=;OS_NO1+=7T7W17TA]^% !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 >-_&[X2Q_%S3?LX98KN%C);RLH(#8P48X+"-^-VW
MD,J/A]FQN#&X7ZQ&VS6J?Z>AXF;9:L?3Y=I)WB[=>SZV?6WD];6/R;\7>#;_
M ,"71L]2@:"<*K;2005;HRLI*L.HRI(#!E/S*0/B*M&5)VDK,_'\3A9X67)4
M5G:_39^:NG\O0YBL3D"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MMT??^NJ/Q3,<NG@9\LM4_AET:_S[KIZ6;\QKC/*"@ H * "@ H * "@ H *
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M,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H * "@ H * "@ H * "@ H * "@ H
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M0PPP&&4@J>#C<J,O)B,-'$*TODUN>9C\NIXZ/+/H]&M&O31[]5^J1^8?Q4^
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M^AAHT%:*]7U?]?<?J>"P%/!1Y::M>UWNW96U?Z*RU=DKG?5U'HA0 4 % !0
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MO%27S79_U^!^XX#&QQM-5(Z7W5T[-;K3[UMHT[*YWU=1Z(4 % !0 4 % !0
M4 % !0 4 <CXX\#V/Q$L9+"_CWQ/RK#AXW&=LD;8.UQDX/(()5@R,RG"M1C6
MCRRV_K4XL7A(8N#A-73^]/NO/_AGH?E'\6O@CJ7PCD4W&V:TE9EBN(P=I()P
MK@_<D*C=MRRD9VN^Q]OQ6*P4L/OJGLU_6C/R',LIJ8!^]K%MVDMO1]G;6WW-
MV9XU7GGB!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MP/URLHOX5[TO\*^:>KLM-5>_0_8JTM(["-(846..-0J(H"JJJ,!5 X  X '
M'%?>I6T1^UQBHJRT25DEHK%BF4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M 4-5TN'6[>6UN%WPSQO'(N2-R.I5AD$$9!(R"".Q!J914TT]FK/YF=2FJD7&
M6JDFFO)JSV/Q&\:>&)/!FI76G2[BUM,\89D*%U!^1]I)P'7#KR058$$C!/YW
M6I^RDXOHVNWS/PC%X=X>I*#^S)K56NNCMYK5',5B<@4 % !0 4 % !0 4 %
M!0 4 ?9/[''CAM+U.;2)),0W<9DB0[S^_B&3MP=J[H]Y<D#=Y<8W9 5O?RBM
MRR<'M)76^Z_X'Y(^WX7Q?)4=)O2:NEK\2_!75[][+4_2:OK3]/"@ H * "@
MH * "@ H * "@ H KW=I'?QO#,BR1R*5=& 965A@JP/!!'!!X(XI-7T9,HJ2
ML]4U9IZJQ\(?%O\ 9$^]=^&_]@&Q=OP9HYI'_P!UBDA_OD2?<CKYK%Y3UI^7
MN_\ !;_/[^A^?9GPS]JAY>XW][4I/\'YZ[(^%]4TJXT29K>ZBD@F3&Z.1&1U
MR 1E6 (R"",CD$'H:^<E%P=FK/L]#X"I3E3?+)--=&FGWV9GU!F% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '3^$?!M_X[NA9Z; T\
MY5FV@@ *O5F9B%4=!EB 6*J/F8 [4J,JKM%79UX;"SQ4N2FKNU^FR\W9+Y^A
M^A_PD_92L?"6VZUGR[V[&\>5C?:J#P#M= 9'QDY<!06X3<BR'ZK"97&GK/WG
MKIO'\5K_ %IU/TG+.'(4/>JVG+73>'W-:OUTUVNDSZYKW#[(* "@ H * "@
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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MVOV5EOH>FUV'JA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?\  _(_,N*<'R355?;5I:.UTE;7S733X6^Y\75\^?#!0 4 % !0 4 % !0
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MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * -_0_"FH>)]_P!@M;BY\O&_R8GDV[L[=VP'&<'&>N#Z5K"E
M*I\*;MV3?Y'31PTZU^2,I6WY8M[^B?8W_P#A5/B#_H%7_P#X"3?_ !%:_5:G
M\LO_  %_Y'1_9U?_ )]S_P# )?Y!_P *I\0?] J__P# 2;_XBCZK4_EE_P"
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M_P"&8?%W_0/_ /)BV_\ CM5_9M7^7\8_YFO^K^)_D_\ )X?_ "0?\,P^+O\
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MG;'&BHBY))PJ@ 9)).!R23U->G&*@K)679:'T5.G&FN6*22Z))+OLB_5&@4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 >1:Y\!?#'B'9YVFVZ[,X\D&WSNQG=Y!CW=.-V=O.,9.>&>!ISW
MBOEI^5CQJV38>K:\(Z?R^Y_Z3:_S/GSQ/^Q59RQYTN^FCD"O\MRJR*[8&P;H
MUC,8SD,VV0X((7C#>74R9?9;^>OY6M^)\WB.%(M?NYM.S^*S3?35*-O/1^A\
M^>)?V5_$_A[<R01W<:QEV>WD#8QG*A)/+D9\#("(V[( RV0/*J994ATOIT?^
M=G^!\Y7X=Q%+9*22O>+O\K.S;]$_+4\#U32KC1)FM[J*2"9,;HY$9'7(!&58
M C(((R.00>AKS91<'9JS[/0^=J4Y4WRR3371II]]F9]09A0 4 % !0 4 % !
M0 4 % !0!Z=X:^#/B'Q;M-II]PR-&)%D=?*C9#C!624HC9R" I)(^8 @$CLI
MX.I4VB]K]E][LCU:&55Z_P ,):JZ;7*K>3E9/?N>]^&OV,-6U#:VH7=O:HT8
M;:@:>17./D9?W:<9.65W&1@;@=P].GD\W\32T]7^B_$^BH<*U)_'*,=.EY._
M9_"OFF_F>^>&OV0/#VD;6NS<7K^6%97D\N/?QEU6((Z]#A6=P <'<0&'IT\I
MIQWN].]E^%G^)]#0X8H4_BYIZ:W=E?NN6S^5W\SZ3T7P_9^&XS#8V\-M&6+%
M(8UC4L0 6(0 9P ,]< #M7K0IJ&D4EZ*WY'U%*A&BK02BKWM%)*_R->M#8*
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M_P#_  $F_P#B*/JM3^67_@+_ ,@_LZO_ ,^Y_P#@$O\ (/\ A5/B#_H%7_\
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M7_\ X"3?_$4?5:G\LO\ P%_Y!_9U?_GW/_P"7^0?\*I\0?\ 0*O_ /P$F_\
MB*/JM3^67_@+_P @_LZO_P ^Y_\ @$O\@_X53X@_Z!5__P" DW_Q%'U6I_++
M_P !?^0?V=7_ .?<_P#P"7^0?\*I\0?] J__ / 2;_XBCZK4_EE_X"_\@_LZ
MO_S[G_X!+_(/^%4^(/\ H%7_ /X"3?\ Q%'U6I_++_P%_P"0?V=7_P"?<_\
MP"7^0?\ "J?$'_0*O_\ P$F_^(H^JU/Y9?\ @+_R#^SJ_P#S[G_X!+_(_7OX
M:6DEAH>FPS(T<D=C;*Z,"K*RQ*"K \@@\$'D'BONL,K0BG_+'\D?LV BXT8)
MZ-4X)IZ._*CN%KH.\=0 4 5+NTCOXWAF19(Y%*NC ,K*PP58'@@C@@\$<4FK
MZ,F45)6>J:LT]58XC_A5/A__ *!5A_X"0_\ Q%<WU6G_ "Q_\!7^1P?V=0_Y
M]P_\ C_D'_"J?#__ $"K#_P$A_\ B*/JM/\ EC_X"O\ (/[.H?\ /N'_ (!'
M_(/^%4^'_P#H%6'_ ("0_P#Q%'U6G_+'_P !7^0?V=0_Y]P_\ C_ )!_PJGP
M_P#] JP_\!(?_B*/JM/^6/\ X"O\@_LZA_S[A_X!'_(T-+^'^CZ),MQ:Z?9P
M3)G;)';Q(ZY!!PRJ",@D'!Y!(Z&KC0A!W44GW22-*>"I4WS1A!-=5&*?;=(Z
MZMSM"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!_PQAX?_ .?F_P#^_D/_ ,8H_L>GWE]Z_P#D0_U5H?S3^^/_ ,@'_#&'A_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % %#5-*M];A:WNHHYX7QNCD171L$$95@0<$ C(X(!ZBIE%35FKKL]3.I3C
M47+))I]&DUWV9Y5K7[/GA;7I!+-IL*L%"@0EX%P"3RD+(I//WB-Q&!G  '%/
M 4IZN*^5U^5CR*N28>J[N"V^S>*^Z+2^9YC=_L;>';B1W6:^C5F)$:RQE4!.
M0JEXF; Z#<S-CJQ/-<;RBF^LOO7ZH\J7"U!N]YK79.-EY:Q;^]L@_P"&,/#_
M /S\W_\ W\A_^,4O['I]Y?>O_D2?]5:'\T_OC_\ (!_PQAX?_P"?F_\ ^_D/
M_P 8H_L>GWE]Z_\ D0_U5H?S3^^/_P @'_#&'A__ )^;_P#[^0__ !BC^QZ?
M>7WK_P"1#_56A_-/[X__ " ?\,8>'_\ GYO_ /OY#_\ &*/['I]Y?>O_ )$/
M]5:'\T_OC_\ (!_PQAX?_P"?F_\ ^_D/_P 8H_L>GWE]Z_\ D0_U5H?S3^^/
M_P @'_#&'A__ )^;_P#[^0__ !BC^QZ?>7WK_P"1#_56A_-/[X__ " ?\,8>
M'_\ GYO_ /OY#_\ &*/['I]Y?>O_ )$/]5:'\T_OC_\ (!_PQAX?_P"?F_\
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M  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^^/\ \@'_  QAX?\
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M=]74>B% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 .6
M@!U !0 F* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
M #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #%
M !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B
M@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q
M0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8
MH ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,
M4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &
M* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #
M% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !
MB@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@
MQ0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0
M8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M&* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
*#% !C% "T ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>May 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  08,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEXCOM, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0857544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6340 Sequence Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">200-0200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DXCM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $&!J5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( $&!J5KYTX'5[0   "L"   1
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !!@:E:1L=-2)4
M  #-    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( $&!J5KYTX'5[0   "L"   1              "  <,   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $&!J5J97)PC$ 8  )PG   3
M          "  =\!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M08&I6B>\F*9&!   >1   !@              ("!( @  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $&!J5J?H!OPL0(  .(,   -
M          "  9P,  !X;"]S='EL97,N>&UL4$L! A0#%     @ 08&I6I>*
MNQS     $P(   L              ( !> \  %]R96QS+RYR96QS4$L! A0#
M%     @ 08&I6AE%%?4W 0  )P(   \              ( !81   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( $&!J5HD'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( $&!J5IED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="dxcm-20250508.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="dxcm-20250508.htm">dxcm-20250508.htm</File>
    <File>dxcm-20250508.xsd</File>
    <File>dxcm-20250508_lab.xml</File>
    <File>dxcm-20250508_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dxcm-20250508_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dxcm-20250508.htm": {
   "nsprefix": "dxcm",
   "nsuri": "http://www.dexcom.com/20250508",
   "dts": {
    "inline": {
     "local": [
      "dxcm-20250508.htm"
     ]
    },
    "schema": {
     "local": [
      "dxcm-20250508.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "dxcm-20250508_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dxcm-20250508_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.dexcom.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20250508.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20250508.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001093557-25-000129-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001093557-25-000129-xbrl.zip
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M&K!XVPJ @BH [P68O>2A,][SB;,]W?'-+Q8OV)&;20#^.WR2_.[-G/Z7H])
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M( AX!H0!D4 <D RD SE 'E (E (50"W0!'P!.H$^X!LP!DP!\\ *L 7L 2<
M @0"X8-(0)0@.A SB!W$ Q("B8-D08J@!R!MT&/0$Y =R!7D#0H"O0!%@A)
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M@ Z),$<#<W60LPOF*2J$.LP<&0?Y?VW^7YO_&]L(E_X"HH2;9)\23%5==S!
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M&J<4<V$3TR.^2,W$("N$H=^K]JG<&K]M"["@.^'JO=A6$A[8C>]>?B^5V6I
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MPR6CJ&KE+3I7%TVFYAFVA"8S5'%#2RIBI$$FH7'(&>,K^'R Y.7&V&[$W('
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M6<.3P_GBO=X""?G)=S,DUN\\JW2[@496;XXB4((G?M" "9Y>_"-%(N(!*ER
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M>,CXX$V&8Q!OO?3/!:6W*6E1#S'A*0*]YK]R]3YU8/+9_O[=Z=>1V_&$=AK
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MNL+W#[FMSE6$M[6=?3?Y8)C?N2\M*[86L"OFX#3D$@%T'?62/R^5/L)&\9K
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M+!X5Q \/.>]4;^H.#9(?8+9VD2? .H&!DKH>\JYPS05]]=IQX +G5>:< T^
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M/A4N0J]1OIZ0EHW;>!&XK(./:%+2:QU9%;B^2)KV;,WARH6NQO^D6F'/93)
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MMJ !TNU9^<.;V"75.W^UQ3,0K.+X13555*Q1(?A=RK$$>R,Q_+F('>;/(FU
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MI'D=I#UA*73>WFP9)]&=SYD,]0UPR9+>1;B;= L%_+YK5[7PWVC !<1N$ W
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M::U"$ZGS+SX%GN%Y[1!;_0(Z%=!;^E .4R+\@OH^WH.DJ*@NXT*!:GFWV;M
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MTE#V)1E=*BUZ#4MZ3EOR:'/2UFX>S@.@">SH-J#\QNC+(]&*86W*%P=CIZ^
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MUWQ$@PP3>'"Q_<MH#^AVE*55^1WJP5U4C[S3T9::UGJD$:7-)7HIL+.SA<Z
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MCZ[%E9KGDS%DUHZ"UPWK0J9X?ORGLI"=O.3A7K >UJ_"1P#F@FE#?#P@,L:
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M;C+B:]BHM3O]GK#OQ!/?UH@,=\O[+RA%C5W)J.09C>I3/7&5)ZD$TG8B.2U
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M!?:-S$1,YFNDG!<95G?\86B-NAM6K_:>-R '\(%YJ=3I</&A._*JFT?>$M9
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MR($@Q(!GR?Q4=7@>%V)?+[;M_Z'U]=_^3P1>%-U%U"2_I#QLW#=;J=JLU-O
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MWDWW$/5QZ_:1 ,E&T;FH(XYZ'W*4U"V39:]L-NK$'F\CZ'1C_&-1-:=VV]:
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MD=M 9NC7/G,\H>'9<^\3+B$*O)"]XHF;H9]95GZ8W$ F-MK>#R[<B7.N@=$
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MJAH-P)C9R+?%^/-$D3::&**:^X!D2P,$H#=8EQ=I@,T5./$PNA7XI]MI#CC
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MO9D[NRU$-Z67^^L>+3B(*=L3%!TIZ WSI KWLCXE]MT8BN)X4J%9>ERW1.Q
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MX0 .9A=U[%S3<WUT\ANL](:A7"38;T%ZOX.IC#^ W;XMVVM/ \XC5X]254%
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M05 LJD7N+X8'5T3$V_.SD_$BK<1#;M.(IOU*[6CMUJ5&?!C*H2,M*% PT)2
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MIKU@8M#FCW9>_<=NN#5OS@LW8FD#0I_<;S#F3M GAQ^/?CYZ=_3QZ.*?O=C
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MY$KVB\%Q;=#[MN!GT,M4]KU,K\3=FNB,JRIHET[#<A1&,,-9GU@-*L$DJ?+
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MHVV:\"9)?9\S#VYC$)0Q^<SK61$'H#;\!UZ<>GWU;.D14U&JVDMO7J-78WF
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M39Z$*<'MC$PBUQA6N!-,L5'(;IW!UFK&IHV/JIQ1$R#+7C64AVAD*4TS;Q0
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M\]EMY7KG0CL1+\<:]T2*B5X-5HC,QC51KI!UY>9G(JQX67'.F%Q#T&,@&V
MU%C_0+% UC!BMVL+"?)/(.J+$S=:>'4/L LTN EL8+8-Y7A5*;B,Y5?Q/W@4
M(NLR/RP?",G,-(T9QD""XFPH)F"9TN&\G,\#(Z4[WH6ZEQ8_A&'Z<$*8#N2]
M:UJ#'J<!!F:""ASO?.GL9$>G N6K$:^5<K,G&OR&25I#X>>=H=ZS7(['TO7H
M+XNT#&$/_'#;4\(&0,>:8Z#88IA/FVS%+!%?&37\=I+J!]]&4KWW=,T J'=&
M04C1Y6>\(ZN7TB+W^$XF'<*D$=.G.TE01=&9$P1:5*BHJ7F=08K+_8U]W.%%
M8OD.'G2\L1T\WK^!33WCR4%$4LP^*018:I<?SJ=3NZ,,\_/D82RK\T'6=E"N
MU[L@RNC%;2V/,NYZ.D5&U)G"IA5@9ZX[K222S^$J\VB>RXG<+"%W:"SM;PT:
M>#/^0;SL\,5*/XIMCAH" H.MA$>-#$;@O]:Q-LL\<>MLQA;X=>C.>+U\O,9"
MZR>?GQ$N*DZ:?5=TR GN:6QJ8TK03-$#6EE%K]*(1DMT>2J8KRYA= O1((BS
MZ^(.3B8#@O=A;-HDVMFF:AF.;3Z\]G#1U&9DJ>QPZ;JC3'\E\-I%&MYA7OW%
M&.IZ<2/SCDQP!O0J9(HP_F53T<"R669(JT2H8Z!$=0K)[M ;>#<21]6(LD2U
MG 5F7R^<;HH%A;:_&,MHRY5ZLDRT/_-NNL6Q^D-:@/.[-;<RHS/;US%K8V@1
MJ[#'WD \T[7&Q@#ZW72W-))C3:2A)X1?N_+,NH\-CQ';U^@TCRW,[LKL\W6(
M#;S*1$I"!LJ;VST148!OSOA\'RTO,_2N''E(*]BY$W26V+7N:= FH>F9.M\S
M&(8,4GS3S92F!E0^],UVO_S:=[+9SK@2D#I(92J=][*SNBHP-VV3=8P R@];
MBVEH<A[*%#U2-(5>E?L]6E'D*K1$IPM[(&-"YQE5G*D&?K3VHDM!XL0F3@V.
MEIF9R1 -8EH323(-"40Z@([-HP\GIX0&QUHUXM;##DZ'9]'H]/3LY+?1QWX<
MU2Z,GU0U&A8#4U_4@$%;?\Y/M\4M7O$0FUPQ6@\/GVN=@<NSLW^P&\UAJ+/*
MT+6BG%K*94J)><56N#40ABX,,,C[P!026!#<T;1Y4&(\@-9C%X=GOV+=[^G'
MT3$5A?U\\MOAV3%V(OLX^KU']F.P@<';]6E%@J"\,7M:S!ML7'@<NZRJ4<;F
M)B=WQE)&?Q_:2S\8FZ41!L9B^IW]Y[MDEWNM_T)17BNPPC08LA^[ER+FVT5*
MZ;?<M@1O^#-8_&RZ%Y?Z*BV6%3@UYEM#94SNMV^>H5N1P*I/@KJUM Q:*G72
MOY/#*0.VBJ'K4E_G<'EFRYS$I6+/R'57II(_$W.@^R$!#O/7= S9-@6@=&<M
M*(\/.L/P@R;@DI2)8Y@?*U3@]>ATI1]2M&18910#:)DR^O7P^ /\_XOHY"Q"
M/7)TS/51HD[ZBM1R3I22OEZ]C=O/MO(I"'@*9Q1BPV_L&:&L-G'EG',;L7;M
MI[A3DM]<@A-9"9EEK3[DO-E"?D@A>?$H5[Q.X7G10,LWC_8 .1,>]_&Z21"0
M CU/3-[*X\!K$"$TH+,AG64WYQ9/4J<N8-^TK&SRT08W$9C@2L7]WL%^,$O=
M5;_@A]WL ^"2/CXY/OR?]Q\_G1_]=G3Q3]SB%[\<BM6 $O#I^*=/QQ\./_2V
M\X]MDRW-YW!+AL)6P1+'IT!_2]J*FW8/IZ!E#^#!73;"-,']+"[*'G/(XX5I
M8A/?"3K L<G"( YY+&]ZC!OBJ[5ZN&"\7N>54"3YO3)=%SJBG43>M]OUQ<&G
MVDP1AENH\%SR5]1XO,@)7.%@"A2V;1%VVBA0,"XQ<&31+DU#)M\R*0([A?AE
M,5Y,S?32A"+D@^*+/1@ 7^S1\?D1.K$79R/J1GQZ\O'H?2]USH?-MB;(Z>?U
M^PB.$2J@77F<6@6(S:IIC]N]VV*Y2@K3.]"%6RPVL.4?.Z MW-A$21&$BQU0
M=1ET#7>QTU"!/ $_?MQ_\6T /QY6R0R .7;T\:/PC$7GG][]]^'["Z140'JG
MT?$_H_<?1[^_&V&K"F1_>G_RZ91\C/XTD=?G;*8S\5G%C.=V8+3M.\MJ$_ _
M&89,5(0+XQ5X4$HJ@C"5$;6M >;T1NLA:= YT/11U?FENF3O>5JJY80=#[P9
MVP=@?U!O'/3;EPG: W +QFQ3(HGXW;EUJHJFX";E24JM=&R<A")U;8@=VR7K
MX'7<;LV+VCB6H%M,3+<2YR<6I?13LY4)\#7<4D >M[X[<TF*(65PQ(:Y8:XG
MQ+IUI=*,4^NYN#Y!?^ F6W"SSJ.KQ-BR;[G1"1D2\E3"YZ!!_M#MG@W\^T%9
M/0/@0OQP^-/1\5%?+!#1J(J6PMW<L)NU[7FMLTI?8R0-ZTQH![H(J%_CSC$Z
MQ_,4?CO7"FG&*J(>&W32\^VVL$_\[4<T# ^>_W OHZ'[?(\M2=+D%M-BR6H>
M7HQI%O9_(!&KZ% C] _7N>*)%L/1@+8P-PW$JFS^BU(]0G+&7?#B@/(_->1R
M8.3/.0M*?&AM?B#ILAD\.2@9>&_1=!6A@RYS(FSC D6^&O8/''IT+(AO2DBL
MSL// ^$;T&9>$,$=[DW.>1GDTK A!F^W!3R\7;OMEDFEOC>CEZS2MTF[-IH.
M; J#A60UUD4^>'[P"FZ<+ZF5DO?SN=:/83=L";IMNW8#FJ9]BSK)9!>LVJ>2
MQHM.!$C:[FA&_P$W(U]6YH\1[ @-'A%9]&?X\/8/HT^Y]!FCQ\,^.=4EYH4H
MD7DGW:UZ%_LMP9EMG]B[E%_/&R!N>8S4'IH&R<:2:0\05-YY]<]C75]KG;<,
MJV81'Z+*<3.!B$N.?EV=@(/*\7=+L-]6SVP<'XX;.(C2+WA=J6'$%B=-J'';
M#\IG"3"$/WX?YI!L0+HR[S3XR<;:56/C<YK-LW>CCM86.V2O.EB^3?3:69-"
M8R)>AJ>0-X>W/V+ 7K/!D-<-F?O$[U2[NV25KFW ,/&:2(?1[DD'D]OZI3#%
M, /71/>;,1VF)J+(6-\'L!>BF_Z)Y,<PI.]^$WG#E+[WV-RK;^G;<0$SEY:&
MDTI.*2:@;)S8NQ8:Y)6\=_;V$9IDR<]STYH-UR/50.J8O!3VOE'X@QQFA,(8
MZ("5FDJI*&P?1_.T<@589*#J^5C_\4=F\40N0*T2_B!A6OE)6LV*'*S2%>,,
MJ*:*.#JF.BOD% ?#8)F9RON41R#]=O&+-2$:KD_R#E@*4U._,CC<*,.@<S"&
M9^OXGY0AYT&40JNGKKR5XUT>NGZXWQS<0/5#,>E=/:#0H9M&/AMQ,AUAP _E
M]PPKB99<SHCRN?_=V]=^F,3OF.+ZJV"OJF5V24#>VN)<ARZ^]YNQ&:KXBNV^
M#3+\WH=[.3\EP(I1L4=1:5'1X&$P^1;X%VH"QYW7X&7JATF")I3V4_1-J)K=
M>"R,QK<=LSC[:MPMS(ARN$53X9,W0"1HGFM33&N'>Z<LC'WLF?OML37</0/R
M1>&Q;=@VDD!B)./C\DCV[[>)RLWR]W;OX&#[Q*\?PIA0\CZ 3U+,8S UDCU;
MM-G)G3EX(>P[);^50IBC8Z5ZCPPS+I9L@3 7PNW3F$8/A0>CL>C&,<, AF]B
MBR]K &G)J[U%VYQ2<_D7.]".-I!S]$]0V!_W7WX;4-C^553?.(:M5%$=! A]
M:RNBP$J290FZ([&<L*V6+L3_44DG34'^R-2RKC-WW3&DNQCL(TR1(.Z$U:B*
M]E_L3';)R]]_B?\J#.6NM%H<)?6NU!?S\.0Y8YWK:4IXV>(Z1Z(U]T2#U8/G
MG"TS#<^8/'O1>>?UZ"BLO6E1>QL-C.V/-3;#(71?44H1SC2=UJ3M49=%.Z^>
M_X=]G[K -IM7!9-D4XV1O4E+P[O2WYG.G_E 5KF!&]GFPL7I&BK@),.PL26"
M;[#;>15.8=$%R0)XDJ>TQE0:PB R2K=Q1!,6XT_/B"F?7#OO?A-@[[%KV$2$
M>\^0SG=QK%8*:[*H_$2:[DW2RAQ?K7.7:7L,S8=+>F9K21U456G3Z(21TUTC
M4;#[RDM^/GY79.FD005KWE\J;0Q?G#5B8T-<0AQ>:^_'@0+FRI/8LZ186Y+5
M"A?[%>YS!&D+5QFS!4D6V:,T9UIC%O%H1V!]XY54S%,PW+LE-]T8:V&21K9@
MVL'(I[YN:(YI7V"'0K+/;3MV[W)GWCP]I>%DWC2FM;/(L$6ZPYJU,T)TM>M)
M@,]3PVLK_7"UT-^(MDSL_JC]_<$JDS$[ZWGFHFL&/=\(2[NDEMP+;T.D91/C
MV2COLKDC2Y/B=%%,VY-":G:#WKP%_1D6UKAPF+M4QH#3&,E)8$B\+'S0@%T;
M[T<ZE8['*NB%+577<_4O)OV&GW&PK0JB;:@LA?]Z$DV6I0%%M3A<#,<RR%[G
M?:XIPJ@6BP)FU62H"%9"['X5J4@P_HNR$K*'8&QXH\[[!L1?IJF'%+AW/2K@
MFN\Z7ZYV3>L<<V:TSHNQUXM\_=3'-YQ3:Q9L[/7A,8?65QTA:]CTR< 0&>7[
M5D&U<?!Z>"=<:=R.EV4!^X.Y1KD1.QDOW* Z(%$GF2*7J))V&Z(8XE M$$.Z
M98YO\M0RML[KP3!>5DB]5H6:P_!]F+#<3:SQ'853!%BB-B5A'M3VYPB*I1M6
MVKI^(+MR5 F_S$*MO(*@H,0<W+/*'*9KJ,6X&IJ'&'#BF=MRK;,TM[G2S3=9
MQS[/0R0R8E:^*V$>L\J%UQA;T>+FN4G+D'L?:B;O!M-&2A@&Y%L*;'"T=@\!
MKKPY-^Q1I E4+L7FI.S]M8BED-WF(=!.EQIR V3N(F9&1AJNR\=]0UD1+&_+
M8-Y@G9;E*CKSTGEX^='9>72Y3)E_A@3*/M//]F&327Y\=PZP/9J!1/>ZG;,;
MMN$ZB71<JD$+:3'X:(KHW/%^0DC;14IP]'7>2(IJ!_8%UN\%)P+KKAP#38H"
M5VA':Q_?06>0I' +6'YUB;>)NMJNFJ?4S._0.5I2ZECVZ)T];/ZD%.:2W</V
MBG>.M=^HT:()?TM]!&"X:.2P->J=_D;+XXZ<M/&/]K0AT2]9OF4Z%^:@ +>)
M*EIOJ'+WS4/A=&-7^GZZG_82%^H;T;^%<2&#WNL[%*2Z$L:#%[B^L?1;*7"5
M&J<9. =]BUP#[7UT?H(0;O+/T49 W(/*\<29V"%'W8;DP<&.WMUY$;JQ7E\P
M\PCVHDW[(<<9[Y.$8R&DDDX"G)$QG%U-:-YTF9&U?X4#"XU29/@";<[-=NS9
MB'==S%85]>5&VP;;@&>@^1<J+>?6MD[0QF4<7U('9WF*T! %UCM&"]I79:JJ
MI6V/!&:*9>5U\$$3@6@?*4BR?R 4HH/?Y7WCU+=PEV]Y;221R!5E>HEN A-2
MW;8:,O9,OV;<@FLAI?S1>L1KPE=DE,&..GCN"=!0MT#?8/EMW +"&=6W\'=#
M GP:*U?"85J <O!9$OF*F+BT:10@T9@&KOL&@("C[I/;<M#"/)A\+TN+/O6^
ML:[*%![=R) 8[ZA:XLND DNW412;O'/=3LW,A#<:_.[K&XJ^C;O/R[OVO0/;
MB/1SYW?[ V5,^HN7/B9]\,+9-]!\FX7SM"PN2S7O6T 5JGT<2$!7S'8.9NV[
MR*TH/E0RZ NA *Y],)&=F_9@4W(5*B%QH6!5O5IXY;7D+DQ2L!<I8\D?[E Z
M<CXV 3T*N1;37:$$ZV[KCGY/>Z@<Y,,PFX2&N>'3AGWU[0#27CT!TAY&!_9=
M.+"5.M#?O5O'J&";J[/B6I"*P8@\*45E&@)A>LAF1/'"&QKU3;VN[5SJWWAL
M=#XZZWPDW7QTANK,:^&%G\I01$<.W5XX>"IR:$W+3RHMHU]5^5G7T6\J6_:_
M7;BG.#IA& "1?G,X,O;>:!?X9&K(>D%XSCMG)7QS\, RNJ-V^Q70 U,%EDI_
M/+\$"_7#8CD&N<HHB6G(OSA<E4=92ATR4?U$;%R%N$MCN<7<9"4#4P:!:J57
M$V]"7F'.U1#:EV!LI0NXZ::[1T6#L2\8OQEC246,M5%U\#*";"DU9CLY!O^P
M^[-[<US 2_R.2?#SNM2P1Q]^>_YWL:0*9X,+Y$Q#!9]RJ"5@IJ$D/<YBEN(9
M15"_0>_(<?\[\N#EU^Q(;/6$P#F)B8G YVLD_A:;E<+/5[K$=)'$F<W>':>L
M 53U64]X)U>;M_( =IC(>P^=GO_T#HM<DGV0FRSI?Y/98R_'N@!;)R(():&U
M%-KNN,4E'JX0"/9E44RBJ8(].'BC^:DHLS4M0LO6>VPMM[3^5.\A"8]N=AQ6
M*@M;\%+I6S4K"8X;CLQ9ICB#4=A_W562-'C!?RKU:PO^60\$]U_-P2-$6X,7
MP"=,80>.N*.O?-\BZ26;I9(0X4B@G>U(NU7RJ512E8^(NNR>&X\.4F@Y*-N[
ME.:.6AHMAX5I66.#S!)@]A-UYH@?/(SHGGMD#E(N6?_T+Y>KH%YLQZO_#8H=
MF7USF8_+XK/.L30B)4BJ]^,*BP717VL6@F$U%)4.%1)&"7[4_40LC9!N]M&B
MJ"I=4="CLP*WY!+=H!*7L\Q@IS1+PZGC8(8%3I7KC(GOXCS/5EETQ24:.')\
M[\%OQR=47]=V-%CMWO>DYRA2$M#KF-FH61R\)#XAW-J2Z'6>V(JV' CSH? H
MJ4J3I.XR5/:?DSUM_CIX5*SU]]P+;_"R^A/1C55]2ZO'-#37V.2%^I!->7!1
M1:0#'5W N-,UM[7@]$B;;#R6,M)Y88MH#95107$YK(N84VDR=A26)!#2 5VE
MDR46),1@?E"\!"\U;$%BA%E47,S1;@<$L9T\\&R 0T'::R,S@:G#7TK_&N?+
MWN;Y\;H!4&;JY]'H-"(,=_Z,_DVDZ5R7+6\Y:1;Q!SV_R>L1J)QA7$><'N/M
M&!:S*/4S[%\USM)JAJ\,ND#7=%L+,[ -VJ3^U8K<9:$RL#J]G[>6M07$<0,T
M;6&QTR*5B".K0(7+?Y>JZAO&,9R6Q13$\AU7'5^H+T\9Z3O+2+]+LTR:@0Y\
M2K<F_R@1[.'/Z*3_&64A/=8UZ-Y',JNZ_UEE.3U4)?4![B)LU^8[H7JP?%G4
M $%](;ND<8U\C%?DL&#F:Z8[]GNQJ FNA)[L#G\QIWTOYNN]Y_OXTB=@SRB*
M4"&+R/P1[)/+OJ?6:!\WM3QMFZ?VVZD.>?T-5H<\_#:8;=\V6) ]/GP-D_8]
MM:_W7KW!EWY?<.-S]G<;\TSG)QZHS2^&OP#_VI8%0 /S])%,ZN>^)]78ES^7
M157=ZLP<PK1F?4^KD56GAZ63'D7#BO:G2E) :!L([OO1.%'SOE?C^=[+5T9S
M/!:+.^][4HVI83W3!4+H$= R_,DMMF5R+PC7X#$/@5:HE^4C4-&+;9EB*<5\
M))+[[VV9UC.24TH(":\P&\9>6X-!3W39]T2_DD/MHHL*EB%46!XV_)FN^IYI
MST:^YI[4OD+F2NEV@M,KF,:I>P1YL+KOA3#Q4Z=;N$/$\*=VV??4MM5VFE]I
MJF1-%))[9\.?Y*O^)YD5R7L$5_V4%=?1CB/QFY9:,^QJBM\$;J+]N'H$:9CK
MOI=AWT3R<%:Y85"%V+5DE3R& OHO?<^OS5G"W!;S-)$C$J[1D^%/[VI;IO?(
M8KQ0B*<IS@?225M\F,6G/0)S^X^^9_WEWHN7-ORODII+>\BM&:OD<U9<#G^2
M5=\HLGT#=ST!G3S3BDK]N3)#(J7,^&>;F@UZNL=] \OVW^SMLU##K*9UQ-;&
M\"<VZ1M>9N7XO,8..Y=P!BZ0J7RBKW16+(@9F8B<YHN,4,;J<4CTI&\4FI7H
M<V[73OV)OH69UWTCU:S('\V)?I]F.L469^7G:8&\.C"C:&@_!G=]VCN4[&#O
M-;N2,!_%7!#_"7;(>@3&WF7?<#*K1H[U-0(XT.2@@$ANNGVE>5Y</1+=,>L;
MMF2G>U37*LU-XP!LI*M*9&@%A>TK<!B$!K'/;W)LOAUXWYLG>-]#8-!Z!Z&]
MV'O;.&.I3%U4%'6/&KX^^E?O4#.9YG=%\?EQU-M\[AMH9LW#4,6[$DH7[.8"
M/]3YMDV-%'4R]2)\,^BUR'I'IXEXCRQ)'<\O=XS#-MMJP>C6J:GY9+^I\EF@
MFU67@R_U?N+UWUCJ#?].B]YY":0:6)H0"N_<)K&,)LN2^&FH;&H%!F7E_[(H
M@^)B[@$\MA7=W/,$;TB%PT.7\1=/?/P;99SXN/H6<<M!\,VR;KQX8L#M$E,A
M$Z=V[=AA:0LD=14ELS2;Q/!TO9!_HMA.Y-\+Z22(7YM_T_?VBT6QK'2,:A:C
M6.;/*AUGU*<^3W4"?^=Z,=/7<30G>P5D\UFFX,^I"OZLBMS^>Z*6,&SORW$9
M_A;);9"JW7SB8S'4!,GZK@RLJ\BK6;JH;$M@PS(9>_T8"4":"D>(N< "\F;X
M6@@8"\C65%3K7#$AI;%U=V/\N(2=2-%3TU>A<DW@=^1$,@_9938+HD.CV[YZ
M_A]FI&.=:VRGB)V!I2H8[S\MEOF$R=]N_1#L EP6&9.LJ%Q=:MO@D2"=7$SL
MB(\Q5E:O;G__XCKO?@<A<S/C'WR+X1=/-,==VJWJD[ 3-F^6\3YB$B&52WL2
M8@!$ZY*Z>5=!K_ JVG^Q,]DEP=]_B?]ZA*S<+YY(D=OB"D96WX<O67L?]!?P
M=.+H*$_VJ/ET=$B(6/P %? 5M\A^3#U(7SSQ';?ET1 *;T/_/:_A'?O2"Y6R
M'RUTQRH!&47?ND%L&?NTL*UKU_?>PSN/S@8OUT]\R:UI.0-[#P2)6P]@2<M6
M<&/ZO-X;&+Q?;_#0F82OJI8-]YY8]529K;I%?? R_D1"?+.,8Z^-+1#QFV-0
MWSWF$-0327%K6LX/W_<ME^U>-.>N@QZZ8=;SH@0  0 '+XI/',1M472K#B[V
M5DLEC \UX_YW+U[<S@W[=E!+;[]!U%(O&N0IM=VA02@!W'?($15(5$DR6E5^
M#ZL8SK"\6F:UPD2);7@%_]?9DRMN,H<CDZ=TO(H]CG#\?#2=IEDJ_6*]W\1^
MLT&*?$Z7I72UG:>U]$51%=&/@F=?Z1H=>RZ*M[:?Z<_9I-UVI.I[T<CKU76=
MPD1@ Z\Q]UIE$G0*QB9:5?PG M[2B6TU9[HG)HI=I)UT%^82(=!9E&GX:1PA
M7 ^AHC!N>&OY$(8&GZ>[7J*"OB$W:UQIS +#N!%=YV,)<'+VHJ/PF7@+UW",
MF<_-3YLWC0WS."\[OBV65QMT LUU^S?Z2Z(7!+S9&>V:22^UA$1@>-X4FZ36
MSKO=D,%59JX#&N'ZJ'+'GCRZQD,KO]P#$8NF)7>J1 (:]G)E .RWVNE FBHZ
MXIISG4XWC+6*:0+HY6E*,+^48C/!*='/UW"7JG(M@K("K#J8, %_$%3)W,#\
MM)*(DEO;"F1V"9N#I-Y2ZJ];)+0@8XXTT<XQS6%L&H_)=[A:NY@W7CC:X:?#
M:"8I[Q0:Y76QS":<#H-7GZ5S' O%N4BJ:W&@Z+$D!_P4&QTCVP+SHT;V*Y$Z
M6\QRIK7[X QU#9D=NW$THT6NX#\\R;!ZEV!#Y&[JN/*KR9@OPBH:I0*;Q9+]
M5_)"M#]-TX*9FM"5WJ3950FV;V5>H:&LZEE9+"]GQ;+FU>:5R=WC,05#JL>]
MTC7\Q?<E*3)W3N>H"$"Y92L,0Q:E569TUSWT$617M?67<6?IU(Q#,7!S"*]&
M_6@]365Z;J,-Z-2YJ%=JS>T&3EJM\J=%,0C2_'*GU)>P +0#Y!9@ &&6V<"1
M@A;?( )^MP3_.W@E,!OA"TKY2D VS:_@E)Q((PBTK;A/5U:@^O1D"?>IT;3_
M DU5@8*EV\+C2MU:\=1?#P]A909E7Z9K;]E9<YTW4M*QG%\S7SO].1:9%-6&
M4@0?XS6L(V(/*(:S"5+O#H$*SK-,E>:2N<)\.-^(9P$1 3+T6XT6CA4>;>P4
M[JRX!N6()S/J 16):YJN4R^DK2II..(=D,0IXXP!.MDG5VE%XN1-1PTKB2]!
M9(*^%&R8]E#R0/OE)'4;$'4QOD **F:25J ^*"X9730:<)AL:H6-2]R%W2T^
MPETV@^&O/?<K'Z;A"[U_!SRG0+UU[=6Q[A#1ZUDJO4M:1P(+'QUSTZE E6DW
M%QZN(51[:X<^]$#$RR?T8-N-(,NH[P"$V&>A,;^FH[B(<\(?,E.8&+,5%\VB
M6N'XQ>";X[Y\0A*V198S:6 $ZR3E\X%LQKZ%^%8YA[>/..?P\@D8MD98WQ7Y
MLG<E>ROY?/.8Y?,)"=:63QM7ZU\\[[*K\UB#0.8W-79F0V)]7^=,574P*/$E
MFP]_:OM\;WOV"2W7FI8+]>79&6;30&2.:CWO\63QD@ F9)]EPE&//;JPID'0
M^]6RI!HEPN&GXR4)*U98K+ ;"5\,?S H'VZ7),628P6R*>&M2WGK%-\Z4F5:
M,;(>;YK+H47[O3L^L3"?^7N9(O[H563Z$MN-^G%>"?)Y]QK\?GI"Z;7W4TG%
MDJOH3%\NI5ZF[].P=$/!.,Q\F5TJKP5PF*VW+_!!HXA3AFKH<OJ$M&M-RR?#
M:+P=01N!CE)LF&*E&,5=:4YK:8K.PP5^1E9%A$]@;IR%P7R#'IZJJZ)LA'^H
MQ"J,ZN YH.MB]PE[\N/^=^NQ)_\U+B8K^,^LGF<__O]02P,$%     @ 08&I
M6JU3V?'Y.   9&L! !D   !E>&AI8FET,3 R+6%R,C Q-65S<' N:'1M[7UK
M<]M(LN7W_178[IV^9 2E$67YW;<C:$GNYKVVI)7DZ3N?-D "%#$& 38>DCF_
M?O-5+Z! R3.V2+H],3.61!"H*F1EY>/DR9_GU2+]Y>=Y'$:__*^?__?>7G"2
M3^M%G%7!M(C#*HZ"NDRRF^#W*"X_!GM[<M5QOEP5R<V\"@X/#I\&O^?%Q^0V
MY,^KI$KC7]1]?OXK__[S7^DA/T_R:/7+SU%R&R31?_Z0A(=/)T\.CR8O7Q[-
MCIZ^?/[BV>3PY?!Y^/SEBX/)\'#V_XY^@*_"Y?R=LEJE\7_^L$BRO7F,SW]U
M^&+_Q;)Z?9=$U?S5\.#@+S\X5U;QIVHO3).;[!6-%SZ=Y5D%XRC@OOPCW[[]
MD+"X@>=,\JK*%Z^&A_"4CKNI;TSS-"]>_7A _WF-G^S-PD62KE[]QZA(PO0_
M!F68E7ME7"0S_KA,_AG#J.'6].L=S^DY?#M-LEC-<7B(TSK]-$\F214,#_8/
MW:$_>-!3>"%Q\:BC/CG]G^/S]X-@?':\OSNC'KT_/3LY/0E&9R?!Y>G5]>CZ
M]&1W1G]X,'P:G+Z_>'?^]]/3X.KZ_/B_@XL/E\>_C:Y.@XMWH[/=F4IO%.5+
M5$.355#-X^!-'A91D&?!^["8SH/G U) _7]Q0O^HRRJ9K?A/21;!_%X]>;9\
MW'T]U/OBL9[Y>AE&$6CUO32>@09]OO_L.<X91.3B_.KT:X[FR+L"^\$UO-IE
M72SS,@[R&;SII PNTC +X-\J#Y9%?IM$<1##6TLF*?RP6*;Y*HY+OCJ& VFQ
M#+-5$&81_7X1%E4R399AA:?7<0ZW+N#G/"N#NZ2:!V&PB&'$^/5P^D>=%'@9
M/"^&GZM5D*"@QV4%/SBWK^9%7M_,@V6X*O(T#:(XJJ=TVP&.,\[F83:-@[(&
MV=1C_.G'%X?#YZ^#,LYX>DLS.)!D>40XFX5)T9S0?G <+I,*Q/6?L E@4(LR
MR/(*'CR#98Q@1<KX;@YC5;=!40Y"^%U= 7^_BFF, 9R5N[Q1#K=EH^"!\.;=
M^.HW."6N@_.WCDY][&VC1!/V"&X?VB\W10B#(!.%]T\-RC($X2OG(!HD8_"U
M!8C$595//Y+H/FAK)7"_-5L+GE/6^&BXH=[#[C!Q9V51:6UQN/:/&L1L!H\H
M<0_B?CD\>*T& HN)8]1S6,*7Z)+AZZ &42RT?!\=/C&#!G712[)I6D>\M>'N
M8(]&:)/2FN1%4,1PKVG,?X(OTK:5F_4'HDO4,&'I8,-/8#AY,(7)5D4=1_O!
M"+4";$O:E?&G)2QOF:[LW6=N,:G-QIW!\T7CT;.[YL"/G8>W,?VMA$GP/1*Z
M'+=^ DL\S@(45?S;@#5<$=_@48DSG<UB5BQPE-)[>H!(\,J2*I679 3C#LU]
M6%2<0QA<U9,RB9*P6.&:PK6CV2Q)$W >@KRN2M3;>)L/,&*8]U4%'Z"V-(=Y
M04].J@K>=0]$0"T1SZT?+,*52/2:\7<,_BS/]G!)4?SR#/V::AZR@L07QM(8
MTS(MXK@RZVZ_CP)/A8+E9* .HV@0)+,@BZ?PPG'N_,SF=P?\/+QM#O]7B I'
MT0(AXA>F=QJM- YM$5<[HJG]F@E$XA^P!KBJ:BV&1["AX ]PE.%T>TD_>#:
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M6G%0-#BH)7ZU$M<^#>\&][Q3<IIB>)UG>86ZKZS"3)MV1CSE2?"VJ@+?H6V
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MJWA9$3H*?E=*$ /+]*%XK.!98IZ"X6WP_5%] ^\E>#(L&:#Y-IX4-;I^AR_
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M1.[=*S:#! ),>#LJ"(F7G<>"!"ID+ HIR(A(Z:<^_:63X0*-G%:)D0_3-#S
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MFVL86G.0GRFB?LE:0P+G>R4SA2#RY1Y54%%=\Z<J&]H:S&1;_MI.<1LU8MD
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M_R0'H]:]"/"".),U:\Q<MD5XM]N'X)-M.00O3Z\_7-+YUVJ$L8EF%VL,4JW
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M_Q]02P$"% ,4    " !!@:E:F874C'48  #M[   $0              @ $
M    9'AC;2TR,#(U,#4P."YH=&U02P$"% ,4    " !!@:E:J7\_"&$"
M!P  $0              @ &D&   9'AC;2TR,#(U,#4P."YX<V102P$"% ,4
M    " !!@:E:A_;7]M,> 0"$L0$ %               @ $T&P  9'AC;2TR
M,#(U,#4P.%]G,2YJ<&=02P$"% ,4    " !!@:E: $K=B1\*  !]50  %0
M            @ $Y.@$ 9'AC;2TR,#(U,#4P.%]L86(N>&UL4$L! A0#%
M  @ 08&I6M!^!/G,!@  G#$  !4              ( !BT0! &1X8VTM,C R
M-3 U,#A?<')E+GAM;%!+ 0(4 Q0    ( $&!J5I+L=1^]%H  (*M @ 8
M          "  8I+ 0!E>&AI8FET,3 Q+6%R,C Q-65I<"YH=&U02P$"% ,4
M    " !!@:E:K5/9\?DX  !D:P$ &0              @ &TI@$ 97AH:6)I
I=#$P,BUA<C(P,35E<W!P+FAT;5!+!08     !P ' -,!  #DWP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>dxcm-20250508_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dxcm-20250508.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2025-05-08</startDate>
            <endDate>2025-05-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001093557</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">DEXCOM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-51222</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">33-0857544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6340 Sequence Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">200-0200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">DXCM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
